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REGULATION OF CONNEXIN40 GAP JUNCTIONS 
 
by 
 
 
THOMAS V. SHEELA 
 
 
Under the Direction of Charles F. Louis 
 
 
ABSTRACT 
 
 
Gap junctions provide direct electrical and biochemical communication between 
cardiomyocytes in the heart.  Connexin40 (Cx40) is the major connexin in the atria of the 
heart and little is known regarding its regulation.  Thus, the goal was to investigate the 
regulation of Cx40 in both physiological and pathophysiological conditions.  The first 
objective of this thesis was to determine whether Cx40 gap junctions were regulated by 
β-adrenergic receptor activation.  Cx40 has previously been shown to be acutely activated 
by cAMP, this cAMP-induced increase in Cx40-mediated cell-to-cell dye transfer has 
been shown to be effected through the β-adrenergic receptor-adenylyl cyclase- Protein 
Kinase A (PKA) pathway in Cx40-transfected HeLa cells.  The second objective of this 
thesis was to determine whether Cx40 gap junctions were regulated by intracellular Ca2+ 
concentration ([Ca2+]i ).  [Ca2+]i  was increased  by addition of the ionophore ionomycin 
and elevating extracellular calcium [Ca2+]o from 1.8 mM to 21.8 mM.  This resulted in an 
elevation of [Ca2+]i  and effected an inhibition of Cx40-mediated cell-to-cell dye transfer 
(IC50 of 500 ± 0.72 nM) which was Calmodulin-dependent.  The third objective of this 
thesis was to determine whether Cx40 gap junctions were regulated by ischemia.  
Inducing ischemia chemically by inhibiting the electron transport chain with sodium 
  
cyanide and glycolysis with iodoacetate and 2-deoxyglucose effected an inhibition of 
Cx40-mediated cell-to-cell dye transfer that was shown to be Calmodulin dependent.  
The main conclusions of this thesis were:  (1) β-adrenergic receptor activation increases 
Cx40-mediated cell-to-cell dye transfer which requires the activation of PKA; (2) A 
sustained elevation in [Ca2+]i causes a partial inhibition of Cx40 gap junction-mediated 
cell-to-cell dye transfer which was Ca2+-and Calmodulin dependent; (3) Chemical 
ischemia causes a  partial inhibition of Cx40 gap junction-mediated cell-to-cell dye 
transfer which was shown to be Calmodulin-dependent. 
 
Index words: Connexin40, Atria, β-adrenergic receptor, Intracellular calcium, Chemical 
ischemia. 
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Cell-cell junctions 
In the process of building a multicellular organism, cells are organized to form 
tissues that adhere to each other by specialized structures or junctions which are critical 
for the development and function of these tissues.  Through development, and also as 
tissues are maintained in a mature organism, cells express informational and junctional 
molecules on their surface, so that cells recognize and adhere to like cells. In mammalian 
cells these cell-to-cell junctions are classified into three types of junctions: tight 
junctions, adherens junctions and gap junctions. 
Tight junctions 
Epithelial and endothelial cells have junctional complexes on their apical domains 
that form seals between adjacent cells called tight junctions.  These are important in 
tissues such as the bladder, intestines and glands where they form a barrier separating two 
fluid compartments and allowing controlled transport of ions and solutes between these 
compartments through the paracellular pathway.  Freeze fracture studies show that tight 
junctions form a network of parallel strands between the lateral faces of two opposing 
cells called zonula occludens (Staehelin, 1973). 
Tight junctions are composed of membrane proteins that include claudins, 
occludins, zonula occludens-1 (ZO-1), ZO-2 and ZO-3.  The extracellular loops of 
claudins and occludins bind to claudins and occludins from the neighboring cells 
(Fig.1.1A).  The carboxyl termini of these membrane proteins directly interact with 
zonula occludens (ZO-1 and ZO-2) found in the cytoplasm (Furuse et al., 1993; 
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Gumbiner, 1987).  Occludins are integral membrane proteins with a molecular mass of 65 
kDa (Furuse et al., 1993).  They contain four transmembrane domains with two 
extracellular loops and one intracellular loop, with the amino and carboxy termini in the 
cytoplasm.  Like occludins, claudins are integral membrane proteins with four 
transmembrane domains, two extracellular loops, one intracellular loop, and their N- and 
C-termini in the cytoplasm (Furuse et al., 1998).  There are 24 members in the claudin 
family with molecular masses ranging from 20 – 27 kDa (Gonzalez-Mariscal et al., 
2003).  Zonula occludens are peripheral membrane proteins in the vicinity of tight 
junctions in the plasma membrane.  They bind to the C-termini of occludins and claudins 
forming an interface between these proteins and the F-actin filaments (Anderson and 
Itallie, 1995).  There are three types of zonula occluding proteins ZO-1, ZO-2 and ZO-3 
with molecular masses of 200, 160 and 100 kDa respectively.   
Adherens junctions 
Adherens junctions are protein complexes found at cell-cell junctions of epithelial 
cells; their main function is to anchor cells by connecting the actin cytoskeleton of 
neighboring cells through direct interaction; they are also responsible for contact 
inhibition of cell growth and cell signaling.  They can appear as bands encircling the 
apical pole of epithelial cells called zonula adherens or as spots of attachment to the 
extracellular matrix called adhesion plaques.   
Adherens junctions are composed of three major proteins, cadherins, α-catenin 
and β-catenin (Fig.1.1B).  Cadherins are integral membrane glycoproteins that mediate 
intercellular adhesion in a calcium-dependent manner (Takeichi, 1990). They are 
composed of a long extracellular region (composed of five domains) where the calcium-
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binding sites are located, a single transmembrane domain, and a relatively short 
cytoplasmic C-terminal tail (two domains) (Fig.1.1B).  Cadherins are classified as type I 
and type II; Type I includes N- (Neural), E- (Epithelial), P-(placental) and R (Retinal)-
cadherins to name a few depending on the tissue they are expressed in; type II comprises 
cadherin-5 through -12.  Cadherins are anchored to the microfilament network of the 
cytoskeleton via a complex composed of multiple intracellular proteins including α- and 
β-catenin. β-catenin binds directly to the carboxy-terminal cytoplasmic domain of E-
cadherin  (Nagafuchi and Takeichi, 1988; Nagafuchi and Takeichi, 1989; Ozawa et al., 
1990).    
Gap junctions 
In tissues, cells are connected to each other by means of intercellular channels 
called gap junctions.  Gap junctions connect the cytoplasms of neighboring cells allowing 
the passage of ions (electrical coupling) and small molecules (biochemical coupling) 
between them.  Gap junction proteins are classified into three classes: innexins, 
pannexins and connexins.   
Innexins 
In invertebrates, cell-to-cell communication occurs via gap junction proteins 
called innexins (Phelan et al., 1998a).  Innexins associate to form hexameric subunits 
forming a hemichannel in the plasma membrane with hemichannels from adjacent cells 
docking to form intercellular channels.  Each innexin subunit is comprised of four 
transmembrane domains with two extracellular loops, one intracellular loop, with the 
carboxy and amino termini in the cytoplasm (Fig.1.2A).  25 C.elegans and 8 Drosophila 
innexins have been identified to date.  Innexin gap junctions mediate both electrical and 
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biochemical coupling.  The first innexin to be expressed in Xenopus oocytes was the 
Shak-B from Drosophila (Phelan et al., 1998b) and Inx-3 from C.elegans (Landesman et 
al., 1999).  Innexins are known to form homotypic junctions (both hemichannels 
composed of a single type of innexin), heterotypic junctions (each hemichannel is 
composed of a unique but different innexin) (Jacobs et al., 2000) and heteromeric 
junctions (both hemichannels are composed of mixtures of different innexins) (Stebbings 
et al., 2000).  Innexins have been shown to form functional intercellular channels that are 
voltage (Landesman et al., 1999; Phelan et al., 1998b) and pH sensitive (Landesman et 
al., 1999).   
Pannexins 
Recently, the human genome database was searched for orthologs of the innexin 
gene family yielding three members of a new family of vertebrate gap junction proteins 
termed pannexins.  These proteins appear to be highly conserved in worms, mollusks, 
insects and mammals (Panchin et al., 2000), and their sequences show significant 
homology to the innexins.  Like the innexins, pannexins contain four transmembrane 
domains, two extracellular loops, and one intracellular loop with both the N- and C-
termini in the cytoplasm (Fig.1.2B).  This suggests that in vertebrates, gap junction 
proteins are classified into two families, the well studied connexins and much less studied 
pannexins.  In mammals, three pannexin genes have been cloned called Panx1, Panx2 and 
Panx3 (Baranova et al., 2004).  Panx1 and Panx2 mRNAs were found in human adult 
brain and other tissues, whereas Panx3 has been found in osteoblasts and synovial 
fibroblasts only (Bruzzone et al., 2003).  When transfected into Xenopus oocytes, Panx1 
but not either Panx2 or Panx3 form functional hemichannels; Panx1 and Panx2 form both 
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homomeric and heteromeric gap junctions (Bruzzone et al., 2003).   Panx1 protein has a 
molecular mass of ~ 48 kDa.  Panx1 hemichannels have been shown to mediate the 
release of ATP from erythrocytes during low oxygen conditions (Locovei et al., 2006).  
The function of Panx 2 and 3 are not yet understood. 
Connexins  
Structure: 
In mammals, gap junctions are composed of protein subunits called connexins 
which form intercellular channels (Fig.1.1C).  Connexin gap junctions are composed of 
two hemichannels termed a connexon (Musil & Goodenough, 1993; Laird, 1996), with 
each connexon hemichannel comprised of six connexin subunits forming a channel with a 
central pore (Musil & Goodenough, 1993; Laird, 1996) (Fig.1.1C). Gap junctions formed 
from two hemichannels each containing the same connexin protein are called homotypic 
gap junctions, while those composed of hemichannels containing different connexins are 
called heterotypic gap junctions.  When both hemichannels in a gap junction are 
composed of a single type of connexin it is called a homomeric gap junction, when 
composed of different connexins it is called a heteromeric gap junction.  Each connexin 
consists of four transmembrane domains with their amino (N-) and carboxy (C-) termini 
in the cytoplasm (Fig.1.2C).  In most connexins the amino acid sequences in the two 
extracellular loops are highly conserved while the sequences of the intracellular loops 
vary. The major difference between the different connexins lies in the length and amino 
acid sequence of their carboxy termini. Although innexins and pannexins do not have 
sequence similarity to the vertebrate gap junction connexin proteins, they share the same 
topology (Fig.1.2).  Using atomic force microscopy and freeze fracture studies, Hoh et al 
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(Hoh et al., 1993) and others (Lal et al., 1995; Revel and Karnovsky, 1967) have shown 
that the center-to-center distance of a gap junction is ~ 9-10 nm, the central pore diameter 
is 2 nm, a depth of 1 nm and width of 3.8 nm (Hoh et al., 1993; Lal et al., 1995; Revel 
and Karnovsky, 1967).  Twenty highly related human connexin genes have been 
identified (Willecke et al., 2002) with their nomenclature based on their expected 
molecular weight in kilodaltons, so that the major connexin (Cx), a protein of 43 kDa, is 
referred to as Cx43.  A problem with this system is that homologous proteins in different 
species may have different molecular weights or different connexin proteins in different 
species may have identical molecular weights. An alternative nomenclature to eliminate 
this problem was developed based on connexin sequence homology (Kumar and Gilula, 
1992) in which connexins are divided into 3 classes α, β and γ, with different members of 
each class being given different number eg., α1 for rodent Cx43 and β1 for rodent Cx32 
etc. 
Formation:  
Gap junctions are formed when six connexin subunits oligomerize to form a 
connexon, with a connexon from one cell pairing with a connexon of the neighboring cell 
to form a gap junction channel.  Large numbers of these gap junctions aggregate in the 
plasma membrane to form gap junctional plaques.  Like other membrane proteins, 
connexins are also synthesized on the endoplasmic reticulum (ER).  The intracellular 
transport of connexins occurs via the secretory pathway, where they are co-translationally 
integrated into the ER membrane, transported by successive vesicle budding and fusion 
of the ER membrane, through the Golgi stacks to the plasma membrane.  Gap junction or 
plaque formation is prevented when cells are treated with various inhibitors of the 
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secretory pathway, suggesting that gap junction formation occurrs via this pathway (Laird 
et al., 1995).  Studies in which connexins were synthesized using translation competent 
cell lysates supplemented with pancreatic ER-derived microsomes have demonstrated 
that connexins are co-translationally integrated into the ER membrane in a signal-
recognition particle-dependent manner (Falk et al., 1994; Zhang et al., 1996). The 
organization of the connexin topology also occurs in the ER (Falk and Gilula, 1998). A 
combination of protease protection assays and antibody binding studies on isolated liver 
and heart gap junction membranes established that Cx32 and Cx43 pass through the 
membrane four times forming two extracellular loops and a cytoplasmic loop with both 
the amino and carboxy termini exposed to the cytoplasm (Milks et al., 1988). 
Following their synthesis, connexins oligomerize to form connexons, with the 
location of connexin oligomerization known to be connexin-type specific (Diez et al., 
1999; Sarma et al., 2001).  Cx32 oligomerization is known to occur in the ER or the 
ER/golgi intermediate compartment, Cx43 oligomerization occurs in the trans-golgi 
network (Martin et al., 2001; Musil and Goodenough, 1993), and Cx26 oligomerization 
occurs in the plasma membrane (integrated directly into the plasma membranes in a 
posttranslational manner) (Evans, 2002). In heteromeric connexons (connexons 
comprised of two different connexins) an oligomeric intermediate is observed, for 
instance in Cx26/Cx32 heteromeric connexons where oligomerization is observed in a 
Golgi membrane fraction (Diez et al., 1999).  
After oligomerization of the connexons they are transported to the plasma 
membrane via the vesicular transport mechanism.  Connexons can be inserted into the 
plasma membrane either directly into the plaque region (Guerrier et al., 1995), or 
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randomly in the membrane and then translocated laterally into the plaque region (Johnson 
et al., 1974) where they dock with a connexon from the neighboring cell to form a gap 
junction.   
Metabolism:  
Connexins are short lived as their half-lives are known to be in the range of ~ 1 - 
5 hrs (Fallon and Goodenough, 1981).  Pulse chase studies have demonstrated that Cx43 
has a half-life of ~ 1-2 hr (Beardslee et al., 1998; Laird DW, 1991).  Gap junction 
internalization occurs via structures called “annular gap junctions” (Jordan et al., 2001), 
double membrane vesicles containing entire gap junctions. Degradation of annular gap 
junctions is known to occur either in lysosomes or proteosomes.  Indeed Rahman, Carlile 
et al. (1993) have demonstrated the presence of Cx32 in lysosomes at levels comparable 
to the Golgi apparatus in rat liver (Rahman et al., 1993).  It has be demonstrated that 
inhibiting lysosomal enzymes results in the intracellular accumulation of Cx43 in BICR-
M1Rk cells, suggesting that like Cx32, Cx43 gap junctions are also degraded in 
lysosomes.  Other studies have demonstrated that specific inhibitors of proteosomal 
enzymes prolonged the half-life of Cx43 in BWEM cells (Laing and Beyer, 1995), 
suggesting that Cx43 gap junctions can be degraded in either lysosomes or proteosomes.  
The preference for one degradative pathway over the other may be cell type dependent 
and that within the same cell type the degradative pathway chosen might depend on the 
metabolic state of the cell. 
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Function: 
Gap junctions are regulated by various factors that include transjunctional 
voltage, intracellular pH, phosphorylation, intracellular Ca2+, and more recently it has 
been recognized that associated proteins may also play this role.  
Transjunctional voltage:  Gap junctions are known to be regulated by 
transjunctional voltage and most gap junctions close when large voltages (~ 60-80 mV) 
are applied.  Different connexins exhibit voltage gating to different degrees, for example 
Cx43, the major connexin ubiquitously expressed in mammals, has a half-maximal 
inactivation of ± 60 mV (Moreno et al., 1994); Cx40 which is expressed in the atria, 
conduction system and endothelium of the heart has a half maximal inactivation of ± 50 
mV (Beblo et al., 1995); Cx45 which is expressed in the cardiac conduction system has a 
half-maximal inactivation of ± 20 mV (Moreno et al., 1995). 
Intracellular pH: Gap junctions are regulated by intracellular pH and in general 
gap junctions close in response to intracellular acidosis.  Different connexins have 
variable degrees of sensitivity to intracellular acidification, for instance the pKa for Cx43 
is 6.71±0.03 (Stergiopoulos et al., 1999), while the pKa for Cx50 is 7.17 ± 0.03 (more 
basic than the pKa for Cx32) (Stergiopoulos et al., 1999).  It is believed that for Cx43 the 
regulatory region for pH gating is within the intracellular loop and carboxy-terminus 
domains of the connexin described as “particle-receptor” or “ball and chain” model 
(Homma et al., 1998). 
Phosphorylation: Connexins are phospho-proteins (except Cx26) whose 
phosphorylation is catalyzed by various protein kinases.  The C-termini and the 
intracellular loop of most connexins contain consensus phosphorylation sites for various 
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protein kinases; phosphorylation of connexins is important for gap junction assembly, 
trafficking, channel function, and turnover (Herve and Sarrouilhe, 2002).  Connexins are 
differentially regulated by phosphorylation.  For example phosphorylation of Cx32 (Saez 
et al., 1990) or Cx40 (Van-Rijen et al., 2000) by c-AMP analog, 8-bromo cAMP resulted 
in an increase in gap junction permeability, whereas phosphorylation of Cx43 by PKC 
resulted in a decrease in gap junction permeability (Lampe et al., 2000).  Lin, Warn-
Cramer et al. (2001) have provided evidence for the interaction of Cx43 with the SH2 and 
SH3 domains of v-src, which is associated with the phosphorylation of Cx43 at Y247 and 
Y265 residues in the carboxyl terminal domain (Lin et al., 2001).  This interaction of 
Cx43 with v-src is known to disrupt gap junctional communication. 
Intracellular Ca2+: Gap junctions are sensitive to Ca2+ and are known to close at 
elevated intracellular [Ca2+] (~ micromolar concentrations) levels.  Ca2+ does not appear 
to directly bind to connexins but this Ca2+ effect on gap junction gating is mediated by 
the Ca2+-binding protein Calmodulin (CaM) (Peracchia, 2004).  It has been postulated 
that CaM serves as a mediator for this Ca2+- mediated effect on Cx32 (Hertzberg and 
Eldik, 1987) and Cx43.  Evidence for the direct interaction of CaM with connexins was 
provided by immunofluorescence studies, where CaM co-localized with Cx32 in HeLa 
cells stably transfected with Cx32 (Peracchia et al., 2000) and with Cx37 and Cx43 in 
transfected HeLa cells (Sotkis et al., 2001). 
Associated proteins: A number of proteins are known to interact with connexins 
to form protein complexes (Duffy et al., 2002).  Such protein-protein interactions can 
regulate several connexin functions including connexin assembly, trafficking, turnover, 
and channel gating.  Connexins are known to interact with various proteins including the 
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tight junction proteins ZO-1(Toyofuku et al., 1998), cytoskeletal proteins such as the α 
and β-tubulins (Giepmans et al., 2001), as well as the adherens junction proteins 
cadherin, β-catenin (Ai et al., 2000),  and the occludins (Kojima et al., 2001).  The C-
terminus of Cx43 is known to interact with the second PDZ domain of ZO-1.  This 
interaction is speculated to have a potential role in the trafficking of Cx43 to the 
intercalated discs of the heart, thus facilitating the formation of Cx43 gap junctions 
(Toyofuku et al., 1998). GST binding assays and immunolocalization studies have shown 
that Cx43 binds to α and β-tubulin, indicating that the connexins interact with the 
cytoskeletal proteins α and β-tubulin (Giepmans et al., 2001).  Co-immunoprecipitation 
and immunofluorescence studies have provided evidence for the direct association of 
Cx32 with the occludins and claudin-1 in cultured hepatocytes, indicating that connexins 
directly associate with tight junction proteins (Kojima et al., 2001).    Finally, there is 
evidence that connexins interact with signaling proteins such as src (Lin et al., 2001).   
 
Gap junctions in diseases  
Gap junction-mediated communication is important for various cellular functions 
such as regulation of cell growth, differentiation, and development.  Gap junctions effect 
multiple cellular functions including the intercellular movement of ions, metabolites, 
transmitting signals such as second messengers between cells to regulate cell growth and 
development, the flow of current between cells to maintain electrical communication, 
maintenance of a constant internal environment (cellular homeostasis), and transport of 
metabolites and products in tissues.  Alteration in gap junction number, distribution, 
function, and mutations in connexin genes are known to result in various diseases in 
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humans.  Several studies have demonstrated the role of connexin mutations in a wide 
spectrum of human diseases, such as in demyelinating neuropathies/peripheral 
neuropathy, various skin disorders, cataracts, deafness, oculodentodigital dysplasia 
(ODDD) and cardiac diseases to name a few (Chang et al., 2003; Wei et al., 2004). 
Peripheral neuropathies:  
Cx32 is expressed in both the peripheral nervous system (located in the paranodal 
loops and Schmidt-Lantermann incisures in myelinating Schwann cells) and central 
nervous system (oligodendrocytes and its processes) (Scherer et al., 1995).  Mutation in 
the Cx32 protein is associated with an X-linked form of Charcot-Marie-Tooth (CMTX) 
disease (Bergoffen et al., 1993).  CMTX is a demyelinating syndrome associated with 
progressive degeneration of peripheral nerves brought on by a defect in Schwann cells.  
Over 200 unique Cx32 mutations have been identified in CMTX patients (Nelis et al., 
1999). 
Skin disorders:  
Cx26, Cx30, Cx31 and Cx43 are the major connexins expressed in the epidermis 
and hair follicles where their main function is to regulate keratinocyte growth and 
differentiation (Choudhry et al., 1997).  Cx26 mutations are associated with skin 
disorders such as palmoplantar keratoderma, which is a group of disorders characterized 
by thickening of the palms and the soles of individuals (Heathcote et al., 2000), and 
Vohwinkel sydrome an autosomal-dominant condition with mutilating keratoderma 
accompanied by deafness (Maestrini et al., 1999).  Cx30.3 and Cx31 mutations are 
associated with erythorokeratoderma variabilis (EKV), autosomal dominant 
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genodermatosis characterized by persistent plaque-like or generalized hyperkeratosis and 
transient red patches of variable size, shape, and location (Richard et al., 2003). 
Cataracts:  
Cx43, Cx46 and Cx50 are expressed in human eye lens.  Cx43 is expressed in the 
lens epithelium, while the fiber cells express Cx46 and Cx50.  The main function of these 
lens connexins is to maintain homeostatis (movement of fluid, ions, nutrients and 
metabolites) and lens growth (White, 2002).  Point mutations in Cx46 and Cx50 genes 
are known to cause zonular pulverulent (dust-like appearance) cataracts (Mackay et al., 
1997; Shiels et al., 1998).  Cx50 knockout mice developed microphthalmia (small eyes), 
suggesting that Cx50 is responsible for lens growth and development (Rong et al., 2002), 
while Cx46 knockout mice developed severe cataracts suggesting that Cx46 is 
responsible for the coupling of central fibers to the peripheral cells, and this coupling is 
essential for fiber cell homeostasis and maintaining lens clarity (Gong et al., 1998). 
Deafness:  
Mutations in at least 4 connexin genes are known to be associated with deafness 
namely, Cx26, Cx30, Cx30.3, and Cx31 (Kelsell et al., 2001).  Cx26 mutations are 
known to result in autosomal-recessive (DFNB1) and dominant (DFNA3) forms of 
genetic hearing impairment (White, 2000).  Knockout mouse studies have also revealed 
the role of Cx26 and Cx30 in hearing.  Cx26 is responsible for cochlear function and cell 
survival in the sensory epithelium of the inner ear (Cohen-Salmon et al., 2002), while 
Cx30 is responsible for generating endocochlear potential and mediating survival of the 
auditory hair cells after the onset of hearing (Teubner et al., 2003). 
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Cardiac gap junctions  
Cardiac Morphology and function 
The heart is a muscular organ in vertebrates, responsible for pumping blood 
through the blood vessels to and from various tissues providing metabolic substrates and 
removing metabolic products from tissues in the body by repeated rhythmic contractions.  
The heart consists of 4 cavities/chambers; the upper 2 cavities comprise the right and left 
atria and the lower 2 cavities the right and left ventricles, each cavity has a valve to 
prevent backflow of blood.  The atria and ventricles are enclosed by 4 layers, the 
pericardium, which is the outermost layer, the epicardium, myocardium and 
endocardium.  The myocardium forms the bulk of the mass of the heart wall and is 
composed of muscular tissue. Energy, nutrients and oxygenated blood are provided to the 
working myocardium by blood vessels called coronary arteries.  The myocardium is 
capable of organized contraction and relaxation propelling blood throughout the body, 
delivering metabolic substrates to and transferring metabolic products from each organ.  
Contraction occurs when the myocardium is excited by electrical impulses that are 
carried through the conduction system.  These impulses control heart rate and rhythm.  
The electrical impulse originates in the sinus node (SA), which is located at the upper 
portion of the right atrium then travels to the atrioventricular node which is located near 
the junction of the four chambers of the heart. Impulses from the atrioventricular node are 
distributed to the ventricular myocardium via the right bundle branch and the left bundle 
branch. 
The myocardium is composed of rod-shaped or fiber-like muscle cells called 
cardiomyocytes.  These cells are striated and contain dense bands called intercalated 
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discs that separate individual cells from one another at their ends. Intercalated discs 
contain specialized intercellular channels between cardiac muscle cells composed of gap 
junctions. Gap junctions allow the cell-to-cell flow of electrical current (electrical 
communication) and the movement of small molecules (intercellular communication) 
between cardiomyocytes.  Propagation of electrical impulses between adjacent 
cardiomyocytes is accomplished via gap junctions.  Any alteration in gap junction 
function affects electrical conduction, thereby affecting heart rate and rhythm indicating 
the critical role of gap junctions in cardiac function. 
Connexin expression and function in the heart 
Cell-to-cell action potential propagation in the heart is mediated through gap 
junction channels that are located in regions called “intercalated discs” found at lateral 
cell-to-cell borders in cardiomyocytes.  The 3 major connexins in the heart are Cx40, 
Cx43 and Cx45, with Cx43 expressed at much higher levels in the heart compared to the 
other connexins (Van-Kempen et al., 1996).  Cx40 is most abundant in the atria (upper 
chambers of the heart) and atrioventricular conduction system (conducting link between 
the atria and ventricles) (Delorme et al., 1995; Van-Kempen et al., 1996) whereas Cx45 is 
restricted to the atrioventricular conduction system.   
Connexin40: Cx40 is the major atrial connexin together with Cx43, it is also 
expressed in the ventricular conduction system along with Cx45 (Beyer et al., 1992) and 
in lower levels in the sinoatrial node (SAN) and atrioventricular nodes (AVN) (Kwong et 
al., 1998).  During neonatal development Cx40 expression can be observed in the 
ventricles but its expression levels declines in adult developmental stages (Kwak et al., 
1999).  Cx40 has been shown to be regulated by voltage (Bruzzone R, 1993; Beblo DA, 
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1995), intracellular pH (Peracchia et al., 2004) (Stergiopoulos et al., 1999) and cAMP-
dependent protein kinase (Van-Rijen et al., 2000).  Thus, in HeLa cells transfected with 
human Cx40, a single open channel conductance of 120 pS, and 2 substates of 30 and 80 
pS were observed (Van Rijen HVM, 2000).  Furthermore, in oocytes transfected with 
mouse Cx40, CO2-induced cytosolic acidification decreased the voltage gating sensitivity 
of these junctions (Peracchia et al., 2004), indicating Cx40 is also regulated by 
intracellular pH.  Cx40 gap junctions are somewhat cation selective and Cx40-transfected 
N2A cells are only slightly permeable to 2',7'-dichlorofluorescein  and also to the more 
polar 6-carboxyfluorescein dye (Beblo et al., 1995).  Cx40 is a phospho-protein and 
contains potential consensus phosphorylation sites for protein kinases including casein 
kinase II, PKA and PKC. The effect of these protein kinases on Cx40 gap junction 
conductance or permeability is still unknown and therefore a focus of this study.   
Connexin43: Cx43 is the major connexin expressed throughout the heart 
including the atria, ventricles and conduction system, except in the sinoatrial and 
atrioventricular nodes (Davis et al., 1995).  The human Cx43 protein sequence consists of 
382 amino acids.  Cx43 gap junctions are known to be regulated by transjunctional 
voltage, intracellular pH, intracellular Ca2+ and protein kinase catalyzed phosphorylation. 
In Cx43-transfected SKHep1 cells, Cx43 channels are regulated by transjunctional 
voltage with a half-maximal inactivation at ± 60 mV (Moreno et al., 1994).  These 
channels have also been shown to be pH sensitive; gap junctional conductance was 
decreased by 60 % when intracellular pH was decreased from 7.0 to 6.3 (Hermans et al., 
1995).  Cx43 gap junctions exhibit minimal ion selectivity and allow the cell-to-cell 
transfer of Lucifer Yellow dye in Cx43-transfected HeLa cells (Elfgang et al., 1995). 
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Cx43 is a phospho-protein and its amino acid sequence contains putative phosphorylation 
consensus sequences for PKC, PKA, PKG and MAP kinases in its carboxy-terminus 
(Kemp and Pearson, 1990).  Direct activation of PKC with the phorbol ester TPA is 
known to catalyze the phosphorylation of Cx43 on S368, S372 (Shah et al., 2002), and 
S262 residues (Doble et al., 2004; Lampe et al., 2000).  Activation of PKC with TPA or 
PKG with 8-bromo cGMP decreased both electrical (gap junctional conductance) and 
biochemical communication (cell-to-cell dye transfer) in Cx43-transfected SKHep1 cells 
(Kwak et al., 1995).  Activation of PKA with 8-bromo cAMP did not affect Cx43-
mediated gap junction conductance or dye permeability in these cells (Kwak et al., 1995).  
Activation of MAP kinase by epidermal growth factor in rat liver epithelial cells 
decreased Cx43-mediated gap junctional conductance that was associated with the 
phosphorylation of Cx43 at residues Ser255, 279 and 282 (Lau et al., 1992), indicating 
Cx43 gap junctions are regulated by MAP kinase, PKC and PKG but not PKA.   
Connexin45: Cx45 is expressed mainly in the ventricular conduction system 
(Coppen et al., 1998), in the sinoatrial (Coppen et al., 1999), and atrioventricular nodes; it 
is also expressed at very low levels in the atria and ventricles.  Cx45 gap junctions are 
known to be regulated by transjunctional voltage, intracellular pH, and phosphorylation 
catalyzed by various protein kinases (PKA and PKC).  Cx45 gap junctions are highly 
sensitive to transjunctional voltage with half maximal activation at ±20 mV (Moreno et 
al., 1995) and unitary conductances of approximately 20 and 40 pS (van-Veen et al., 
2000).  Like Cx40, Cx45 gap junctions are cation selective and allow the cell-to-cell 
transfer of 2',7'-dichlorofluorescein but not the more polar dye 6-carboxyfluorescein 
between Cx45-transfected N2A cells (Veenstra et al., 1994).  SKHep1 cells endogenously 
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express Cx45 and gap junctional conductance mediated by Cx45 channels in these cells 
was completely inhibited when intracellular pH was decreased from 7.0 to 6.3, indicating 
that Cx45 gap junctions like Cx40 and Cx43 are also highly sensitive to intracellular pH 
(Hermans et al., 1995).  Cx45 is a phospho-protein that contains putative phosphorylation 
consensus sequences for PKA and PKC (Kemp and Pearson, 1990; Kennely and Krebs, 
1991). The conductance of Cx45 gap junctions in SKHep1 cells increased upon 
activation of PKC with TPA and elicited a third conductance state of 16 pS.  Although 
Cx45 electrical communication was increased  by PKC activation, it did not affect Cx45-
mediated biochemical communication (dye permeability) (Kwak et al., 1995).  In 
contrast, activation of PKA with 8-bromo cAMP resulted in a decrease in Cx45-mediated 
gap junctional conductance (van-Veen et al., 2000) suggesting that Cx45 gap junctions 
are regulated by both PKA and PKC.   
 
Gap junction mutations in Cardiac diseases  
Gap junctions are responsible for electrical and intercellular communication in the 
heart.  Studies using connexin knockout mice have revealed the function of the individual 
cardiac connexins.  Thus, Cx43 knockout mice die shortly after birth (Reaume et al., 
1995).  Tissue-specific Cx43 knockout mice (heart)  are known to develop normal heart 
structure and function, but exhibit sudden cardiac death due to spontaneous ventricular 
arrhythmia by ~ 2 months of age (Gutstein et al., 2001).  Endothelial cell-specific Cx43 
knock out mice developed hypotension and bradycardia (Liao et al., 2001), suggesting 
that Cx43 plays an essential role in heart outflow tract morphogenesis and development 
of the coronary arteries.  Cx43 mutations are associated with oculodentodigital dysplasia, 
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a rare autosomal dominant congenital disorder mainly affecting the development of the 
face, eyes, skeletal system, heart, dentition (Kelly et al., 2006) and congenital heart 
malformation (Chen et al., 2005).  Connexin43 mutations are associated with abnormal 
heart morphogenesis that includes atrial septal defect (ASD), ventricular septal defect 
(VSD) and other cardiac defects (Xie et al., 2005). Cx43 mutations are thought to be 
associated with congenital heart malformation.  Thus, when fetuses with congenital heart 
malformation were examined for Cx43 mutations, several amino acid substitutions were 
found that included Arg239Trp, Ser251Thr, Ala253Pro, Pro283Leu and Thr290Asn 
(Chen et al., 2005), suggesting that Cx43 mutations are associated with several cardiac 
diseases. Reduction in gap junction number or expression is known to be associated with 
a number of pathological conditions. For example there is reduction in Cx43 expression 
following myocardial ischemia and hypertrophy in the heart, suggesting that this 
reduction in Cx43 content may play an important role in the development  of hypertrophy 
(Peters et al., 1993).  During end-stage ischemic heart disease there is a remodeling of 
gap junctions, and Cx43 gap junction distribution is altered from the lateral cell-cell 
borders (intercalated discs) to the transverse cell-cell borders (Smith et al., 1991a), 
suggesting that alteration in gap junction distribution is a response to the development of 
cardiac diseases. 
In studies with Cx40 knock-out mice (mice lacking Cx40), there is an increased 
incidence of death, reduced velocity of impulse conduction in both the atria and 
ventricular conductive myocardium (Kirchhoff et al., 1998) (Simon et al., 1998; Verheule 
et al., 1999), dysrhythmias (abnormality in the rate, regularity or sequence of cardiac 
activation), and various morphological defects in the heart (Kirchhoff et al., 2000). Cx40 
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polymorphism is known to be associated with atrial standstill, a rare form of arrhythmia, 
where P waves are absent in electrocardiogram suggesting the absence of atrial activity 
(Hauer et al., 2006).  
Cx45 knockout mice die during embryogenesis due to abnormalities of vascular 
development and cardiogenesis (Kruger et al., 2000), suggesting an important role of 
Cx45 in the development of these organs.   
 
Significance of Connexin40 in the heart  
In the heart, Cx40 is most abundant in the atria and atrioventricular conduction 
system, with lower levels of expression in the ventricles (Vozzi et al., 1999a).  Cx40 
together with Cx43 is expressed in vascular smooth muscle, endothelial cells, and a 
subpopulation of cardiomyocytes in the vertebrate cardiovascular system  (Little et al., 
1995). 
There is evidence that Cx40, together with Cx43 and Cx45 is required for normal 
cardiac rhythm (Hagendorff et al., 1999),(Kumai et al., 2000), (Kruger et al., 2000), 
(Tamaddon et al., 2000).  Thus, studies of Cx40 deficient mice show an increased 
incidence of death between embryonic day (ED) 11.5 and embryonic day 13.5, and fewer 
than 50% of the mice survive after birth.  These mice that do survive show reduced 
velocity of impulse conduction in the atria and the ventricular conductive myocardium 
(Kirchhoff et al., 1998; Simon et al., 1998; Verheule et al., 1999), together with both 
spontaneous as well as inducible dysrhythmias (abnormal rate, regularity or sequence of 
cardiac activation).  These mice express various morphological defects in the heart which 
includes an absence of  the mesenchymal cup on the rim of the primary atrial septum, 
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myocardial hypertrophy and atrioventricular septal defects between the two bridging 
valvar leaflets (Kirchhoff et al., 2000). 
Cx40 deficiency in the heart is also associated with disturbances of sinoatrial 
electrophysiology, intra-atrial pulse propagation and a prolongation of the PQ interval 
and QRS duration.  This results in spontaneous atrioventricular block (impaired electrical 
conduction in the AV node and His-Purkinje system) indicating a decreased AV 
conduction capacity (Hagendorff et al., 1999).  These results point to the critical role that 
Cx40 plays in electrical conduction in the heart.  Any alteration in Cx40 function will 
clearly impact normal cardiac muscle performance. 
In the atria, gap junctions are mainly comprised of Cx40 and Cx43 proteins.  
However, several studies have demonstrated that Cx40 and Cx43 do not form heterotypic 
gap junctions (Bruzzone et al., 1993; Elfgang et al., 1995; Haubrich et al., 1996), 
suggesting that gap junctions formed by these connexins are regulated independently of 
each other in this region of the heart.  Cx43 is a well studied connexin and its regulation 
has been studied under both physiological and pathophysiological conditions, whereas 
Cx40 regulation is still not well characterized.   
 Although Cx40 has been shown to be regulated by transjunctional voltage 
(Bruzzone R, 1993; Beblo DA, 1995), intracellular pH (Peracchia et al., 2004) 
(Stergiopoulos et al., 1999) and 8-bromo-cAMP (Van-Rijen et al., 2000), its regulation 
by intracellular [Ca2+], purinergic and adrenergic receptor agonists and  ischemia as 
occurs during pathological conditions in the heart is still unknown and is therefore the 
focus of this study.  Understanding the biochemical basis and pathways involved in these 
conditions should provide insight into the role of Cx40 gap junctions in the progression 
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of arrhythmias such as atrial fibrillation, and open the possibility of developing new 
therapeutic approaches for their management and treatment. 
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Thesis objectives 
 The goal of this thesis was to examine the regulation of Cx40 gap junctions in 
both physiological and pathophysiological conditions.  This thesis has four main 
objectives: To study the regulation of  
1. Cx40 gap junctions by β-adrenergic receptor activation  
2. Cx40 gap junctions by intracellular [Ca2+] 
3. Cx40 gap junctions by ischemia 
4. Cx43 hemichannels by purinergic receptor activation 
Cardiomyocytes express at least three different connexins, namely Cx40, Cx43 
and Cx45 and therefore are not an optimal cell type for determining the functional 
properties of individual cardiac connexins. Thus, to study the regulation of gap junctions 
comprised of Cx40 alone, studies were conducted using this connexin stably transfected 
in communication-deficient HeLa cells.  Cell-to-cell communication mediated by Cx40 
gap junctions was determined by measuring the level of cell-to-cell transfer of the 
fluorescent dye Alexa Fluor 594. 
Beta-adrenergic regulation of Cx40 gap junctions 
Catecholamines play an important role in cardiac physiology and 
pathophysiology.  Sympathetic nerve activation is known to release the catecholamines 
epinephrine and norepinephrine into the blood stream affecting both contraction and 
relaxation of the heart through α- and β- adrenergic receptors.  The human heart 
expresses both α- and β- adrenergic receptors, and Cx40 is the major connexin in the atria 
of the heart where the action potential originates.  Previous investigators have shown that 
cell-permeant analogs of cAMP caused an increase in Cx40-mediated cell-to-cell dye 
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transfer in Cx40-transfected SkHep cells.  This study will be the first to examine whether 
Cx40-mediated cell-to-cell dye transfer can be regulated via β-adrenergic receptor-
dependent activation of Protein Kinase A as would occur in the intact heart. The first 
objective of this thesis will be to determine whether Cx40 gap junctions are regulated by 
β-adrenergic receptor activation and the signaling pathway/s involved in the β-adrenergic 
receptor-mediated effects on Cx40 gap junctions.  Cx40-transfected HeLa cells will be 
incubated with β- adrenergic receptor agonists for various times and Cx40 gap junction 
function detected by measuring the extent of cell-to-cell transfers of Alexa Fluor 594 dye.  
Components of the signal transduction pathway and the receptor subtypes will then be 
characterized through a pharmacological approach using selective agonists for the 
receptor subtypes and inhibitors for various protein kinases. 
Regulation of Connexin40 Gap junctions by Intracellular Ca2+ 
During myocardial ischemia there is accumulation of intracellular Ca2+ 
concentration [Ca2+]i in cardiomyocytes (Watts et al., 1980) that may be due to the influx 
of Ca2+ from the extracellular space via the Na+/Ca2+ exchanger  or release from the 
sacroplasmic reticulum (during ischemia there is increase in intracellular [H+] along with 
[Ca2+] (Lazdunski et al., 1985). This increased [Ca2+]i is known to be associated with a 
decrease in gap junction-mediated electrical (gap junction conductance) and biochemical 
communication (gap junction permeability) in cardiomyocytes (Burt, 1987a; White et al., 
1990). The major connexins present in cardiomyocytes are Cx40, Cx43 and Cx45, and 
Cx43, the major connexin in the heart is known be to inhibited by elevated [Ca2+]i (Crow 
et al., 1994).  Previously our laboratory has demonstrated that Cx43-mediated cell-to-cell 
dye transfer is inhibited by elevated [Ca2+]i with an IC50 of approximately 350 nM in 
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transfected HeLa cells.  Although Cx40 is most abundantly expressed in the atria, its 
regulation by [Ca2+]i is unknown.  Therefore the second objective of this thesis will be to 
examine the possible effect of [Ca2+]i on Cx40 gap junctions and the mechanisms 
underlying any action of [Ca2+]i on Cx40 gap junction permeability.  Intracellular Ca2+ 
will be measured ratiometrically (340 nm /380 nm) with Fura-2.  [Ca2+]i will be elevated 
in Cx40-transfected HeLa cells by adding ionomycin (2 µM) to permeabilze the plasma 
membrane  to Ca2+, and then elevating extracellular Ca2+ ([Ca2+]o) from 1.8 to 21.8 mM 
by adding CaCl2 to the bathing buffer which elevates [Ca2+]i from nano molar to micro 
molar.  Cx40 gap junction function will be detected by measuring the level of cell-to-cell 
transfer of Alexa Fluor 594 dye.  The mechanism/s responsible for the [Ca2+]i-dependent  
changes in Cx40 gap junction permeability will be determined using inhibitors of [Ca2+]i-
dependent  protein kinases and Ca2+-binding proteins.  
Regulation of Connexin40 Gap junctions by Ischemia 
Myocardial ischemia is known to cause arrhythmias which lead to sudden cardiac death 
(Janse and Wit, 1989). During ischemia there is a significant decrease in cellular ATP and 
oxygen concentration that is associated with inhibition of cardiac gap junction-mediated 
electrical conduction (Beardslee et al., 2000).  One of the important mechanisms responsible for 
the myocardial ischemia-induced origin of arrhythmias is the uncoupling of gap junctions (Groot 
and Coronel, 2004). Other studies have also shown that gap junction-mediated electrical 
conduction was inhibited during ischemia in cardiomyocytes (Beardslee et al., 2000).  Since 
cardiomyocytes express at least three different connexins, namely Cx40, Cx43 and Cx45, 
whether this ischemia-induced inhibition of gap junction-mediated electrical conduction is due to 
inhibition of all three connexins, or just one or more connexins is still not clear.  Cx43, the major 
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connexin in the heart is known to be inhibited in ischemia (Li and Nagy, 2000).  Although Cx40 
is most abundantly expressed in the atria, it remains to be determined whether it is affected by 
ischemia.  Therefore the third objective of this thesis will be to determine whether Cx40 gap 
junction permeability is affected by ischemia.  Chemical ischemia will be induced by inhibiting 
the electron transport chain with sodium cyanide and glycolysis with iodoacetate and 2-
deoxyglucose.   
Regulation of Cx43 hemichannels 
Hemichannels are “half” gap junctions, composed of 6 connexin subunits that 
connect the interior of the cell to its exterior space.  Evidence for a physiologic role for 
non-junctional connexin hemichannels in vivo was first provided by electrical studies on 
horizontal cells of fish retina (DeVries and Schwartz, 1992; Malchow et al., 1993).  
Cardiomyocytes are known to express functional hemichannels in the heart (Kondo et al., 
2000) and Kondo and colleagues (John et al., 1999) (Kondo et al., 2000) have examined 
the presence of functional hemichannels in isolated cardiomyocytes.  In isolated 
cardiomyocytes hemichannel-mediated conductance and calcein dye uptake was shown 
to be increased in the presence of reduced extracellular Ca2+ concentration or metabolic 
inhibition in the presence of normal extracellular Ca2+ concentration (John et al., 1999). 
These results suggested that functional hemichannels existed in the heart.  The presence 
of endogenous hemichannels in cardiac myocytes may have both physiological and 
pathophysiological significance, since their activation during ischemia is known to enable 
a non-selective current to exchange [K+]i for [Na+]o and [Ca2+]o.  The physiological 
function of these hemichannels is unclear, although hemichannel activity has been 
reported to be gated by [Ca2+]o (Ebihara and Steiner, 1993; Pfahnl and Dahl, 1998; 
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Valiunas and Weingart, 2000), metabolic state (Contreras et al., 2002; John et al., 1999), 
membrane potential (Trexler et al., 1996; Valiunas and Weingart, 2000), Protein Kinase 
C (Li, 1996), and Ca2+-dependent volume regulation (Quist et al., 2000).  Many of the 
properties of these hemichannels are similar to those of the corresponding gap junction 
channels (Trexler et al., 1996).  
ATP is released with norepinephrine from sympathetic nerve terminals 
(Burnstock, 1995), from endothelial cells during vascular injury (Born and Kratzer, 
1984), and from cardiomyocytes during hypoxia (Forrester and Williams, 1977).  Little 
information is known about the subcellular ionic changes which accompany purinergic 
receptor activation (caused by ATP) of cardiac myocytes, even under physiological 
conditions. It has been shown previously in our laboratory that Cx43-mediated cell-to-
cell dye transfer was transiently inhibited by ATP via activation of PKC in Cx43-
transfected HeLa cells. Since cardiomyocytes are known to express Cx43 hemichannels 
(Kondo et al., 2000) it is important to understand the effect of agonists such as ATP on 
Cx43 hemichannels. Therefore the fourth objective of this thesis will be to determine 
whether like Cx43 gap junctions, Cx43 hemichannels are regulated by agonists such as 
ATP that are released during cardiovascular ischemia.  
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Fig.1.1: A model of cell-cell junctions. A. The protein complex (occludins, ZO-1, ZO-2 
and ZO-3) that is responsible for the formation of tight junctions,  B. Protein complex 
(cadherins and catenins) that is responsible for the formation of adherens junctions,  and 
C. Assembly of six gap junction proteins called connexins to form a connexon.  Two 
connexons from opposing cells dock to form an intercellular gap junction channel.  
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Fig.1.2: A model of gap junction proteins with all the proteins with similar topology, 
each protein is comprised of 4 transmembrane domains with two extracellular loops, one 
intracellular loop, with the carboxy (C) and amino (N) termini in the cytoplasm.  A. 
Innexins- invertebrate gap junction proteins, B. Pannexins- possible vertebrate gap 
junction proteins, and C. Connexins- vertebrate gap junction proteins.   
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Introduction 
 
Cardiomyocytes are tightly interconnected by gap junctions that are found in 
every mammalian tissue, except adult skeletal muscle.  These junctions are comprised of 
connexin proteins that form intercellular channels and are composed of two hemichannels 
termed a connexon (Laird, 1996; Musil and Goodenough, 1993) with each hemichannel 
comprised of six connexin subunits. Each connexin consists of four transmembrane 
domains with the amino (N-) and carboxy (C-) termini in the cytoplasm. Twenty highly 
related human connexin genes have been identified with their nomenclature based on 
their expected molecular weight in kilodaltons, so that the major known connexin (Cx), a 
protein of 43 kDa, is referred to as Cx43.  A problem with this system is that homologous 
proteins in different species may have different molecular weights or different connexin 
proteins in different species may have identical molecular weights. An alternative 
nomenclature to eliminate this problem was developed based on connexin sequence 
homology (Kumar and Gilula, 1992), in which connexins were divided into 3 classes α, β 
and γ, with different members of each class being given different number eg., α1 for 
Cx43 and β1 for Cx32 etc.  The permeability properties of gap junctions are regulated by 
various factors that include voltage, intracellular pH, phosphorylation and intracellular 
calcium and more recently it is recognized that associated proteins may play this role; gap 
junctions allow the passive cell-to-cell diffusion of small molecules of up to 
approximately 1000 Dalton.  This form of cell communication is important for the 
intercellular movement of metabolites, transmitting signals such as second messengers 
between cells to regulate cell growth and development, the flow of current between cells 
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to maintain electrical communication, and the maintenance of a constant internal 
environment (cellular homeostasis) in cardiomyocytes.  
Three major connexins expressed in the heart include connexin 40 (Cx40), 
connexin 43 (Cx43) and connexin 45 (Cx45). Cx43 is expressed at much higher levels in 
the heart compared to other connexins (Van-Kempen et al., 1996).  Cx40 is most 
abundant in the atria (upper chambers of the heart) and atrioventricular conduction 
system (conducting link between the atria and ventricles) (Delorme et al., 1995), whereas 
Cx45 is restricted to the atrioventricular conduction system.  Impaired electrical 
communication due to alterations in the number, spatial distribution, or function of 
myocardial gap junctions have a causative role in the origin of arrhythmias which is 
associated with a number of different pathophysiological conditions including acute 
ischemia, chronic myocardial infarction, atrial fibrillation, diabetes, hypertension, 
valvular dysfunction, heart failure  and hyperthyroidism (Cooklin et al., 1997) indicating 
the importance of functional gap junctions for maintaining normal functioning of the 
heart.  In studies with Cx40 knock-out mice (mice lacking Cx40), there is an increased 
incidence of death, reduced velocity of impulse conduction in both the atria and 
ventricular conductive myocardium (Kirchhoff et al., 1998) (Simon et al., 1998; Verheule 
et al., 1999), dysrhythmias (abnormality in the rate, regularity or sequence of cardiac 
activation) and various morphological defects in the heart (Kirchhoff et al., 2000).  These 
several studies demonstrate that Cx40 is critically important for normal cardiac rhythm 
(Hagendorff et al., 1999); (Kruger et al., 2000); (Tamaddon et al., 2000). 
Cx40, the major connexin in the atria has been shown to be regulated by voltage 
(Bruzzone R, 1993; Beblo DA, 1995), intracellular pH (Peracchia et al., 2004) 
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(Stergiopoulos et al., 1999) and cAMP-dependent Protein Kinase (Van-Rijen et al., 
2000).  Thus, in HeLa cells transfected with human Cx40, a single open channel 
conductance of 120 pS, and 2 substates of 30 and 80 pS respectively were observed (Van 
Rijen HVM, 2000).  Furthermore, in oocytes transfected with mouse Cx40, CO2-induced 
cytosolic acidification decreased the voltage gating sensitivity of Cx40 gap 
junctions(Peracchia et al., 2004) indicating Cx40 is also regulated by intracellular pH.  
Finally, van Rijen HVM et al have observed an increase in Cx40 permeability following 
addition of cAMP-dependent Protein Kinase (PKA) activators (Van-Rijen et al., 2000), 
indicating Cx40 regulation by this protein kinase. 
Extracellular ATP is generated from different sources in the heart, being released 
from cardiomyocytes during hypoxia or ischemia (Forrester and Williams, 1977), from 
sympathetic nerve terminals (Burnstock and Sneddon, 1985), endothelial cells (Bodin and 
Burnstock, 1996) during vascular injury, and activated platelets during aggregation (Mills 
et al., 1968).  There is little information about any changes which accompany purinergic 
receptor activation (effected by extracellular ATP) of cardiomyocytes, even under normal 
physiologic conditions. In the heart, purinergic receptor activation results in the 
activation of Protein Kinase C, and increases intracellular Ca2+ concentration (Kusakari et 
al., 2002; Scamps and Vassort, 1994). The regulation of Cx40 following purinergic 
receptor activation is not known; therefore this study is the first to examine whether 
Cx40-mediated cell-to-cell dye transfer can be regulated via purinergic receptor-
dependent activation of Protein Kinase C as would occur in the intact heart.  
Catecholamines play an important role in cardiac physiology and 
pathophysiology.  Sympathetic nerve activation is known to release the catecholamines 
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epinephrine and norepinephrine into the blood stream affecting both contraction and 
relaxation of the heart through α- and β- adrenergic receptors.  Human heart expresses 
both α- and β- adrenergic receptors and Cx40 is the major connexin in the atria of the 
heart where the action potential initially originates.  Previous investigators have shown 
that cell-permeant analogs of cAMP caused an increase in Cx40-mediated cell-to-cell dye 
transfer in Cx40-transfected SkHep cells.  This study is the first to examine whether 
Cx40-mediated cell-to-cell dye transfer can be regulated via β-adrenergic receptor-
dependent activation of Protein Kinase A as would occur in the intact heart. Because 
cardiomyocytes express at least three different connexins, namely Cx40, Cx43 and Cx45, 
they are not optimal for determining how the functional properties of individual cardiac 
connexins are regulated in this cell type. Thus, to study the regulation of gap junctions 
comprised of Cx40 alone, studies were conducted using this connexin that was stably 
transfected into communication-deficient human cervix carcinoma (HeLa) cells.  These 
HeLa cells also contain most of the regulatory systems (second messenger systems) 
present in cardiomyocytes. 
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Methods 
HeLa cell culture 
 Untransfected or stably Cx40-transfected HeLa cells generously provided by Dr. 
Richard Veenstra were grown on 25 mm coverslips in 35 mm culture dishes until 
confluent (single monolayer).  Cells were grown in DMEM supplemented with 10% v/v 
fetal bovine serum and Pen-Strep (100 U/ml Penicillin and 0.1 mg/ml Streptomycin) with 
or without 0.025 mg/ml (G418) geneticin, and were grown at 37ºC in a 5% CO2 
atmosphere maintained with nearly 100% relative humidity. 
Membrane isolation 
Cells were harvested from 100 mm or 150 mm culture dishes by adding 500 µl of 
ice-cold Buffer 1 (in mM: 25 Tris base, 100 NaCl, 10 EDTA, 50 NaF, 0.5 Na3VO4, pH 
8.0), supplemented with protease inhibitors: 2 mM PMSF, 1 mg/L each: aprotinin, 
leupeptin, and pepstatin) to each culture dish, removing the cells from the coverslip with 
a cell scraper (Sarstedt, Newton, NC), and transferring the suspended cells to a thick-
walled 1.5 ml microfuge tube (Beckman/Coulter, Fullerton, CA).  Culture dishes were 
washed twice with 200 µl of ice-cold Buffer 1 and the final volume in each sample 
brought to 1 ml.  Cells were centrifuged (5 min at 1260 x g at 4ºC) in a Beckman 
TLA100.3 centrifuge, the supernatant was removed, and the cell pellet resuspended in 
500 µl ice-cold Buffer 1 and incubated on ice 30 min.  Cells were homogenized with a 1 
ml glass-on-glass Potter-Elvehjem tissue homogenizer (Bellco Glass Inc., Vineland, NJ, 
USA).   Homogenates were centrifuged at 100,000 x g at 4ºC for 30 min in a Beckman 
TLA 100.3 centrifuge.  The supernatant was removed and discarded, and the membrane 
pellet resuspended in 65 µl of ice-cold Buffer 2 (10 mM HEPES, pH 7.2) by drawing the 
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membranes through a Hamilton GASTIGHT 1700 syringe (Sigma-Aldrich, St. Louis, 
MO) until the membrane suspension was homogenous (~ 30 times).  The protein 
concentration of each membrane preparation was determined using the micro BCA assay 
using bovine serum albumin as standard (36).  Membranes were either used immediately 
or flash-frozen in liquid nitrogen and stored at -80ºC. 
Western Imunoblotting 
Following electrophoretic analysis of proteins on 10 % PAGE gels with a 5 % 
stacking gel in 0.1 % SDS (Laemmli, 1970), gels were equilibrated with transfer buffer 
for 15 min before electrophoretic transfer to nitrocellulose membranes (Schleicher & 
Schuell Inc., Keene, NH)  using a Trans-Blot Cell (Bio-Rad, Richmond, CA) according 
to the manufacturer’s instructions.  Nonspecific antibody binding sites on the 
nitrocellulose membranes were blocked in PBS-Tween (137 mM NaCl, 2.7 mM KCl, 1.8 
mM Na2HPO4 and 0.1 %v/v Tween-20, pH 7.2) containing  3 % w/v dried milk for  4-5 
hr at ambient temperature, or overnight at 4ºC, with gentle agitation.  After blocking of 
non-specific antibody binding sites, the nitrocellulose membranes were washed 3 times 
for  15 min each in fresh PBS-Tween without dried milk, before overnight incubation 
(4ºC, gentle agitation) with anti Connexin40 antibody from Santa Cruz Biotechnology 
(1:1000 or 1:750 dilution in PBS-Tween with 3 % dried milk) as indicated in the figure 
legends.  Following removal of the primary antibody solution, the nitrocellulose 
membranes were washed 3 times for 15 min in fresh PBS-Tween with  3 %  dried milk 
before addition of the appropriate horse radish peroxidase (HRP)-conjugated secondary 
antibody (1:1000 dilution, in PBS-Tween with 3 %  dried milk) for 3-4 hr at ambient 
temperature, or overnight at 4ºC, with gentle agitation.  The nitrocellulose membranes 
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were washed 3 times for 15 min each in fresh PBS-Tween without milk, and 
immunoreactive components were detected on Kodak BIOMAX MS film after incubating 
membranes for 1 min with ECL detection reagent (Amersham Pharmacia Biotech Inc., 
Piscataway, NJ).   
To identify the β-adrenergic receptor subtypes expressed in HeLa cells, cells were 
analyzed by Western Immunoblotting.  β-1, β-2 (Ablad B, 1974) and β -3 adrenergic 
receptor subtype antibodies were purchased from Santa Cruz Biotechnology (1:1000 
dilution in PBS-Tween with 5 % dried milk).  Goat anti-rabbit HRP conjugated 
secondary antibody  was used for the identification of both β-1 and β-2 (Ablad B, 1974) 
adrenergic receptor subtypes, while donkey anti-goat HRP conjugated secondary 
antibody  was used for the identification of the β -3 adrenergic receptor subtype (1:1000 
dilution in PBS-Tween with 5 % dried milk). 
Immunofluorescence 
Untransfected or Cx40-transfected HeLa cells were grown on 25 mm coverslips 
in 35 mm petri-dishes until cells reached confluence.  Media was removed from cells that 
were fixed with 4 % paraformaldehyde for 5 minutes, gently washed with 1x PBS 2x for 
2 minutes on an orbital shaker. Samples were incubated with 3 % BSA, 3 % normal 
donkey serum and 1 % Triton X-100 diluted in 1X PBS (Blocking solution) for one hour 
at 20ºC to block non-specific antibody binding sites.  This solution was then removed and 
the cells were incubated with primary antibody (1:100 Goat anti-connexin 40) in 
Blocking Solution overnight at 4○C on an orbital shaker.  The cells were washed 3 times 
with 1x PBS for 5 min and then incubated with secondary antibodies (1:250 Donkey anti-
goat rhodamine) in Blocking Solution for 2 hours at room temperature in the dark.  The 
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cells are then washed 4 times with 1x PBS, once with deionized water, when cells were 
visualized using a Nikon Epifluorescence microscope. 
Microinjection of dye 
Glass micropipettes were pulled from capillary glass using a Flaming/brown 
micropipette puller (Sutter Instrument Co.) and confluent monolayers of cells were then 
impaled with micropipette filled with 1mM Alexafluor 594 dye.  Dye was 
iontophoretically injected into a single cell for 1 min with a pulse protocol of 5 ms every 
100 ms for 3 s total using a Duo 773 electrometer with a WPI A310 Accupulser.  Cells 
were visualized using a Nikon Epifluorescence microscope and digitized images were 
recorded using Universal Imaging Metafluor software from which the number of cells 
receiving dye (excluding the impaled cell) was counted (Fig.2.3). 
Analysis of consensus phosphorylation sites in Connexin40 
The potential consensus phosphorylation sites for protein kinases were 
determined using the Expasy Prosite-Scan database from the following website: 
http://ca.expasy.org/prosite/.  The Rat Cx40 protein sequence was inserted into the prosite 
tool box and a quick scan for the patterns with a high probability of occurrence for the 
different phosphorylation consensus sequences was performed. 
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Results 
 
Expression of Cx40 in Cx40-transfected HeLa cells 
 
 To demonstrate that Cx40 was indeed expressed, Cx40-transfected HeLa cells 
were either immunolabeled or analyzed by Western Immunoblotting as shown in Fig.2.1.    
Punctate labeling of Cx40 at cell borders (arrows) as seen in Fig. 2.1B and some labeling 
in the cytoplasm (intracellular) was observed in Cx40-transfected HeLa cells (Fig. 2.1A 
is phase-contrast image and Fig. 2.1B is rhodamine fluorescence image). In contrast, 
there was no comparable immunolabeling when Cx40-transfected HeLa cells were 
incubated with secondary antibody alone [Fig. 2.1C (phase image) and D (rhodamine 
fluorescence image)].  As a negative control, when wild type untransfected HeLa cells 
were immunolabeled [rhodamine fluorescence image] no punctate Cx40 immuno-
fluorescence labeling was observed in these cells.  
 To demonstrate the expression of Cx40 by Western Immunoblotting, whole cell 
lysates from Cx40-transfected HeLa cells were solubilized in SDS and electrophoresed 
on 10 % polyacrylamide gels and prepared for Western Immunoblotting as described in 
Methods. Lane 1 contains whole cell lysates from untransfected HeLa cells, lane 2 and 3 
contain whole cell lysates from Cx40-transfected HeLa cells. A single component of 40 
kDa was observed only in Cx40-transfected HeLa cells (lanes 2 and 3 in Fig. 2.1I), 
demonstrating the expression of this connexin only in Cx40-transfected HeLa cells. 
 
Functional analysis of Cx40 in transfected HeLa cells 
 
Functional expression of Cx40 was demonstrated as cell-to-cell transfer of 
injected Alexa Fluor 594 dye.  Traub et al (Traub et al., 1994) have shown that Cx40-
transfected HeLa cells transfer Lucifer Yellow dye from the injected cell to the 
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neighboring cells.  In the work reported here cell-to-cell communication was determined 
using the fluorescent dye Alexa Fluor 594 because the fluorescence intensity is two-fold 
greater than that of Cy3 conjugates and Lucifer Yellow, it is photostable, and its 
excitation (590 nm)/emission (617 nm) wavelength allows it to be use with Fura-2 to 
monitor changes in [Ca2+]i.  To demonstrate that Cx40-transfected HeLa cells mediate 
cell-to-cell dye transfer, a single cell in a confluent monolayer of untransfected or Cx40-
transfected HeLa cells was microinjected with 1mM Alexafluor 594 dye as described in 
Methods, and 5 min later the number of cells receiving dye was determined. Although 
Cx40 gap junctions are known to be cation selective (Beblo et al., 1995) this was not an 
issue in this study because significant number of cells received dye in Cx40-transfected 
HeLa cells even with the anionic dye Alexa Fluor 594 compared to untransfected HeLa 
cells (Fig 2.2).  In HeLa cells stably transfected with rat Cx40, Alexa Fluor 594 dye 
transferred to 11.0 ± 0.7 cells (n = 8); in contrast dye transferred to 1.8 ± 0.4 cells in 
untransfected HeLa cells (n=11), (Fig. 2.2).  This small percentage of cell-to-cell dye 
transfer in untransfected wild type HeLa cells could be due to membrane damage in the 
injected cell causing Alexa Fluor 594 to leak into neighboring cells, or the small amount 
of signal leakage that has been reported in untransfected HeLa cells in other laboratories 
(Diestel et al., 2004).  Cell-to-cell dye transfer mediated by Cx40 gap junctions was 
inhibited by the gap junction blocker, carbenoxolone (CBX, 35 µM) (Goldberg et al., 
1996) [11.0 ± 0.7 (n = 8) cells in the absence and 2.3 ± 0.2 (n = 10) cells in the presence 
of the inhibitor] indicating dye transfer was indeed gap junction mediated (Fig. 2.2).  To 
determine if Alexa fluor 594 dye transfer increased with time in Cx40-transfected HeLa 
cells, dye was microinjected into a single cell for 1 min and then images were collected at 
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various times.  Alexa fluor594 dye transfer reached a maximum by 2 min of dye injection 
as shown in Fig. 2.3. 
Identification of putative Cx40 consensus phosphorylation sequences 
 
Van Rijen HVM et al (Van-Rijen et al., 2000) have reported that Cx40 is 
phosphorylated by cAMP-dependent Protein Kinase (PKA) as indicated by a mobility 
shift on Western Immunoblots, indicating that Cx40 is a phospho-protein and contains 
consensus phosphorylation sites for cAMP dependent Protein Kinase.  To determine 
which protein kinases could effect the phosphorylation of Cx40, the potential consensus 
phosphorylation sites for several protein kinases was determined by analysis of the Cx40 
sequence using the Expasy Prosite-Scan database from the following website: 
http://ca.expasy.org/prosite/, as described in Methods.  11 predicted consensus substrate 
sites for protein kinases were identified in Cx40:  five putative phosphorylation sites for 
casein kinase II, five for Protein Kinase C, and one for Protein Kinase A as shown in Fig.  
2.4.  The consensus sequence for casein kinase II  requires  acidic amino acid residues 
gluatamate, aspartate or serine phosphate immediately C-terminal to the phosphoacceptor 
serine/threonine (Kennely and Krebs, 1991).  Five recognition sequences for casein 
kinase II in Cx40 using the Expasy prosite scan database were identified where two were 
in the first extracellular loop, one in the third transmembrane domain, one in the carboxy-
terminus region adjacent to the fourth transmembrane domain, and the last one in the 
carboxy-terminus.  The consensus sequence for Protein Kinase C requires basic amino 
acids near the phosphoacceptor group; it can also be influenced by both N- and C-
terminal basic residues and phosphorylates substrates containing both. Five recognition 
sequences were identified for Protein Kinase C in Cx40 using the Expasy prosite scan 
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database, with one in the intracellular loop, one in the second extracellular loop, and three 
in the carboxy-terminus. The consensus sequence for Protein Kinase A requires basic 
amino acids particularly arginine, N-terminal to the phosphoacceptor serine or threonine. 
A single consensus recognition sequence for Protein Kinase A that contains the basic 
amino acid arginine before the phosphoacceptor serine was identified in the carboxy-
terminus of Cx40 at residue 343. 
Cx40 mediated cell-to-cell communication is not affected by purinergic receptor 
activation 
Given the presence of these several Protein Kinase C consensus sequences in 
Cx40 it was important to determine whether agonists that activate Protein Kinase C are 
able to regulate Cx40 gap junctions.  It has been demonstrated in this study (Fig. 2.5) and 
previously in our laboratory that purinergic receptor activation by ATP effects a Protein 
Kinase C-dependent partial inhibition of the major cardiac connexin Cx43. The heart 
contains P2X and P2Y purinergic receptors, that are classified based on the order of 
agonist potency of structural analogues of ATP (Burnstock and Kennedy, 1985).  
Furthermore extracellular ATP is generated from different sources in the heart, being 
released from cardiomyocytes during hypoxia or ischemia (Forrester and Williams, 
1977), from sympathetic nerve terminals (Burnstock and Sneddon, 1985), endothelial 
cells (Bodin and Burnstock, 1996) during vascular injury, and activated platelets during 
aggregation (Mills et al., 1968).  There is little information about any changes which 
accompany purinergic receptor activation (effected by extracellular ATP) of 
cardiomyocytes, even under normal physiologic conditions. In the heart, purinergic 
receptor activation by ATP results in the activation of Protein Kinase C, and increases 
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intracellular Ca2+ concentration (Kusakari et al., 2002; Scamps and Vassort, 1994) as 
shown in Fig. 2.5.  To determine whether, like Cx43, Cx40 gap junctions are regulated 
following purinergic receptor activation, the effect of ATP on cell-to-cell dye transfer 
mediated by Cx40 gap junctions was studied.  As shown here and previously, 
extracellular addition of ATP (25 µM) resulted in a delayed, transient inhibition of Cx43 
gap junctions (Fig. 2.6); it has been demonstrated previously that this concentration of 
ATP activates purinergic receptors increasing [Ca2+]i in HeLa cells (Paemeleire et al., 
2000).  To determine if Cx40 is regulated in a similar manner, experiments were 
performed in the absence or presence of 25 µM ATP.  Alexa Fluor 594 dye transferred to 
9.1 ± 0.4 cells in the absence of ATP.  Dye transferred to 8.5 ± 0.4 cells at 5 min, 8.5 ± 
0.5 cells at 15 min and 9.1 ± 0.5 cells at 30 min following the addition of  ATP (25 µM) 
(Fig. 2.7A).  Thus, Cx40 mediated cell-to-cell dye transfer was unchanged over a 30 min 
period following ATP addition indicating Cx40 is not regulated by purinergic receptor 
activation of Protein Kinase C. 
It has been demonstrated previously that the Protein Kinase C activator, 12-O-
tetradecanoylphorbol-13-acetate (TPA) activates Protein Kinase C (Chanson et al., 1988), 
and that in Cx43-containing cells this results in an inhibition of cell-to-cell dye transfer 
that has been correlated with the phosphorylation of Cx43 (Bao et al., 2004a); (Richards 
et al., 2004).  To further determine whether Cx40 gap junctions are regulated by direct 
activation of  Protein Kinase C, experiments were performed in the presence or absence 
of the Protein Kinase C activator, TPA (81 nM); this concentration of TPA has been 
shown previously to inhibit gap junction communication in lens cells (Tenbroek et al., 
1997) and Cx43-transfected HeLa cells via the PKC pathway.  Alexa Fluor 594 dye 
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transferred to 9.4 ± 0.6 cells (n=7) in the absence of TPA and there was no significant 
change when dye transfer was determined up to 90 min in the continuous presence of 
TPA (In the presence of 81 nM TPA dye transferred to 9.0 ± 0.4 cells (n=5) at 5 min, 9.7 
± 0.6 cells (n=4) at 30 min, 9.2 ± 0.6 cells (n=5) at 60 min and 10.7 ± 0.7 cells (n=4) at 
90 min).  Thus, TPA did not appear to affect the dye permeability of Cx40 gap junctions 
(Fig. 2.7B), confirming that in HeLa cells Cx40 gap junctions do not appear to be 
regulated by Protein Kinase C. 
Cx40 mediated cell-to-cell communication is regulated by Protein Kinase A activation 
It has been demonstrated previously that activation of Protein Kinase A by 
membrane permeant cAMP analog increased the dye permeability of Cx40 gap junction 
channels in Cx40-transfected SkHep 1 cells.  This action of cAMP was correlated with a 
mobility shift of Cx40 protein on Western Immunoblots, which was concluded to be due 
to Cx40 phosphorylation by these authors (Van-Rijen et al., 2000).  Analysis of the Cx40 
sequence with the Expasy Prosite-Scan database identifies one Protein Kinase A 
consensus phosphorylation sequence in the carboxy-terminus of Cx40 at amino acid 
residues 340 – 343 as shown in Fig. 2.4. To determine whether the results obtained from 
the previous study in SKHep cells (Van-Rijen et al., 2000) are reproducible in Cx40-
transfected HeLa cells, a monolayer of Cx40-transfected HeLa cells was incubated with 
the membrane –permeant cAMP analogs dibutyryl cAMP (0.5 mM) or 8 bromo cAMP (1 
mM); this concentration of dibutyryl cAMP is known to enhance gap junction 
communication in lung epithelial cells (Banoub et al., 1996) and 8 bromo cAMP is 
known to enhance gap junction communication in Cx40-transfected SKHep1 cells (Van-
Rijen et al., 2000).  Alexa Fluor 594 was then microinjected into one cell, and 2 min later 
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the number of cells receiving dye was determined. Alexa Fluor 594 dye transferred to 8.5 
± 0.3 cells (n=12) in the absence of dibutyryl cAMP, whereas in the presence of 0.5 mM 
dibutyryl cAMP, dye transferred to 13.1 ± 0.5 cells (n=7) at 5 min, 13.8 ± 0.9 cells (n=6) 
at 15 min and 12.1 ± 0.9 cells (n=6) at 30 min. Alexa Fluor 594 dye transferred to 8.7 ± 
0.3 (n= 11) cells in the absence of 8 bromo cAMP, whereas in the presence of 1 mM 8 
bromo cAMP dye transferred to 13.7 ± 0.7 cells (n=4) at 5 min, 12.0 ± 0.9 cells (n=4) at 
15 min  and 15.5 ± 0.5 cells (n=4) at 30 min (Fig. 2.9). Thus, both cAMP analogues, 
dibutyryl cAMP and 8 bromo cAMP, increased the level of Cx40-mediated cell-to-cell 
dye transfer as reported previously by van Rijen et al using 8-bromo cAMP (Van-Rijen et 
al., 2000). 
Protein Kinase A-dependent increase in Cx40 mediated cell-to-cell communication is 
via the β-adrenergic signaling pathway 
Since beta-adrenergic receptors are coupled to the adenylate cyclase/cAMP/PKA 
signaling pathway as shown in Fig. 2.8, it was hypothesized that the Protein Kinase A 
dependent increase in Cx40-mediated cell-to-cell dye transfer (Fig. 2.9) is coupled to the 
β-adrenergic receptor pathway. To test this hypothesis, the effect of activating each step 
in this signaling pathway on Cx40-mediated cell-to-cell dye transfer was studied. The 
first step was to demonstrate that direct activation of adenylate cyclase resulted in an 
increase in Cx40-mediated cell-to-cell dye transfer which was Protein Kinase A 
dependent.  To accomplish this, the effect of the adenylate cyclase activator forskolin 
(Jakobs and Watanabe, 1985) on Cx40-mediated cell-to-cell dye transfer was analyzed.  
Alexa Fluor 594 was microinjected into one cell after the addition of either 10 or 100 µM 
forskolin, concentrations of forskolin that are known to increase cAMP levels in oocytes 
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(Bornslaeger and Schultz, 1985), and 2 min later the number of cells receiving dye 
determined. Alexa Fluor 594 dye transferred to 8.6 ± 0.2 cells (n=6) in the absence of 
forskolin, whereas in the presence of 10 µM forskolin dye transferred to 10.0 ± 0.4 cells 
(n=4) at 5 min, 10.8 ± 0.5 cells (n=6) at 30 min, 10.0 ± 0.4 cells (n=5) at 60 min and 10.0 
± 0.5 cells (n=6) at 90 min.  At higher forskolin concentrations Alexa Fluor 594 dye 
transferred to 8.7 ± 0.1 cells (n=16) in the absence of forskolin, whereas in the presence 
of 100 µM forskolin dye transferred to 11.7 ± 0.2 cells (n=8) at 5 min, 11.3 ± 0.7 cells 
(n=6) at 30 min, 11.7 ± 0.1 cells (n=8) at 60 min and 11.3 ± 0.4 cells (n=11) at 90 min 
Fig. 2.10A). Thus, the action of forskolin on Cx40-mediated cell-to-cell dye transfer 
appears to be concentration dependent in these HeLa cells and confirms that cAMP 
activates cell-to-cell dye transfer in Cx40-transfected HeLa cells.   
To confirm that this forskolin-mediated increase in cell-to-cell dye transfer in 
Cx40-transfected HeLa cells was mediated via the activation of cAMP-dependent Protein 
Kinase, the PKA inhibitor KT-5720 (Haddad et al., 2005) was included prior to the 
addition of forskolin.  Thus, experiments were conducted with  0.5 µM KT-5720 given  
the Ki for KT-5720 is 50 nM (Kase et al., 1987); adding a concentration 10 times the Ki 
ensured the KT-5720 concentration used was sufficient to inhibit PKA in HeLa cells,.  
Following addition of forskolin (100 µM), Alexa Fluor 594 dye was microinjected into 
one cell and 2 min later the number of cells receiving dye determined. Alexa Fluor 594 
dye transferred to 8.8 ± 0.1 cells (n=6) in the absence of KT-5720 and 8.0 ± 0.2 cells 
(n=6) in the presence of KT-5720 (0.5 µM), indicating that inhibiting Protein Kinase A 
alone did not affect Cx40-mediated cell-to-cell dye transfer.  When forskolin was added 
to cells in the presence of 0.5 µM KT-5720 (5 min pre-incubation) dye transferred to  7.1 
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± 0.1 cells (n=6) at 5 min, 8.6 ± 0.4 cells (n=6) at 30  min  and 9.4 ± 0.2 cells (n=5) at 60 
min (Fig.2. 10B). Thus, the inhibition of Protein Kinase A with KT-5720 significantly 
inhibited the forskolin-dependent increase in Cx40-mediated cell-to-cell dye transfer 
indicating that the forskolin-mediated increase in cell-to-cell dye transfer was Protein 
Kinase A-dependent. 
It has been shown previously that in frog erythrocytes TPA  can effect a Protein 
Kinase C-mediated phosphorylation of one of the adenylate cyclase components (Sibley 
et al., 1986), suggesting that activation of Protein Kinase C may indirectly be responsible 
for activating Protein Kinase A.  Therefore to confirm that the forskolin-mediated 
increase in cell-to-cell dye transfer in Cx40-transfected HeLa cells was not dependent on 
the activation of Protein Kinase C, the Protein Kinase C inhibitor, Bisindolylmaleimide I 
(35 µM) was added to Cx40-transfected HeLa cells prior to the addition of forskolin; this 
concentration of Bisindolylmaleimide I was shown previously to prevent the PKC-
mediated inhibition of Cx43-mediated cell-to-cell dye transfer in Cx43-transfected HeLa 
cells, demonstrating that 35 µM Bisindolylmaleimide I inhibits PKC in HeLa cells.  A 
single cell in a confluent monolayer of Cx40-transfected HeLa cells was microinjected 
with Alexa Fluor 594 dye and the number of cells receiving dye was later determined as 
described in Methods.  Alexa Fluor 594 dye transferred to 8.6 ± 0.2 cells (n=5) in the 
absence of forskolin or KT-5720, and 8.8 ± 0.3 cells (n=5) in the presence of 35 µM 
Bisindolylmaleimide I indicating that Bisindolylmaleimide I alone did not alter Cx40 gap 
junction function.  When cells were pre-incubated with 35 µM Bisindolylmaleimide I and 
100 µM forskolin, dye transferred to 12.8 ± 0.7 cells (n=5) at 5 min and 14.0 ± 0.3 cells 
(n=5) at 30 min (Fig. 2.10B). Thus, inhibition of Protein Kinase C with 
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Bisindolylmaleimide I did not prevent the forskolin-dependent increase in Cx40-
mediated cell-to-cell dye transfer, indicating that activation of Protein Kinase C was not a 
required step in this forskolin-dependent increase in Cx40-mediated cell-to-cell dye 
transfer.  
Cx40 mediated cell-to-cell communication is regulated by adrenergic receptor 
activation 
Sympathetic activation is known to release the catecholamines epinephrine and 
norepinephrine into the blood circulating in the heart.  Catecholamines are known to 
increase heart beat and blood pressure, dilate bronchial tubes, dilate some blood vessels 
while contracting others, and alter insulin secretion and sweat production. These effects 
of catecholamines occur via activation of adrenergic receptors. Two distinct types of 
adrenergic receptors have been identified in the heart; alpha (α) and beta (β), and each 
group has several sub-types. Catecholamines activate both α and β-adrenergic receptors, 
activating second messenger systems that include adenylyl cyclase and phospholipase C.  
α -adrenergic receptors activate the Protein Kinase C pathway, whereas β-adrenergic 
receptors activate the Protein Kinase A pathway.  To determine which adrenergic 
receptor subtype effects the activation of Cx40-mediated cell-to-cell dye transfer, the 
effect of α and β specific agonists on Cx40-mediated cell-to-cell dye transfer was 
determined.   
To determine whether activation of α -adrenergic receptors affects Cx40-mediated 
cell-to-cell dye transfer, Cx40-transfected HeLa cells were incubated with the α-
adrenergic agonist Metaraminol (100 µM) for various times.  Alexa Fluor 594 was then 
microinjected into one cell and 2 min later the number of cells receiving dye was 
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determined. Alexa Fluor 594 dye transferred to 8.8 ± 0.2 cells (n=16) in the absence of 
metaraminol, whereas in the presence of metaraminol (100 µM) dye transferred to 7.6 ± 
0.4 cells (n=14) at 5 min, 7.8 ± 0.5 cells (n=16) at 30 min and 8.1 ± 0.4 cells (n=14) at 60 
min (Fig. 2.11).  The α-1A receptor is known to be expressed in HeLa cells (Gibson and 
Gilman, 2006), but the expression of other α-adrenergic receptor subtypes in HeLa cells 
is not known.  Therefore this absence of α-adrenergic receptor-mediated regulation in 
Cx40-transfected HeLa cells may be due either to the lack of appropriate α-adrenergic 
receptors in HeLa cells, or because Cx40-mediated cell-to-cell dye transfer is not 
regulated by α-adrenergic receptor activation. 
To determine whether activation of β-adrenergic receptors affects Cx40-mediated 
cell-to-cell dye transfer, Cx40-transfected HeLa cells were incubated with the β-
adrenergic agonist Isoproterenol (10 µM); this concentration of Isoproterenol has been 
shown to increase cAMP concentration and enhance gap junction communication in 
cultures of rabbit gastric epithelial cells which was prevented by the β-blocker, 
propranolol (Ueda et al., 1994).   Alexa Fluor 594 was then microinjected into one cell 
and 2 min later the number of cells receiving dye was determined.  In the absence of 
Isoproterenol Alexa Fluor 594 dye transferred to 9.0 ± 0.5 cells (n=5) at  0 min, 8.8 ± 0.7 
cells (n=4) at 5 min, 9.6 ± 0.2 cells (n=6) at 30 min, and 9.1 ± 0.3 cells (n=5) at 60 min. 
Alexa Fluor 594 dye transferred to 9.1 ± 0.2 cells (n=7) prior to the addition of 
Isoproterenol, whereas in the presence of Isoproterenol (10 µM) dye transferred to 12.0 ± 
0.3 cells (n=6) at 5 min, 11.6 ± 0.4 cells (n=6) at 30 min, and 11.0 ± 0.8 cells (n=5) at 60 
min (Fig. 2.12A), where p ≤ 0.05 when compared to the number of cells receiving dye in 
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the absence of Isoproterenol (Fig 2.12).  Thus, β-adrenergic receptor activation affects an 
increase in Cx40-mediated cell-to-cell dye transfer. 
To determine whether the Isoproterenol-mediated increase in cell-to-cell dye 
transfer in Cx40-transfected HeLa cells was mediated via activation of cAMP-dependent 
Protein Kinase A, Cx40-transfected HeLa cells were pre-incubated with the PKA 
inhibitor, KT-5720 prior to the addition of Isoproterenol.  When cells were pre-incubated 
with KT-5720 (0.5 µM) prior to the addition of Isoproterenol (10 µM), dye transferred to 
8.9 ± 0.3 cells (n=10) at 5 min, 9.7 ± 0.5 cells (n=7) at 30 min and 9.2 ± 0.2 cells (n=10) 
at 60 min (Fig. 2.12A). Thus, inhibition of Protein Kinase A with KT-5720 significantly 
inhibited the Isoproterenol-dependent increase in Cx40-mediated cell-to-cell dye transfer, 
indicating that this adenylate cyclase mediated activation of Cx40 required the activation 
of Protein Kinase A. 
To determine whether the Isoproterenol-mediated increase in cell-to-cell dye 
transfer in Cx40-transfected HeLa cells could be further amplified by preventing the 
dephosphorylation of any Protein Kinase A substrate, the protein phosphatase inhibitor 
okadaic acid was added prior to the addition of Isoproterenol.  Alexa Fluor 594 dye 
transferred to 8.6 ± 0.2 cells (n=9) in the absence of okadaic acid, whereas in the 
presence of okadaic acid (250 nM) dye transferred to 9.0 ± 0.3 cells (n=5), indicating that 
okadaic acid did not alter the basal level of Cx40-mediated cell-to-cell dye transfer.  
When cells were pre-incubated with okadaic acid (250 nM) prior to the addition of 
Isoproterenol (10 µM) dye transferred to 9.0 ± 0.7 cells (n=7) at 5 min, 11.8 ± 0.1 cells 
(n=6) at 30 min and 11.4 ± 0.6 cells (n=5) at 60 min (Fig. 2.12B). Thus, inhibition of 
protein phosphatases with okadaic acid did not further amplify the Isoproterenol-
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dependent increase in Cx40-mediated cell-to-cell dye transfer, indicating that the increase 
seen in these experiments was not further enhanced by preventing the dephosphorylation 
of Protein Kinase A substrate.   
Three β-adrenergic receptor subtypes have been cloned and pharmacologically 
(Dhein, 1998) classified into β-1, β-2 (Ablad B, 1974) and β -3 subtypes.  The β-1 
receptor subtype is the most abundant subtype in the heart and is known to coexist with 
β-2 (del Monte F, 1993).  In the human heart, the β1/ β2-subtype ratio is approximately 
70:30 in the atria, and about 80:20 in the ventricles (Brodde, 1991);  there is controversy 
regarding the expression of β-3 receptor subtype in the human heart (Chamberlain et al., 
1999).  Human cardiac β-1 and β-2 receptors are coupled to Gs which activate adenylyl 
cyclase, increasing intracellular levels of cAMP that in turn activate cAMP dependent 
Protein Kinase.  
Tallman et al, 1977 have shown using radioactive ligand (1-[3H] 
dihydroalprenolol) binding studies that HeLa cells contain some β-adrenergic receptors 
and that the activity of these receptors increased with butyrate treatment.  However, the 
β-adrenergic receptors subtypes expressed in HeLa cells are still not known. Therefore to 
determine which β-adrenergic receptor subtypes are expressed in HeLa cells, cells were 
analyzed by Western Immunoblotting as shown in Fig. 2.13.  The molecular weight of 
the β receptors have been reported to be approximately 68 kDa but is known to exhibit a 
lower molecular weight (~ 55 KDa) on SDS-PAGE gels depending on the extent of its 
glycolysation (Xiang and Kobilka, 2003).  No components were observed in the 68 kDa 
or 55 kDa region for the β-1 subtype (Fig. 2.13A) and the β-3 subtype (Fig.2.13C) in both 
untransfected and Cx40-transfected HeLa cells, suggesting that β-1 and β-3 subtypes 
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were not expressed in HeLa cells.  55 kDa and 68 kDa components of the β-2 subtype 
were observed in both untransfected and Cx40-transfected HeLa cells as seen in Fig. 
2.13B.  These data demonstrate that HeLa cells express only the β-2 adrenergic receptor 
subtypes. 
To further confirm that the β-1 receptor subtype was absent in HeLa cells, Cx40-
transfected HeLa cells were incubated for various times with the β-1 agonist Dobutamine 
(Steinle et al., 2005).   Alexa Fluor 594 dye transferred to 8.8 ± 1.6 cells (n=4) in the 
absence of the β-1 agonist Dobutamine, whereas in the presence of Dobutamine (10 µM) 
dye transferred to 9.0 ± 1.0 cells (n=3) at 5 min, 8.8 ± 1.0 cells (n=4) at 30 min and 8.0 ± 
0.4 cells (n=4) at 60 min (Fig. 2.14); this concentration of dobutmaine is known to 
activate β-1 receptor subtype in transfected HEK 293 cells and catalyses its 
phosphorylation (Steinle et al., 2005).  Thus, incubation with a β-1 agonist did not 
increase cell-to-cell dye transfer in Cx40-transfected HeLa cells, likely due to the absence 
of β-1 receptor subtype in these cells. 
To further confirm that the β-2 receptor subtype was absent in HeLa cells, Cx40-
transfected HeLa cells were incubated for various times with the β-2 agonist Salbutamol 
(Cramb, 1986).   Alexa Fluor 594 dye transferred to 8.6 ± 0. 3 cells (n=10) in the absence 
of Salbutamol, whereas in the presence of Salbutamol (50 µM) dye transferred to 10.7 ± 
0. 6 cells (n=10) at 5 min, 11.8 ± 0.6 cells (n=10) at 30 min and 12.4 ± 0.5 cells (n=8) at 
60 min (Fig. 2.15); these concentrations of Salbutamol have been shown previously to 
inhibit propranolol uptake in BC3H1 cells (Cramb, 1986).  These data demonstrates that 
β-2 receptor activation effects an increase in Cx40-mediated cell-to-cell dye transfer in 
these cells that was indistinguishable from that effected by Isoproterenol (Fig. 2.12A). 
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To further confirm that the β-3 receptor subtype was absent in HeLa cells, Cx40-
transfected HeLa cells were incubated for various times with the β-3 agonist BRL 37344 
(Pott et al., 2006).   Alexa Fluor 594 dye transferred to 9.2 ± 0. 3 cells (n=11) in the 
absence of the β-3 agonist BRL 37344, whereas in the presence of BRL 37344 (10 µM), 
dye transferred to 9.6 ± 0. 4 cells (n=11) at 5 min, 8.7 ± 0.3 cells (n=9) at 30 min and 9.3 
± 0.3 cells (n=11) at 60 min (Fig.2.16.); this concentration of BRL 37344 is known to 
activate β-3 receptor subtype in choroidal endothelial cells and is also responsible for the 
phosphorylation of Akt, Src, and MAPK (Pott et al., 2006).  Thus, activation by β-3 
receptor agonists was without effect on Cx40-transfected HeLa cells likely due to the 
absence of the receptor in these cells.  These data demonstrate that in Cx40-transfected 
HeLa cells, the β-2 receptor subtype appears to be responsible for the Isoproterenol-
dependent increase in Cx40-mediated cell-to-cell dye transfer. 
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Discussion 
The present study has demonstrated that β-adrenergic receptor activation is tightly 
coupled to the regulation of gap junctions comprised of Cx40.  Thus, Cx40-mediated 
cell-to-cell dye transfer was increased following the activation of several steps in the β-
adrenergic receptor signaling pathway which in the intact heart would result in an 
increase in both electrical communication and an increase in cell-to-cell movement of 
metabolites, ions and second messengers. It has been shown previously that addition of 
the cell permeant cAMP analog, 8-bromo cAMP effected an increase in cell-to-cell dye 
transfer in Cx40-transfected SkHep cells (Van-Rijen et al., 2000), but the pathway by 
which this cAMP analog effected this activation of Cx40 gap junctions was not 
determined.  The data reported here has identified the pathway by which this action of a 
cAMP analog on cell communication is effected.   
In the atria, catecholamines are released during psychological stress (Brodde and 
Zerkowski, 1989),  exercise (Kato et al., 2006) and sex (Schouwenberg et al., 2006) and 
also its release is increased during a number of patho-physiological conditions associated 
with arrhythmias in the heart (Lameris et al., 2000; Mackins et al., 2006). Catecholamines 
are known to activate both α- and β- adrenergic receptors. β-adrenergic stimulation 
mediates an increase in heart rate that is much greater than that effected via α-adrenergic 
stimulation. Since electrical coupling is mediated via gap junctions in the heart, and Cx40 
is abundantly expressed in the atria where the action potential originates, it was important 
to understand whether catecholamines regulated Cx40-mediated cell-to-cell 
communication. As shown in this study, the β-adrenergic-dependent increase in Cx40-
mediated cell-to-cell communication may be responsible for the origin of atrial 
  
 68 
fibrillation, because only the Cx40-mediated conduction is shown to be increased, 
whereas the conduction mediated by the only other major connexin in the atria Cx43 has 
been shown previously to not be affected by β-adrenergic agonists (Kwak et al., 1995). 
To demonstrate that β-adrenergic receptor activation is tightly coupled to the 
regulation of Cx40 gap junctions, β-adrenergic receptors were activated by Isoproterenol 
in Cx40-transfected HeLa cells.  This in turn resulted in a Cx40-mediated increase in 
cell-to-cell dye transfer which was prevented by inhibiting Protein Kinase A (Fig. 
2.12A).  To determine whether this β- adrenergic receptor-mediated increase in Cx40-
mediated cell-to-cell dye transfer was mediated via the adenylate cyclase/cAMP/PKA 
pathway, each step in the pathway was activated independently, and its role in Cx40-
mediated cell-to-cell dye transfer determined.  Thus, activation of adenylate cyclase by 
forskolin was associated with an increase in Cx40-mediated cell-to-cell dye transfer 
(Fig.2.10B), indicating that the β- adrenergic receptor-mediated increase in Cx40-
mediated cell-to-cell dye transfer was likely mediated via adenylate cyclase. Cell 
permeant cAMP analogs dibutyryl cAMP or 8-bromo cAMP resulted in an increase in 
Cx40-mediated cell-to-cell dye transfer (Fig. 2.9) which is consistent with previous 
reports (Van-Rijen et al., 2000), indicating that the β- adrenergic receptor-mediated 
increase in Cx40-mediated cell-to-cell dye transfer occurred via the cAMP pathway. The 
requirement for PKA was shown by using the PKA-selective inhibitor KT-5720, which 
prevented the β-adrenergic receptor-mediated increase in Cx40-mediated cell-to-cell dye 
transfer (Fig. 2.12A).  The concentration of KT-5720 used in these experiments (0.5 µM) 
is known to specifically inhibit PKA because at higher concentrations (>2 µM) KT-5720 
is also known to inhibit PKC and Protein Kinase G (PKG). Although KT-5720 did not 
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completely inhibit the Isoproterenol-dependent increase in Cx40-mediated cell-to-cell 
dye transfer, it did significantly decrease the Isoproterenol-dependent increase in Cx40-
mediated cell-to-cell dye transfer. Collectively these data showed that the β- adrenergic 
receptor-mediated increase in Cx40-mediated cell-to-cell dye transfer occurred via the 
adenylate cyclase/cAMP/PKA signaling pathway.   
Although, both Cx40 and Cx43 are expressed in the atria of the heart, it is 
unresolved as to whether or not Cx40/Cx43 form functional heterotypic gap junctions. 
Numerous studies have reported previously that Cx40 and Cx43 do not form functional 
heterotypic gap junctions (Bruzzone et al., 1993; Elfgang et al., 1995; Haubrich et al., 
1996) suggesting that they are regulated independently in the atria.  However a smaller 
number of studies have shown that Cx40/Cx43 form lower amounts of heterotypic gap 
junctions (Cottrell and Burt, 2001; Valiunas et al., 2000).  Regulation of Cx43 by direct 
β-adrenergic receptor activation is still unclear; it has been shown that PKA activation 
with 8-bromo cAMP, as occurs during β-adrenergic receptor activation did not alter 
Cx43-mediated cell-to-cell transfer of fluorescent dyes in Cx43-transfected SKHep1 cells 
(Kwak et al., 1995) and neonatal rat cardiomyocytes (Kwak and Jongsma, 1996), 
suggesting that PKA activation via the β- adrenergic receptor pathway does not modify 
the permeability properties of Cx43 gap junctions.  Cx45 is expressed at lower levels 
compared to Cx40 or Cx43 in the atria of the human heart (Davis et al., 1995).  Although 
Cx40 is known to form heterotypic gap junctions with Cx45, there may be fewer of these 
channels expressed in the atria due to the low expression level of Cx45 in this region of 
the heart.  Like Cx43, the regulation of Cx45 by direct β-adrenergic receptor activation is 
still unclear.  It has been shown that PKA activation with 8-bromo cAMP, as occurs 
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during β-adrenergic receptor activation decreased gap junction conductance in Cx45-
transfected HeLa cells (van-Veen et al., 2000).  Although PKA regulated Cx45 gap 
junction conductance in these cells, analyzing the potential consensus phosphorylation 
sites for several protein kinases in Cx45 sequence using the Expasy Prosite-Scan database 
did not yield any consensus sequences for PKA in Cx45 (Fig. 2.17). 
 This data reported here has demonstrated for the first time that β-adrenergic 
receptor activation by Isoproterenol effected an increase in Cx40-mediated cell-to-cell 
dye transfer, suggesting that the β-adrenergic receptor activation-mediated increase in 
heart rate may be mediated in part via the action of this signaling pathway on Cx40- 
containing gap junctions in the conduction pathway in the atria.  Since it has been shown 
previously that addition of cell permeant cAMP analog, 8-bromo cAMP effected an 
increase in both Cx40-mediated cell-to-cell dye transfer and Cx40-mediation electrical 
conductance in transfected SkHep cells (Van-Rijen et al., 2000), it can be assumed that β-
adrenergic activation may increase Cx40-mediated gap junction conductance.  This 
indicates differential modulation of all three atrial connexins following β-adrenergic 
activation in the heart.  
The three β-receptor subtypes expressed in the human heart are β-1, β-2 and β-3.  
Tallman et al, 1977 have shown using radioactive ligand (1-[3H] dihydroalprenolol) 
binding studies that HeLa cells contain β-adrenergic receptors. When cells were grown in 
culture in the presence of butyrate, the number of β-adrenergic receptors, cyclic AMP 
levels, and adenylate cyclase activation by Isoproterenol was increased (Tallman et al., 
1977).  This sodium butyrate-mediated increase in β-adrenergic receptors may be due to 
the synthesis of new receptor molecules, because this increase was prevented by the 
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protein synthesis inhibitor cycloheximide (Schmitt et al., 1978).  The β-adrenergic 
receptors subtypes expressed in HeLa cells are still not known. Therefore to determine 
the β-adrenergic receptor subtypes expressed in HeLa cells, cells were analyzed by 
Western Immunoblotting as shown in Fig. 2.13.  The molecular weight of the 
glycosylated β-adrenergic receptor is 68 kDa, whereas the non-glycosylated receptor has 
a mass of 55 kDa.  Both the unglycosylated and glycosylated forms of β-adrenergic 
receptor were observed in both untransfected and Cx40-transfected HeLa cells when 
probed for the β-2 subtype as seen in Fig. 2.13B. These components were absent when 
probed for β-1 or β-3 subtypes indicating that only the β-2 adrenergic receptor subtype 
was expressed in the HeLa cells used in these studies.  The β-2 receptor-specific agonist 
Salbutamol effected an increase in Cx40-mediated cell-to-cell dye transfer, indicating 
that β-2 receptor subtype was functionally responsible for the Isoproterenol-dependent 
increase in Cx40-mediated cell-to-cell dye transfer in transfected HeLa cells reported 
here. Although this does not directly correlate to the heart where all three β-adrenergic 
receptor subtypes are expressed, it does demonstrate that activation of β-2 receptors is 
coupled to an increase in Cx40-mediated increase in cell-to-cell communication. 
Both α-1 and α-2 adrenergic receptors are expressed in the human heart, while in 
agreement with our data reported here, the  α-2 adrenergic receptor subtypes α-2a and  α-
2b are the only ones shown previously to be expressed in HeLa cells (Gibson and 
Gilman, 2006).  The α-1 adrenergic receptor agonist Metaraminol did not affect Cx40-
mediated cell-to-cell dye transfer, indicating that α-2 adrenergic receptor activation does 
not regulate Cx40-mediated cell-to-cell dye transfer in Cx40-transfected HeLa cells.  
Although this does not directly correlate to the heart where all α-adrenergic receptor 
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subtypes are expressed, again it does demonstrate that Cx40-mediated cell-to-cell 
communication is not regulated by α-2 receptor activation in the heart. 
Potential consensus phosphorylation sites for several protein kinases have been 
identified following analysis of the Cx40 sequence using the Expasy Prosite-Scan 
database.  Together with casein kinase II and Protein Kinase A, five consensus sequences 
were identified for Protein Kinase C (Table 2.1).  Activation of Protein Kinase C by ATP 
(Fig. 2.7A) via the purinergic receptor pathway or direct activation of Protein Kinase C 
by the phorbol ester (TPA) (Fig. 2.7B) did not affect Cx40-mediated cell-to-cell dye 
transfer in Cx40-transfected HeLa cells indicating that activation of PKC does not appear 
to affect the permeability properties of Cx40 gap junctions.  It has been shown in this 
study and in previous studies in our laboratory (Lurtz et al., 2006) that Cx43-mediated 
cell-to-cell dye transfer was transiently inhibited by ATP via activation of PKC (Fig. 2.6).  
PKC activation by the phorbol ester PMA has been shown to increase gap junction-
mediated electrical conductance in Cx45-transfected HeLa cells (van-Veen et al., 2000), 
and analysis of the potential consensus phosphorylation sites for several protein kinases 
in the Cx45 sequence using the Expasy Prosite-Scan database identified five consensus 
sequences for PKC (Fig. 2.17).  This data demonstrates that unlike Cx43 or Cx45, Cx40 
gap junctions do not appear to be regulated by Protein Kinase C although consensus 
phosphorylation sites for this protein kinase are present in the Cx40 sequence, suggesting 
differential modulation of these atrial connexins in the heart. 
In summary, our data provides evidence for the first time that β-adrenergic 
receptor activation is tightly coupled to the regulation of gap junctions comprised of 
Cx40 and that it is PKA-dependent.  This β-adrenergic receptor-dependent increase in 
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Cx40-mediated cell-to-cell permeability may be responsible for the β-adrenergic 
activation-mediated increase in heart rate during physiological and pathophysiological 
conditions. 
Abnormal Ca2+ homeostasis is known to be responsible for cardiac contractility 
dysfunction (Morgan, 1991).  Changes in the expression or function of the Ca2+-
regulatory molecules such as sarcoplasmic reticulum Ca2+-adenosine triphosphatase 
(SERCA), phospholamban, sarcolemmal Na+/Ca2+ exchanger (NCX), sarcolemmal L-
type Ca2+ channels, and ryanodine receptors are known to result in  abnormal Ca2+ 
homeostasis in failing hearts (Hasenfuss et al., 1999; Mercadier et al., 1990; Meyer et al., 
1995; Movsesian et al., 1994).  β-blockers are currently thought to decrease heart rate by 
acting on the SERCA, and its regulatory protein phospholamban, in turn normalizing 
intracellular Ca2+-handling in failing hearts.  It has been shown that in tropomodulin-
overexpressing transgenic mice that suffer from dilated cardiomyopathy, there was a 
reduction of SERCA and an increase in Na+/Ca2+ exchanger (NCX) protein levels (Plank 
et al., 2003).  When these mice were treated with the β-blocker propranolol the alterations 
in SERCA and NCX protein levels were reversed thus restoring normalized intracellular 
Ca2+-handling (Plank et al., 2003).  Others have shown that in patients with congestive 
heart failure there was a reduction in SERCA, phospholamban, and Na+/Ca2+ exchanger 
protein levels, when these patients were treated with the β-blockers the alterations in 
SERCA, phospholamban, and NCX protein levels were reversed thus restoring 
normalized intracellular Ca2+-handling (Kubo et al., 2001).  Collectively these studies 
indicate that β-blockers normalize intracellular Ca2+-handling in failing hearts by acting 
on Ca2+-regulatory proteins. 
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Although drugs such as β-blockers have had success in the treatment of atrial 
fibrillation by suppressing β-adrenergic receptor signaling and by intracellular Ca2+-
handling, the downstream target of their action is still not fully understood.  This study 
clarifies that β-adrenergic receptors are likely tightly coupled to the regulation of atrial 
gap junctions suggesting that the use of β-blockers may prevent the β-adrenergic 
receptor-dependent increase in gap junction-mediated coupling thus decreasing electrical 
conduction in the heart.  Since atrial fibrillation is associated with alterations in atrial 
conduction mediated by gap junctions, gap junctions present an interesting alternative 
potential therapeutic target.  In this case drugs that specifically inhibit or close Cx40 gap 
junctions might be of value when used together with β-blockers to decrease electrical 
conduction thus assisting in the treatment of atrial fibrillation. 
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Table 2.1: Several putative Cx40 consensus phosphorylation sequences were identified 
for casein kinase II, Protein Kinase C and Protein Kinase A using Expasy prosite scan 
database. 
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Table 2.1 
 
Protein Kinase Amino acid Consensus 
phosphorylation sites 
Casein kinase II 39-42 taae 
 44-47 swgd 
 160-163 tame 
 221-224 slae 
 272-275 spde 
Protein Kinase C 99-101 tvr 
 201-203 tek 
 287-289 srk 
 337-339 sdk 
 346-348 ssk 
Protein Kinase A 340-343 rrls 
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Table 2.2: Several receptors, receptor ligands, activators and inhibitors of various protein 
kinases/phosphatases. 
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Table 2.2 
 
Receptors Agonists 
Purinergic receptor ATP 
α – adrenergic 
receptor 
Metaraminol 
β – adrenergic 
receptor 
Isoproterenol 
β –1 adrenergic 
receptor 
Dobutamine 
β –2 adrenergic 
receptor 
Salbutamol 
β –3 adrenergic 
receptor 
BRL-37344 
Protein 
Kinases/ 
phosphatases 
Activators Inhibitors 
PKC TPA Bisindolylmaleim
ide I 
Adenylate 
cyclase 
forskolin - 
PKA - KT-5720 
Protein 
phosphatases 1 
and 2A 
- Okadaic acid 
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Fig. 2.1: Expression of Cx40 in HeLa cells transfected with rat Cx40.  Immunolabeling 
of Cx40 in Cx40 transfected HeLa cells. Panels A, C and E show phase images while 
Panels B, D and F show Rhodamine fluorescence images.  (A) & (B) Cx40-transfected 
HeLa cells immunolabeled with both primary and secondary antibodies for Cx40. 
Punctate labeling of Cx40 is seen in panel B (arrows) after incubation with anti-Cx40 
primary antibody and rhodamine-conjugated secondary antibody. (C) & (D) Cx40-
transfected HeLa cells labeled with secondary antibody only.  (E) & (F) untransfected 
HeLa cells immunolabeled with both anti-Cx40 primary antibody plus rhodamine-
conjugated secondary antibody.  No punctuate labeling of Cx40 was observed in panels D 
& F.  Panel I: Western blot of Cx40.  Lane 1 contains cell lysate from wild type 
untransfected HeLa cells, lanes 2 and 3 contain cell lysates from Cx40-transfected HeLa 
cells. 50 µg of protein was loaded per lane. A 40 kDa band was seen in Cx40-transfected 
HeLa cells (lanes 2 and 3) which was absent in untransfected HeLa cells (lane 1). 
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Figure 2.1 
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Fig. 2.2: Cell-to-cell dye transfer in Cx40-transfected HeLa cells. Cell-to-cell dye 
transfer mediated by untransfected (bar 1) or Cx40-transfected HeLa cells (bar 2). Alexa 
Fluor 594 (1 mM) was microinjected into one cell and 2 min later the number of cells 
receiving dye was determined. Pre-incubation with the gap junction blocker, 
carbonexolone (35 µM CBX) inhibited the Cx40-mediated cell-to-cell dye transfer (bar 
3). * p ≤ 0.05 significantly different from Cx40 transfected HeLa cells. 
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Fig. 2.3: Cell-to-cell transfer of Alexa Fluor 594 dye in Cx40-transfected HeLa cells. 
Alexa Fluor 594 (1 mM) was microinjected into one cell and the number of cells 
receiving dye was determined at various times after dye injection. 
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Figure 2.3 
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Fig. 2.4: Cx40 amino acid sequence with the putative transmembrane regions (TM1- 
TM4) and several putative consensus phosphorylation sequences for casein kinase II, 
Protein Kinase C and Protein Kinase A. 
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Figure 2.4 
 
   TM 1 
mgdwsflgef leevhkhstv igkvwltvlf ifrmlvlgta aesswgdeqa dfrcdtiqpg 
                           
                          TM 2 
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                                       TM 3 
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Fig. 2.5: Schematic diagram of the Purinergic receptor pathway. ATP binds to the 
purinergic receptor and activates phospholipase C (PLC) which hydrolyzes 
phosphatidylinositol 4,5-bisphosphate (PIP2) to inositol 1,4,5-triphosphate (IP3) and 
diacylglycerol (DAG).  DAG activates Protein Kinase C (PKC) which in turn 
phosphorylates various residues in connexins thus altering gap junction function, while 
IP3 binds to ER receptors to effect the release of Ca2+ from this intracellular organelle. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 95 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.5 
 
 
ATP 
Gap junctions
Purinergic 
PLCreceptor PIP2
activates
Membrane 
bilayer 
IP3 DAG
Ca2+
PKC
ER
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 96 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 2.6: Effect of the purinergic receptor agonist ATP on Cx43 mediated cell-to-cell dye 
transfer. ATP (25 µM ATP ) was added to a monolayer Cx40-transfected HeLa cells 
when Alexa Fluor 594 (1mM) was microinjected into one cell prior to (Control) or at 5, 
15 or 30 min after ATP addition; 2 min after each microinjection the number of cells 
receiving dye were counted. * p ≤ 0.05 significantly different from Control. 
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Figure 2.6 
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Fig. 2.7: Effect of the purinergic receptor agonist ATP on Cx40 mediated cell-to-cell dye 
transfer. Effect of (A) ATP or (B) TPA on Cx40 mediated cell-to-cell dye transfer in 
HeLa cells.  A monolayer of Cx40-transfected HeLa cells was incubated with either ATP 
(25 µM) or TPA (81 nM). At various intervals following the addition or ATP or TPA, 
Alexa Fluor 594 was microinjected into one cell and 2 min later the number of cells 
receiving dye was counted. 
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Figure 2.7 
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Fig. 2.8: Schematic diagram of the β-adrenergic receptor pathway.  Beta-adrenergic 
receptor agonists bind to β -adrenergic receptors resulting in the activation of adenylate 
cyclase (AC) which catalyzes the conversion of ATP to cAMP.  Subsequently, cAMP 
activates Protein Kinase A (PKA) which in turn catalyzes the phosphorylation of various 
residues in connexins that may or may not affect gap junction function.   
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Figure 2.8 
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Fig. 2.9: Effect of cAMP analogs on Cx40 mediated cell-to-cell dye transfer.  A 
monolayer of Cx40-transfected HeLa cells were either incubated with 0.5 mM dibutyryl 
cAMP or 1 mM 8-bromo cAMP. At various intervals following the addition of the cAMP 
analog, Alexa Fluor 594 was microinjected into one cell and 2 min later number of cells 
receiving dye was counted. * p ≤ 0.05 from control.  
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Figure 2.9 
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Fig. 2.10: Effect of forskolin on Cx40 mediated cell-to-cell dye transfer.  (A) Monolayer 
of Cx40-transfected HeLa cells were incubated with forskolin (10 or 100 µM). (B) Cells 
were pre-incubated with KT-5720 (500 nM) or Bisindolylmaleimide I (35 µM) prior to 
the addition of forskolin.  At various intervals following the addition of forskolin, Alexa 
Fluor 594 was microinjected into one cell and 2 min later the number of cells receiving 
dye was counted. * p ≤ 0.05 significantly different from cells receiving dye at zero time 
(i.e. prior to the addition of forskolin). ** p ≤ 0.05 significantly from cells receiving dye 
in the presence of forskolin. 
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Figure 2.10 
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Fig. 2.11: Effect of the α-adrenergic agonist metaraminol on Cx40 mediated cell-to-cell 
dye transfer.  Cx40-transfected HeLa cells were incubated with metaraminol (100 µM) 
for various times.  At various intervals following the addition of metaraminol, Alexa 
Fluor 594 was microinjected into one cell and 2 min later the number of cells receiving 
dye was counted.  
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Fig. 2.12: Effect of the β-adrenergic agonist Isoproterenol on Cx40 mediated cell-to-cell 
dye transfer. Cx40-transfected HeLa cells were pre-incubated with the (A) PKA inhibitor 
KT-5720 (500 nM), or (B) phosphatase inhibitor Okadiac acid (250 nM) before addition 
of Isoproterenol (10 µM).  At various intervals following the addition of Isoproterenol, 
Alexa Fluor 594 was microinjected into one cell and 2 min later the number of cells 
receiving dye was counted. * p ≤ 0.05 significantly different from cells receiving dye at 
zero time. 
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Figure 2.12 
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Fig. 2.13:  Western blots of β-adrenergic receptor subtypes in untransfected or Cx40-
transfected HeLa cells.  (A) No bands at 55 or 68 kDa were observed in either 
untransfected (lane 1) or Cx40-transfected HeLa cells (lanes 2) when incubated with β-1 
adrenergic receptor antibody and goat anti-rabbit HRP conjugated secondary antibody. 
(B) 55 kDa and 68 kDa bands were observed in both untransfected (lane 1) and Cx40-
transfected HeLa cells (lanes 2) when incubated with β-2 adrenergic receptor antibody 
and goat anti-rabbit HRP conjugated secondary antibody. (C) No bands at 55 or 68 kDa 
were observed in either untransfected (lane 1) or Cx40-transfected HeLa cells (lanes 2) 
when incubated with β-3 adrenergic receptor antibody and donkey anti-goat HRP 
conjugated secondary antibody. 
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Figure 2.13 
 
A. Beta-1 adrenergic receptor subtype 
 
 
 
 
 
 
 
B. Beta-2 adrenergic receptor subtype 
 
 
 
 
 
 
C. Beta-3 adrenergic receptor subtype 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 112 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 2.14: Effect of the the β-1 adrenergic agonist Dobutamine on Cx40 mediated cell-to-
cell dye transfer.  Cx40-transfected HeLa cells were incubated with the β-1 adrenergic 
receptor agonist Dobutamine (10 µM) for various times. At various intervals following 
the addition of Dobutamine, Alexa Fluor 594 was microinjected into one cell and 2 min 
later the number of cells receiving dye was counted. 
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Fig. 2.15: Effect of the β-2 adrenergic receptor agonist Salbutamol on Cx40 mediated 
cell-to-cell dye transfer.  Cx40-transfected HeLa cells were incubated with the β-2 
adrenergic receptor agonist Salbutamol (50 µM) for various times. At various intervals 
following the addition of Salbutamol, Alexa Fluor 594 was microinjected into one cell 
and 2 min later the number of cells receiving dye was counted. * p ≤ 0.05 significantly 
different from control (i.e. prior to the addition of Salbutamol). 
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Fig. 2.16: Effect of the β-3 adrenergic agonist BRL 37344 on Cx40 mediated cell-to-cell 
dye transfer.  Cx40-transfected HeLa cells were incubated with the β-3 adrenergic 
receptor agonist BRL 37344 (10 µM). At various intervals following the addition of BRL 
37344, Alexa Fluor 594 was microinjected into one cell and 2 min later the number of 
cells receiving dye was counted. 
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Fig. 2.17: Cx45 amino acid sequence with the putative transmembrane regions (TM1- 
TM4) and several concensus sequences for casein kinase II (highlighted in green) and 
Protein Kinase C are highlighted in pink while concensus sequences for both Protein 
Kinase C and casein kinase II are highlighted in yellow. 
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Figure 2.17 
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Introduction 
 
Electrical and intercellular communication in the heart is mediated by gap 
junctions, non-specific plasma membrane channels that connect the cytoplasm of 
adjacent cells (Uehara and Burnstock, 1970).  Alterations in gap junction function has 
been implicated in various diseases of the heart that are associated with altered electrical 
communication such as arrhythmias, myocardial infarction, atrial fibrillation, 
hypertension, valvular dysfunction, heart failure  and hyperthyroidism (Cooklin et al, 
1997; Kaprielian et al, 1998) indicating the importance of functional gap junctions for 
maintaining normal cardiac function.  Gap junctions are comprised of proteins called 
connexins that form intercellular channels (Laird, 1996; Musil and Goodenough, 1993).  
Each connexin consists of four transmembrane domains with the amino (N-) and carboxy 
(C-) termini in the cytoplasm. Twenty highly related human connexin genes have been 
identified with their nomenclature based on their expected molecular weight in 
kilodaltons (kDa).  Gap junctions are known to be regulated by voltage, intracellular pH, 
phosphorylation state, intracellular calcium ([Ca2+]i) and more recently it is recognized 
that associated proteins may also play an important role in regulating gap junctions.  The 
major connexins expressed in the atria of the heart include connexin 40 (Cx40) and 
connexin 43 (Cx43).  
Gap junctions are regulated by [Ca2+]i, one of the most important intracellular 
signaling molecules (Burt, 1987a; Peracchia, 2004; Peracchia and Girsch, 1985).  In the 
heart, maintaining Ca2+ homeostasis (influx and efflux equilibrium) is important for 
excitation-contraction coupling of cardiac muscle (Zhang et al., 2001), activating various 
signaling pathways (El-Armouche et al., 2006), enzymes (Guo et al., 2006), genes 
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(Weissgerber et al., 2006), and regulating a number of important ion channels in both the 
plasma membrane and sacroplasmic reticulum (Kockskamper and Pieske, 2006). As in all 
other cell types, there is a 104 gradient of Ca2+ across the plasma membrane, with 
extracellular [Ca2+] ([Ca2+]o) in the range of ~ 1-2 mM while [Ca2+]i is in the range of ~ 
100 – 200 nM.  Most of the intracellular Ca2+ is stored in the sacroplasmic reticulum 
(SR); release of this Ca2+ into the cytoplasm during excitation-contraction coupling 
occurs via SR Ca2+ release channels termed ryanodine receptors and to a smaller extent 
via IP3 receptors (Berridge, 1993).   
During ischemia there is an increase in [Ca2+]i in cardiomyocytes (Watts et al., 
1980) which may be due to the influx of Ca2+ from the extracellular space via the 
Na+/Ca2+ exchanger [during ischemia there is increase in intracellular [H+] and [Ca2+] 
(Lazdunski et al., 1985)], so removal of  [H+] by the plasma membrane Na+/ H+ 
exchanger would lead to Na+ influx which would in turn trigger Ca2+ influx via the 
Na+/Ca2+ exchanger).  Increased [Ca2+]i can also result from an influence of Ca2+ 
mediated by plasma membrane store-operated Ca2+ channels, or a decreased rate of 
removal of cytosolic Ca2+ by the sarcoplasmic reticulum during ischemia (Chen et al., 
1998; Moreau et al., 2005).  This increased [Ca2+]i is known to result in a decrease in gap 
junction-mediated electrical (gap junction conductance) and biochemical communication 
(gap junction permeability) in cardiomyocytes (Burt, 1987a; White et al., 1990).  
The major connexins present in cardiomyocytes are Cx40, Cx43 and Cx45. Cx43, 
the major connexin in the heart is known be to inhibited by elevated [Ca2+]i (Crow et al., 
1994).  Previously our laboratory has demonstrated that Cx43-mediated cell-to-cell dye 
transfer is inhibited by elevated [Ca2+]i with an IC50 of approximately 350 nM in Cx43-
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transfected HeLa cells.  Although Cx40 is most abundantly expressed in the atria, its 
possible regulation by [Ca2+]i is unknown.  Therefore we have examined the effect of 
[Ca2+]i on Cx40 gap junctions and the mechanisms underlying any action of [Ca2+]i on 
Cx40 gap junction permeability. Because cardiomyocytes express at least three different 
connexins, namely Cx40, Cx43 and Cx45 they do not provide an optimal system for 
determining how the functional properties of individual cardiac connexins are regulated. 
Thus, to study the regulation of gap junctions comprised of Cx40 alone, studies were 
conducted using this connexin that was stably transfected in a communication-deficient 
HeLa cell line.  This study, which is the first to examine the effect of [Ca2+]i on Cx40 gap 
junction-mediated cell-to-cell dye transfer, reveals that a sustained elevation in [Ca2+]i 
caused a partial inhibition of Cx40 gap junction-mediated cell-to-cell dye transfer with an 
IC50 ~ 500 nM that appears to be Calmodulin-dependent. 
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Methods 
Materials 
Dulbecco’s Modified Eagles Medium (DMEM), Hank’s balanced salt solution 
without divalent cations (HBSS--) or with divalent cations (HBSS++), ATP, CaCl2, 
Calmidazolium, Ionomycin and Thapsigargin were purchased from Sigma-Aldrich 
Chemical Co. (St. Louis, MO). Fetal bovine serum (FBS) was purchased from Hyclone 
(Logan, UT).  G418 (Geneticin) and Hygromycin B were obtained from Invitrogen 
(Carlsbad, CA).  Fura-2 AM, and Alexa Fluor 594 were from Molecular Probes (Eugene, 
OR).  Connexin40 and Donkey anti-goat IgG-HRP antibodies were from Santa Cruz 
Biotechnology, Inc., (Santa Cruz, CA). KT-5720 was from Tocris Bioscience (Ellisville, 
MI). Bisindolymaleimide I and Lavendustin C were from EMD Biosciences (San Diego, 
CA). 
HeLa cell culture 
Cx40 stably transfected HeLa cells generously provided by Dr. Richard Veenstra 
(SUNY Upstate Medical University, Syracuse, NY) were grown as a single monolayer on 
25 mm coverslips in 35 mm culture dishes until confluent.  Cells were grown in DMEM 
supplemented with 10% v/v fetal bovine serum and Pen-Strep (100 U/ml Penicillin and 
0.1 mg/ml Streptomycin) with or without 0.025 mg/ml (G418) geneticin, and were kept at 
37ºC in a 5% CO2 atmosphere maintained with nearly 100% relative humidity. 
Membrane isolation and Western Immunoblotting  
Membranes were isolated from untransfected of Cx40-transfected HeLa cells as 
described previously in Chapter 2.   
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Microinjection 
Cell-to-cell communication was detected by measuring the extent of cell-to-cell 
transfer of Alexa Fluor 594 dye as described previously in Chapter 2.   
Intracellular Ca2+ measurements 
Cx40-transfected HeLa cells were loaded with Fura-2-AM (1 mM) in the dark for 45 
min at room temperature. The buffer containing Fura-2 was then removed; the cells were 
rinsed with fresh HBSS++ buffer, then incubated an additional 30 min in 2 ml HBSS++ 
buffer to allow for complete hydrolysis of the intracellularly loaded Fura-2 AM. 
Intracellular Ca2+ was measured ratiometrically (340 nm /380 nm) with Fura-2 
throughout the experiment. Ca2+ concentrations were determined as described previously 
by Grynkiewicz et al, 1984. The Ca2+ concentration was calculated using the equation:  
 
(R-Rmin) (Fmin)[Ca2+] = Kd  
(Rmax-R)(Fmax)
 
Where:    Kd = 0.224 µM (Kd is the Ca2+ dissociation constant of Fura-2) 
R    = fluorescence intensity ratio Fλ1/F λ2, in which λ1 (340 nm) and λ2 
(380 nm) are the fluorescence detection wavelengths for the ion-bound and 
ion-free indicator, respectively 
                Rmin = fluorescence intensity ratio at 10 nM Ca2+;  
                Rmax = fluorescence intensity ratio at 39 µM Ca2+;  
                Fmin = fluorescence intensity λ 380 10 nM Ca2+;  
                Fmax = fluorescence intensity λ 380 at 39 µM Ca2+; 
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Raising intracellular Ca2+ 
Intracellular Ca2+ concentration ([Ca2+]i) was elevated in Cx40-transfected HeLa cells 
by adding ionomycin (2 µM) and then increasing extracellular Ca2+ concentration 
([Ca2+]o) from 1.8 to 21.8 mM by adding CaCl2 to the bathing buffer (Hank’s balanced 
salt solution with divalent cations (HBSS++). 
Data analysis 
The data are expressed as Mean ± SEM. In cell-to-cell dye transfer assays, n reflects 
the number of times the experiments were performed. Differences between groups were 
analyzed by ANOVA.  Student’s paired t-test was used to calculate levels of significance, 
with p-value below 0.05 indicating significance. Statistical significance is indicated in the 
graphs with a ‘*’ for p ≤ 0.05. 
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Results 
 
 
Expression of Cx40 in transfected HeLa cells 
 
 To demonstrate the expression of Cx40 by Western Immunoblotting, membranes 
were isolated from Cx40-transfected HeLa cells, proteins were separated on SDS-PAGE 
gels and immunolabeled with Cx40 antibodies as described in Methods (Fig.3.1). A 
single component of 40 kDa was observed only in Cx40-transfected HeLa cells as shown 
previously (Vozzi et al., 1999b) (Fig.3.1 lane 2 compared with lane 1), demonstrating the 
expression of this connexin in the Cx40-transfected HeLa cells used in this study. There 
was a non-specifically immunolabeled band at 52 kDa in both untransfected wild type 
and Cx40-transfected HeLa cells. 
A sustained increase in intracellular Ca2+ causes a decrease in Cx40-mediated cell-to-
cell dye transfer 
In the heart, a sustained increase in [Ca2+]i occurs during myocardial ischemia 
where [Ca2+]i increases from ~ 300 nM (resting) to ~ 900 nM (20 min ischemia) in 
perfused rat hearts (Marban et al., 1990). An ischemia-mediated increase in [Ca2+]i is 
known to decrease gap junction-mediated electrical (gap junction conductance) and 
biochemical communication (gap junction permeability) in cardiomyocytes (Burt, 1987a; 
White et al., 1990).  Cardiomyocytes express at least 3 different connexins, namely Cx40, 
Cx43 and Cx45. The question addressed here is whether inhibition of these connexins are 
responsible for this elevated [Ca2+]i -mediated inhibition of gap junctions in 
cardiomyocytes during ischemia. Cx43, the major connexin in the heart is known be to 
inhibited by elevated [Ca2+]i (Crow et al., 1994) but the possible regulation of the major 
connexin in the atria Cx40 by [Ca2+]i is unknown, and was the focus of this study.  To 
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determine whether like Cx43 cell-to-cell dye transfer mediated by Cx40 was inhibited by 
a sustained increase in [Ca2+]i, Cx40-transfected HeLa cells were incubated with the Ca2+ 
ionophore ionomycin and extracellular Ca2+ was then increased from 1.8 mM 
(physiological [Ca2+]o) to 21.8 mM (this [Ca2+]o was required to increase [Ca2+]i to micro-
molar levels as occurs during ischemia in the heart).  This high calcium gradient across 
the plasma membrane was likely required due to the presence of numerous plasma 
membrane Ca2+ pumps which pump intracellular Ca2+ out of cells (Negulescu and 
Machen, 1993).  Under physiological conditions ([Ca2+]o = 1.8 mM),  [Ca2+]i was ~ 0.1 
µM and dye transferred to 9.6 ± 0.3 cells (n=13).  When cells where incubated with the 
Ca2+ ionophore ionomycin (2 µM) (Churchill et al., 2001) and [Ca2+]o was increased to 
21.8 mM, [Ca2+]i increased to micromolar levels and dye transfer decreased to 4.0 ± 0.8 
cells (n=10) (Fig.3.2).  The number of cells receiving dye at different [Ca2+]i is shown in 
Fig.3.2.  Given the Kd for Fura-2 of 224 nM (Grynkiewicz et al., 1985), intracellular Ca2+ 
concentrations greater than approximately 1 µM cannot be estimated accurately in these 
experiments.   Elevating [Ca2+]i to greater than 2 µM resulted in cell shrinkage and death 
of the Cx40-transfected HeLa cells (data not shown).  Thus, these data demonstrate a ~ 
50% inhibition in Cx40-mediated cell-to-cell dye transfer when [Ca2+]i ≥ 0.5 µM.  A 
sustained elevation in [Ca2+]i caused a partial inhibition of Cx40 gap junction-mediated 
cell-to-cell dye transfer with an IC50 = 500 ± 0.72 nM. 
 
 
The [Ca2+]i-dependent  decrease in Cx40-mediated cell-to-cell dye transfer does not 
require the activation of Protein Kinase A 
  
 129 
Elevating [Ca2+]i levels to higher that 0.5 µM partially inhibited Cx40 gap 
junction-mediated cell-to-cell dye transfer (Fig.3.2).  This [Ca2+]i-mediated inhibition of 
Cx40 may be effected by at least three different mechanisms: 1) Ca2+ activates a Ca2+-
dependent Protein Kinase 2) direct binding of Ca2+ to Cx40 protein or 3) via a Ca2+-
binding protein such as Calmodulin. 
Analysis of the Cx40 sequence for putative phosphorylation sites as described in 
Methods (Chapter 2) using the Expasy Prosite-Scan database predicted substrate sites for 
Protein Kinase A and Protein Kinase C.  Therefore, to determine whether the [Ca2+]i-
mediated decrease in Cx40 gap junction-mediated cell-to-cell dye transfer was dependent 
on the activation of Protein Kinase A,  Cx40-transfected HeLa cells were pre-incubated 
with the PKA inhibitor, KT-5720 (0.5 µM) (RM Fried, 1986) before adding the Ca2+ 
ionophore ionomycin, and [Ca2+]i was then increased to micro molar levels by increasing 
[Ca2+]o to 21.8 mM as described above. Alexa Fluor 594 dye transferred to 9.5 ± 0.6 cells 
(n=13) under physiological [Ca2+]o (1.8 mM) when [Ca2+]i was < 0.1 µM.  In the presence 
of the PKA inhibitor alone dye transferred to 9.3 ± 0.9 cells (n=9), indicating that the 
PKA inhibitor alone did not alter [Ca2+]i (0.16 ± 0.005 µM) or the number of cells 
receiving dye from control levels [absence of PKA inhibitor].  When [Ca2+]i was elevated 
to micromolar levels in the presence of the PKA inhibitor, dye transferred to 4.5 ± 0.4 
cells (n=6)  as shown in Fig.3.3 indicating that inhibition of Protein Kinase A had no 
effect on the [Ca2+]i-dependent inhibition of Cx40-mediated cell-to-cell dye transfer.  
Thus, the Ca2+-dependent inhibition of Cx40 does not appear to require the activation of 
PKA.   
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The [Ca2+]i-dependent  decrease in Cx40-mediated cell-to-cell dye transfer does not 
require the activation of Protein Kinase C 
It has been demonstrated previously in our laboratory that purinergic receptor 
activation by ATP effects a Protein Kinase C-dependent inhibition of the major cardiac 
connexin Cx43.  To determine whether, like Cx43, the [Ca2+]i-dependent decrease in 
Cx40 gap junction-mediated cell-to-cell dye transfer was effected by activating the Ca2+-
dependent enzyme Protein Kinase C (PKC),  Cx40-transfected HeLa cells were pre-
incubated with the PKC inhibitor bisindolylmaleimide I (2 µM)  before the addition of 
the Ca2+ ionophore ionomycin (Fried and Tashjian, 1986); [Ca2+]i was then increased to 
micro molar levels by increasing [Ca2+]o to 21.8 mM as described above (Fig 3.4).  Alexa 
Fluor 594 dye transferred to 9.5 ± 0.2 cells (n=10) in physiological [Ca2+]o (1.8 mM) 
when [Ca2+]i was ~ 0.1 µM.  In the presence of the PKC inhibitor bisindolylmaleimide I 
alone dye transferred to 8.9 ± 0.2 cells (n=23); [Ca2+]i was unchanged from control levels 
in the presence of the PKC inhibitor.  Thus, PKC inhibitor alone did not alter either 
[Ca2+]i (0.21 ± 0.008 µM) or the number of cells receiving dye.  When [Ca2+]i was 
elevated to micromolar levels in the absence of PKC inhibitor, dye transferred to 4.0 ± 
0.2 cells (n=5) whereas in the presence of the PKC inhibitor dye transferred to 5.5 ± 0.6 
cells (n=17)  (Fig.3.4) indicating that inhibition of Protein Kinase C had minimal effect 
on the [Ca2+]i-dependent inhibition of Cx40-mediated cell-to-cell dye transfer. Thus, the 
Ca2+-dependent inhibition of Cx40 does not appear to require the activation of PKC.    
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The [Ca2+]i-dependent  decrease in Cx40-mediated cell-to-cell dye transfer does not 
require the activation of Calmodulin  Kinase II 
To determine whether the [Ca2+]i-dependent inhibition of Cx40-mediated cell-to-
cell dye transfer was dependent on the activation of Calmodulin-dependent Protein 
Kinase II (CaMK II), experiments were performed in the presence or absence of an 
inhibitor of this Protein Kinase (Fig 3.5).  Alexa Fluor 594 dye transferred to 9.9 ± 0.5 
cells (n=12) in physiololgical [Ca2+]o conditions in Cx40-transfected HeLa cells.  When 
Cx40-transfected HeLa cells were incubated with the CaMK II inhibitor, lavendustin C (2 
µM) (Watanabe et al., 1999) alone dye transferred to 9.0 ± 0.2 cells (n=31) and [Ca2+]i 
was unchanged from control levels in the presence of this CaMK II inhibitor (Fig.3.5).  
This suggests that CaMK II inhibitor alone did not alter either [Ca2+]i (0.18 ± 0.008 µM) 
or the number of cells receiving dye when compared to control levels (in the absence of 
CaMK II inhibitor).  When [Ca2+]i was elevated to micromolar levels in the absence of 
CaMK II inhibitor dye transferred to 4.4 ± 0.8 cells (n=4) whereas in the presence of the 
CaMK II inhibitor dye transferred to 4.0 ± 1.0 cells (n=3)  (Fig.3.5) indicating that 
inhibition of CaMK II had no effect on the [Ca2+]i-dependent inhibition of Cx40-
mediated cell-to-cell dye transfer.  Thus, the Ca2+-dependent inhibition of Cx40 does not 
appear to require the activation of CaMK II. 
 
The [Ca2+]i-dependent  decrease in Cx40-mediated cell-to-cell dye transfer does not 
appear to be due to direct binding of Ca2+ to Cx40 
To determine whether the [Ca2+]i-dependent inhibition of Cx40 gap junction-
mediated cell-to-cell dye transfer was due to a direct binding of Ca2+ to Cx40 protein, the 
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Cx40 protein sequence was scanned for EF hand Ca2+ binding domains using the EF-hand 
prediction server (Zhou et al., 2006).  No Ca2+ binding domains were found in the Cx40 
protein sequence suggesting that the [Ca2+]i-dependent inhibition of Cx40 gap junction-
mediated cell-to-cell dye transfer is unlikely due to a direct binding of Ca2+ to Cx40 
protein.   
Collectively these data suggest that the elevated [Ca2+]i-dependent inhibition of 
Cx40 gap junctions was not due to the activation of Ca2+-activated proteins kinases or 
from direct binding of Ca2+ to Cx40 protein. 
The [Ca2+]i-dependent  inhibition of Cx40-mediated cell-to-cell dye transfer appears to 
be Calmodulin-dependent 
When the Cx40 protein sequence was examined using the Calmodulin target database 
for identifying Calmodulin binding sites obtained from Ikura Lab, Ontario Cancer 
Institute (Zhou et al., 2006), one site was identified in the C-terminus just distal to the 
fourth transmembrane domain of Cx40 as shown in Fig.3.6.    Scores range from 0-9 for 
protein sequences based on the probability for a Calmodulin binding site, 9 being the 
highest probability for the Calmodulin binding site.  These normalized scores ranging 
from 0 to 9 are shown below the amino acid sequence indicating the highest affinity for 
Calmodulin within the given protein sequence.  This scoring is based on a consecutive 
string of high values indicates the location of a putative binding site, the higher the score, 
the higher the predicted affinity for Calmodulin.  Criteria for determining putative CaM-
binding sites is based on hydropathy, alpha-helical propensity, residue weight, residue 
charge, hydrophobic residue content, helical class and occurrence of particular residues.  
Furthermore, a second scoring system also ranging from 0-9 is shown above the protein 
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sequence when they are scanned for Calmodulin binding affinity.  This scoring system is 
based on the Calmodulin binding affinity of Cx40 to the Calmodulin binding affinity of 
other proteins in the data base.   When the Cx40 protein sequence was examined using 
the Calmodulin target database a maximum score of 2 was obtained; although there was a 
probable site in Cx40 it may have a low predicted affinity for Calmodulin albeit the 
predictive scores do not always reflect the actual affinity of such sites for Calmodulin.  
Since a Calmodulin binding site was predicted in a region of Cx40 that the membrane 
spanning domain algorithms would indicate to be in a cytosolic region of Cx40, 
Calmodulin may bind directly to Cx40 thus altering the conformation of the connexin and 
closing the channel.   
To determine whether the [Ca2+]i-dependent inhibition of Cx40 gap junctions was 
effected via the Ca2+-binding protein Calmodulin (CaM), Cx40-transfected HeLa cells 
were incubated with a Calmodulin inhibitor and [Ca2+]i was elevated as described 
previously.  Dye transferred to 9.0 ± 0.3 cells (n=12) in physiololgical [Ca2+]o in Cx40-
transfected HeLa cells.  When Cx40-transfected HeLa cells were incubated with the CaM 
inhibitor Calmidazolium alone dye transferred to 9.0 ± 0.3 cells (n=19) and [Ca2+]i was 
unchanged from control levels indicating that addition of this Calmodulin inhibitor alone 
did not alter either [Ca2+]i (0.15 ± 0.04 µM)  or the number of cells receiving dye when 
compared to control levels (in the absence of Calmodulin inhibitor).  When [Ca2+]i was 
elevated to micromolar levels in the absence of CaM inhibitor, dye transferred to 4.1 ± 
0.3 cells (n=5) whereas in the presence of the CaM inhibitor, dye transferred to 9.0 ± 0.4 
cells (n=4)  indicating that the inhibition of Calmodulin prevented the [Ca2+]i-dependent 
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inhibition of Cx40 gap junctions (Fig.3.7).   Thus, the Ca2+-dependent inhibition of Cx40 
appears to be Calmodulin-dependent. 
A transient increase in intracellular calcium did not affect Cx40-mediated cell-to-cell 
dye transfer 
A number of physiological agonists such as ATP (Niedergerke and Page, 1981), 
phenylephrine (α-1 adrenergic receptor activation) (Zhang et al., 2005), histamine 
(Hardwick et al., 2006), and acetylcholine (Weber et al., 2005) are also known to cause a 
transient increases in [Ca2+]i concentration which returns to basal levels within tens of 
seconds, unlike the ionomycin-induced increase in [Ca2+]i described here where the 
increase in [Ca2+]i is sustained.  The [Ca2+]i increase during an agonist-mediated Ca2+ 
release, and the ionomycin-induced increase in [Ca2+]i are all in the micromolar range, the 
difference being that the agonist-mediated increase is transient whereas the ionomycin-
induced increase is sustained.  The goal of these experiments was to determine whether 
an agonist-dependent transient elevation in [Ca2+]i similar to the ionomycin-induced 
sustained increase in [Ca2+]i, inhibited Cx40-mediated cell-to-cell dye transfer.  This was 
accomplished by incubating Cx40-transfected HeLa cells with ATP (25 µM) as ATP has 
been shown to transiently increase [Ca2+]i via purinergic receptor activation (Muscella et 
al., 2003) in HeLa cells.  This same signaling system is also present in the heart, where 
purinergic receptor activation is coupled to an IP3-dependent increase in [Ca2+]i (Kusakari 
et al., 2002; Scamps and Vassort, 1994).  To confirm that extracellular ATP increases 
[Ca2+]i in Cx40-transfected HeLa cells, these cells were incubated with ATP (25 µM) and 
changes in [Ca2+]i was measured ratiometrically using Fura-2 as described in Methods.  
Addition of ATP to the media transiently increased [Ca2+]i in Cx40-transfected HeLa 
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cells from ~ 0.1 µM to ~0.5 µM within 1 min of adding ATP and this declined to control 
levels by about 4 min after the addition of ATP as shown in Fig. 3.8A. 
To determine whether this ATP-dependent increase in [Ca2+]i modulated Cx40-
mediated cell-to-cell dye transfer, cells were incubated with  ATP (25 µM) for various 
times prior to microinjection of dye.   Alexa Fluor 594 dye transferred to 9.1 ± 0.5 cells 
(n=22) prior to addition of ATP, whereas following the addition of ATP (25 µM) during 
the period when there was a transient increase in [Ca2+]I, dye transferred to 8.8 ± 0.4 cells 
at 1 min (n=5) ([Ca2+]i maximum was ~ 0.5 µM),  8.6 ± 0.3 cells at 5 min (n=7) when 
[Ca2+]i had returned back to basal levels, 8.6 ± 0.6 cells (n=7) at 15 min, and 9.1 ± 0.6 
cells (n=7) at 30 min (Fig.3.8B).  Thus, addition of extracellular ATP did not appear to 
affect Cx40-mediated cell-to-cell dye transfer suggesting that the ATP-dependent 
increase in [Ca2+]i does not affect Cx40 gap junction permeability.  This data 
demonstrates that an agonist-dependent, transient increase in [Ca2+]i does not appear to 
affect cell-to-cell dye transfer in Cx40-transfected HeLa cells. 
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Discussion 
  
The present study demonstrates for the first time that a sustained elevation in 
[Ca2+]i, such as occurs during myocardial ischemia, causes a partial inhibition of Cx40-
mediated cell-to-cell dye transfer which appears to be Calmodulin-mediated.   
 [Ca2+]i is elevated by physiological agonists such as ATP, catecholamines, and 
also during pathophysiological conditions such as during arrhythmias.  The absolute 
[Ca2+]i increase following addition of agonists or during ischemia is similar, except that 
during ischemia there is a sustained increase in [Ca2+]i whereas agonist-mediated 
increases in [Ca2+]i are transient.  [Ca2+]i, one of the most important intracellular signaling 
molecules in the heart, is required for maintaining the contraction-relaxation function of 
the heart muscle (Zhang et al., 2001), activating various signaling pathways (El-
Armouche et al., 2006), enzymes (Guo et al., 2006), gene expression (Weissgerber et al., 
2006) and regulating a number of ion channels  including gap junctions in the plasma 
membrane (Kockskamper and Pieske, 2006).  In the heart, electrical and intercellular 
communication is mediated by gap junctions, and alterations in gap junction function 
have been implicated in various pathologic conditions in the heart (Cooklin et al., 1997; 
Kaprielian et al., 1998).   
Myocardial ischemia is known to cause arrhythmias, and during myocardial 
ischemia there is an elevation in [Ca2+]i (Watts et al., 1980).  This increase in intracellular 
[Ca2+] is known to be associated with a decreased gap junction-mediated electrical (gap 
junction conductance) and biochemical communication (gap junction permeability) in 
cardiomyocytes (Burt, 1987a; White et al., 1990).  In the atria, gap junctions are mainly 
comprised of Cx40 and Cx43 proteins.  Thus, examining the regulation of gap junctions 
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comprised of individual connexins by elevated [Ca2+]i would help us better understand 
the role of gap junctions in various pathological conditions such as arrhythmias that are 
associated with elevated [Ca2+]i.  Indeed, that the modulation of gap junction function can 
directly regulate electrical conduction in the heart makes gap junctions an ideal 
therapeutic target in the treatment of these pathologic conditions.   
In the atria, gap junctions are comprised mainly of Cx40 and Cx43 proteins.  
However, several studies have demonstrated that Cx40 and Cx43 do not form heterotypic 
gap junctions (Bruzzone et al., 1993; Elfgang et al., 1995; Haubrich et al., 1996), 
suggesting that gap junctions formed by these two connexins are regulated independently 
of each other in this region of the heart.   
It has been shown previously that elevation of [Ca2+]i inhibits Cx43-mediated 
cell-to-cell dye transfer (Crow et al., 1994), while the role of [Ca2+]i  in regulating Cx40 
gap junctions has not been examined previously.  Therefore it was hypothesized that like 
Cx43, Cx40-mediated cell-to-cell dye transfer would be inhibited by increased [Ca2+]i.  
This was accomplished by raising [Ca2+]i by 2 different methods in these cells 1) a 
sustained elevation in [Ca2+]i using the Ca2+ ionophore ionomycin and then raising 
[Ca2+]o and, 2) a transient increase in [Ca2+]i using agonists such as ATP.  
During the myocardial ischemia that may cause arrhythmias, [Ca2+]i has been 
shown to increase up to micromolar levels (Marban et al., 1990).  A sustained elevation 
in [Ca2+]i accomplished by addition of ionomycin increased [Ca2+]i to micromolar levels 
when the [Ca2+]o was elevated from 1.8 mM to 21.8 mM (Fig.3.2).  This increase in 
[Ca2+]i resulted in > 50% inhibition of Cx40-mediated cell-to-cell dye transfer which was 
prevented by prior addition of an inhibitor of the Ca2+ binding protein Calmodulin.  
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Whether this action of Ca2+ + Calmodulin results from the direct interaction of 
Calmodulin with Cx40 is not known, but it can be speculated that like other gap junction 
proteins [for example Calmodulin directly binds to Cx32 resulting in channel closure 
(Peracchia et al., 2000)], Calmodulin may directly bind to Cx40 protein.  When the Cx40 
protein sequence was examined using the Calmodulin target database obtained from 
Ikura Lab, Ontario Cancer Institute for identifying Calmodulin binding sites, there was 
one site identified in the C-terminus just outside the fourth transmembrane domain as 
shown in Fig.3.6.  Since this shows that a Calmodulin binding site was found in the Cx40 
C-terminus, we can speculate that Calmodulin may directly bind to Cx40 thus altering the 
conformation of the connexin and closing the channel.   
In the myocardium, Ca2+ transients result when various agonists such as ATP, 
histamine, and acetylcholine are released during sympathetic nerve stimulation.  The 
question is whether this transient increase in [Ca2+]i alters electrical coupling-mediated by 
gap junctions in the heart. Among the three major connexins expressed in 
cardiomyocytes Cx43 [fully open single channel conductance of 220 pS (Contreras et al., 
2003)] and Cx40 [fully open single channel conductance of 120 pS (Van-Rijen et al., 
2000)] gap junctions have large conductances and are also expressed at much higher 
levels compared to Cx45 [fully open single channel conductance of 40 pS (van-Veen et 
al., 2000)], thus these three major cardiac connexins play an important role in 
maintaining electrical conduction in the heart.  However, the data reported here indicate 
that a transient elevation of [Ca2+]i by ATP did not affect cell-to-cell dye transfer in 
Cx40-transfected HeLa cells, indicating that Cx40-mediated cell-to-cell communication 
is not affected by an agonist-dependent transient increase in [Ca2+]i. 
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 A sustained increase in [Ca2+]i as occurs during myocardial ischemia, would 
likely result in the inhibition of Cx40-mediated cell-to-cell dye transfer,  whereas a 
transient increase in [Ca2+]i effected by ATP mediated purinergic receptor activation to  ~ 
0.5 µM did not result in an inhibition of Cx40-mediated cell-to-cell dye transfer.  The 
possible explanation for this could be as described by Dakin et al (Dakin et al., 2005), 
when there is an influx of Ca2+ from the extracellular space [Ca2+]i is likely higher  in 
close proximity to the gap junctions in the plasma membranes rather than in the 
cytoplasm.  When Ca2+ is released from intracellular stores, the cytosolic [Ca2+] increases 
to ≥ 0.5 µM but the [Ca2+] in the vicinity of gap junctions may be lower than that reported 
by Fura-2 for the average cytoplasmic [Ca2+] because the distance when Ca2+ enters cells 
from the extracellular space in the vicinity of gap junctions. 
Taken together with previous studies in our laboratory it is possible to conclude 
that under physiological conditions [Ca2+]i transients induced by agonists in the heart 
would likely not result in a Ca2+-dependent inhibition of gap junction-mediated electrical 
conduction mediated by either Cx40 or Cx43.  However, a sustained increase in [Ca2+]i as 
occurs during myocardial ischemia might be expected to inhibit gap junction coupling 
mediated by either of these connexins.  Such an inhibition may be both beneficial and 
detrimental to cardiomyocytes, this phenomenon is described by Andrade-Rozental et al 
(Andrade-Rozental et al., 2000) as  “kiss to life” and “kiss of death”.  Inhibiting gap 
junction-mediated biochemical communication in the heart during ischemia protects 
neighboring cardiomyocytes from the movement of toxic metabolites such as free 
radicals which causes cell injury and death described as “kiss to life” thus being 
beneficial. Reduction or inhibition of gap junction-mediated electrical coupling in the 
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heart during arrhythmias may slow or stop heart rate described as “kiss of death” thus 
being detrimental eventually leading to heart failure and death. Although various anti-
arrhythmic drugs such as β-blockers have been used with moderate success for the 
treatment of arrhythmias, most have significant side effects.  Since arrhythmias result 
from an inhibition in gap junction-mediated electrical coupling in the heart leading to 
abnormal heart rhythms, gap junctions may be valuable therapeutic targets for the 
treatment of this condition.  Our data reported here could suggest that this ischemia-
mediated inhibition of cardiac gap junction function may be due in part to the increase in 
[Ca2+]i as occurs during myocardial ischemia (Burt, 1987b).  Drugs that specifically 
open/enhance gap junction function may be of value in the treatment of arrhythmias, thus 
preventing the myocardial ischemia-mediated inhibition in gap junction-mediated 
electrical conduction in the heart.   
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Fig. 3.1: Expression of Cx40 in rat Cx40 transfected-HeLa cells.  Western Immunoblot 
of Cx40.  Lane 1 contains whole cell lysates from untransfected HeLa cells, and lane 2 
contains whole cell lysates from Cx40-transfected HeLa cells (50 µg of protein per lane). 
A 40 kDa band was seen in Cx40-transfected HeLa cells (lane 2) which was absent in 
untransfected HeLa cells (lane 1). 
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Figure 3.1 
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Fig. 3.2: Effect of a sustained increase in [Ca2+]i on Cx40-mediated cell-to-cell dye 
transfer. Cx40-transfected HeLa cells were incubated with ionomycin (2 µM), [Ca2+]o 
was increased from 1.8 mM to 21.8 mM and at various subsequent times Alexa Fluor 594 
was microinjected into one cell and 2 min later the number of cells receiving dye was 
counted.  Inhibition curve is shown in dashed line. 
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Figure 3.2 
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Fig.3.3: Effect of Protein Kinase A inhibition on the Ca2+-mediated inhibition of Cx40-
mediated cell-to-cell dye transfer. Cx40-transfected HeLa cells were pre-incubated with 
the PKA inhibitor KT-5720 (0.5 µM) for 15 min and then incubated with ionomycin (2 
µM), [Ca2+]o was increased from 1.8 mM to 21.8 mM and at various times subsequently 
Alexa Fluor 594 was microinjected into one cell and 2 min later the number of cells 
receiving dye was counted. * p ≤ 0.05 from control (1.8 mM [Ca2+]o) . 
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Figure 3.3 
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Fig. 3.4: Effect of Protein Kinase C inhibition on the Ca2+-dependent inhibition of Cx40-
mediated cell-to-cell dye transfer. Cx40-transfected HeLa cells were pre-incubated with 
the PKC inhibitor, bisindolylmaleimide I (2 µM) for 15 min and then incubated with 
ionomycin (2 µM); [Ca2+]o  was increased from 1.8 mM to 21.8 mM.  At various times 
subsequently Alexa Fluor 594 was microinjected into one cell and 2 min later the number 
of cells receiving dye was counted. * p ≤ 0.05 from control (1.8 mM [Ca2+]o). 
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Figure 3.4 
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Fig.3.5: Effect of CaMK II inhibition on the Ca2+-dependent inhibition of Cx40-mediated 
cell-to-cell dye transfer. Cx40-transfected HeLa cells were pre-incubated with CaMK II 
inhibitor, Lavendustin C (2 µM) for 15 min and then incubated with 2 µM ionomycin, 
extracellular Ca2+ was then raised from 1.8 mM to 21.8 mM.  At various times following 
the elevation of [Ca2+]o to 21.8 mM, Alexa Fluor 594 was microinjected into one cell and 
2 min later the number of cells receiving dye was counted. * p ≤ 0.05 from control (1.8 
mM [Ca2+]o). 
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Figure 3.5 
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Fig.3.6: Cx40 amino acid sequence with the putative transmembrane regions (TM1- TM4 
in gray) and the possible Calmodulin binding region (highlighted in pink) in the C-
terminus when examined for Calmodulin binding sites using the Calmodulin target 
database obtained from Ikura Lab, Ontario Cancer Institute (Zhou et al., 2006).   
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Figure 3.6 
 
 
Minimum score for sequence: 0 Maximum score: 2 
 
 
                                                   TM1 
....1 MGDWSFLGEF LEEVHKHSTV IGKVWLTVLF IFRMLVLGTA AESSWGDEQA 
..... 0000000000 0004444444 4444444444 4440000000 0000000000 
                                                        TM2 
...51 DFRCDTIQPG CQNVCYDQAF PISHIRYWVL QIIFVSTPSL VYMGHAMHTV 
..... 0000000000 0000000000 0000000000 0000000000 0000000000 
 
..101 RMQEKQKLRE AEKAKEAGGT GTYEYLAEKA ELSCWKEVNG KIVLQGTLLN 
..... 0000000000 0000000000 0000000044 4444444444 4444444400 
                          TM3 
..151 TYVCTILIRT AMEVAFMVGQ YLLYGIFLDT LHVCRRSPCP HPVNCYVSRP 
..... 0000000000 0000000000 0000000000 0000000000 0000000000 
                         TM4 
..201 TEKNVFIVFM MAVAGLSLFL SLAELYHLGW KKIRQRLAKS RQGDKHQLLG 
..... 0000000000 0000000000 0499999999 9999999999 9400000000 
 
..251 PSTSLVQGLT PPPDFNQCLK NSPDEKFFSD FSNNMGSRKN PDPLATEEVP 
..... 0000000000 0000000000 0000000000 0000000000 0000000000 
 
..301 NQEQIPEEGF IHTQYGQKPE QPSGASAGHR FPQGYHSDKR RLSKASSKAR 
..... 0000000000 0000000000 0000000000 0000000000 0000000000 
 
..351SDDLSV 
..... 000000 
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Fig. 3.7: Effect of a Calmodulin inhibitor on the Ca2+-dependent inhibition of Cx40-
mediated cell-to-cell dye transfer. Cx40-transfected HeLa cells were pre-incubated with 
Calmodulin inhibitor, Calmidazolim (2 µM) for 15 min and then incubated with 
ionomycin (2 µM), [Ca2+]o was then increased from 1.8 mM to 21.8 mM and at various 
times subsequently Alexa Fluor 594 was microinjected into one cell and 2 min later the 
number of cells receiving dye was counted. * p ≤ 0.05 from control (1.8 mM [Ca2+]o). 
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Figure 3.7 
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Fig. 3.8: Effect of a transient increase in [Ca2+]i on Cx40-mediated cell-to-cell dye 
transfer. A. Effect of ATP on [Ca2+]i in Cx40-transfected HeLa cells. B. Effect of ATP-
induced increase in [Ca2+]i on Cx40-mediated cell-to-cell dye transfer. Cx40-transfected 
HeLa cells were incubated with ATP (25 µM) for various times when Alexa Fluor 594 
was microinjected into one cell and 2 min later the number of cells receiving dye was 
counted. 
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Figure 3.8 
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Regulation of Connexin40 Gap Junctions during Ischemia 
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Introduction 
 
Intercellular communication in the heart occurs through gap junctions, which mediate 
both electrical and biochemical cell-to-cell communication in cardiomyocytes.  Gap junctions are 
composed of connexin proteins that form intercellular channels that are important determinants 
of action potential propagation in the heart. The major connexins expressed in cardiomyocytes 
are Cx40, Cx43, and Cx45 and alterations in gap junction function, expression and distribution 
have been implicated in various cardiac pathological conditions (Kirchhoff et al., 1998; Kleber et 
al., 1987; Simon et al., 1998) such as myocardial ischemia (Peters et al., 1993; Smith et al., 
1991b), indicating the importance of functional gap junctions for maintaining normal cardiac 
function.   
Ischemia is associated with various pathological conditions including arrhythmia which 
leads to sudden cardiac death (Janse and Wit, 1989), as well as atrial and ventricular fibrillation 
in the heart.  Several changes that occur in cardiomyocytes during myocardial ischemia include a 
reduction in [ATP]i and [Mg2+]i (Kirkels et al., 1989), accumulation of various ions such as [H+]i, 
[Ca2+]i (Kihara et al., 1989), [Na+]i (Malloy et al., 1990), [K+]o (Wilde and Aksnes, 1995), 
accumulation of fatty acids (Vusse et al., 1994), catecholamines (Newton et al., 1997), and free 
radicals (Kukreja and Hess, 1992). 
One of the important mechanisms responsible for the myocardial ischemia-induced origin 
of arrhythmias is the uncoupling of gap junctions (Groot and Coronel, 2004).  During ischemia 
there is a significant decrease in cellular ATP and oxygen concentrations that is known to be 
associated with inhibition in cardiac gap junction-mediated electrical conduction (Beardslee et 
al., 2000).  Cardiomyocytes express at least three different connexins, namely Cx40, Cx43 and 
Cx45.  Whether this ischemia-induced inhibition of gap junction-mediated electrical conduction 
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is due to the inhibition of all three connexins or one or more connexins is still not clear.  Cx43, 
the major connexin in the heart is known to be inhibited in ischemia (Li and Nagy, 2000).  
Although Cx40 is most abundantly expressed in the atria, its permeability in ischemia is still not 
known. Therefore we have examined the effect of ischemia on Cx40 gap junctions and the 
mechanisms underlying any action of ischemia on Cx40 gap junction permeability. Because 
cardiomyocytes express at least three different connexins, namely Cx40, Cx43 and Cx45, they do 
not provide an optimal system for determining how the functional properties of individual 
cardiac connexins are regulated. Thus, to study the regulation of gap junctions comprised of 
Cx40 alone, studies were conducted using this connexin that was stably transfected in a 
communication-deficient HeLa cell line.  In these cells ischemia was induced chemically by 
inhibiting the electron transport chain with sodium cyanide, and inhibiting glycolysis with 
iodoacetate and 2-deoxyglucose. This study, which is the first to examine the effect of chemical 
ischemia on Cx40 gap junction-mediated cell-to-cell dye transfer, revealed that there was a 
partial inhibition of Cx40 gap junction-mediated cell-to-cell dye transfer after 3 hours of 
chemical ischemia.  This ischemia-mediated inhibition in Cx40-mediated cell-to-cell dye transfer 
appears to be Calmodulin-dependent. 
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Methods 
Materials 
Dulbecco’s Modified Eagles Medium (DMEM), Hank’s balanced salt solution 
with divalent cations (HBSS++), ATP, and all other chemicals were purchased from 
Sigma Chemical Co. (St. Louis, MO). Fetal bovine serum (FBS) was purchased from 
Hyclone (Logan, UT).  G418 (Geneticin) and Hygromycin B were obtained from 
Invitrogen (Carlsbad, CA).  Fura-2 AM, and Alexa Fluor 594 were from Molecular 
Probes (Eugene, OR). Cell Titer-Glo Luminescent Cell Viability Assay kit was from 
Promega (Madison, WI). 
HeLa cell culture 
A single monolayer of untransfected or Cx40-transfected HeLa cells generously 
provided by Dr. Richard Veenstra were grown on 25 mm coverslips in 35 mm culture 
dishes until they reached confluency.  Cells were grown in DMEM supplemented with 
10% v/v fetal bovine serum and Pen-Strep (100 U/ml Penicillin and 0.1 mg/ml 
Streptomycin) with or without 0.025 mg/ml (G418) geneticin, and were kept at 37ºC in a 
5% CO2 atmosphere maintained at nearly 100% relative humidity. 
Normoxia and Chemical ischemia 
Cx40-transfected HeLa cells were subjected to normoxia or chemical ischemia for 
various times at 37ºC (Rodriguez-Sinovas et al., 2006).  Chemical ischemia was induced 
by inhibiting the electron transport chain with NaCN and inhibiting glycolysis with 
iodoacetate and 2-deoxyglucose.  Cells were washed with normoxic buffer [40 NaCl, 3.6 
KCl, 2 CaCl2, 1.2 MgSO4, 20 HEPES, and 5 glucose(in mM), pH 7.4] and then subjected 
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to chemical ischemia in the same buffer lacking glucose and containing  NaCN (2 mM) 
and 2-deoxyglucose (20 mM).   
Intracellular Ca2+ measurements 
Cx40-transfected HeLa cells were loaded with Fura-2-AM (1 mM) in the dark for 
45 min at room temperature. The buffer containing Fura-2 was then removed; the cells 
were rinsed with fresh HBSS++ buffer, then incubated an additional 30 min in 2 ml 
HBSS++ buffer to allow for complete hydrolysis of the intracellularly loaded Fura-2 AM. 
Intracellular Ca2+ was measured ratiometrically (340 nm /380 nm) with Fura-2 
throughout the experiment. Intracellular Ca2+ concentrations were determined as 
described previously by Grynkiewicz et al, 1984. The Ca2+ concentration was calculated 
using the equation:  
 
(R-Rmin) [Ca2+] = Kd  (Rmax-R)(Fmax)
 
Where:    Kd = 0.224 µM [Kd is the Ca2+ dissociation constant of the 
indicator (Grynkiewicz et al., 1985)] 
R    = fluorescence intensity ratio Fλ1/F λ2, in which λ1 (340 nm) and λ2 
(380 nm) are the fluorescence detection wavelengths for the ion-bound and 
ion-free indicator, respectively 
                Rmin = fluorescence intensity ratio at 10 nM Ca2+;  
                Rmax = fluorescence intensity ratio at 39 µM Ca2+;  
                Fmin = fluorescence intensity λ 380 at 10 nM Ca2+;  
                Fmax = fluorescence intensity λ 380 at 39 µM Ca2+; 
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ATP assay 
The amount of ATP in Cx40-transfected HeLa cells treated with normoxic or 
hypoxic buffer was measured using the CellTiter-Glo luminescent cell viability assay 
(Promega, Madison, Wis., USA). This assay quantifies the amount of ATP and is based 
on the luciferase-catalyzed reaction of luciferin and ATP. In particular, mono-
oxygenation of luciferin is catalyzed by luciferase in the presence of Mg2+, ATP, and 
molecular oxygen.  Cx40-transfected HeLa cells were plated at the appropriate density 
(1.25 x 104 cells/well) in an opaque-walled 96-well plate.  Twenty-four hours after 
plating, cells were exposed to either normoxic or hypoxic buffer for various times.  
CellTiter-Glo® Reagent was then added to each well and the contents were mixed for 2 
minutes on an orbital shaker to induce cell lysis. The plates were then allowed to incubate 
at room temperature for 10 minutes to stabilize luminescent signal. The Luminescent 
signal was recorded for 1 second per well using a BMG-Lumistar luminometer.  At least 
four independent experiments were performed for each condition. 
Data analysis 
The data are expressed as Mean ± SEM. In cell-to-cell dye transfer assays, n 
reflects the number of times the experiments were performed. Differences between 
groups were analyzed by ANOVA.  Student’s paired t-test was used to calculate levels of 
significance, with p-value less than 0.05 indicating significance. Statistical significance is 
indicated in the graphs with a ‘*’ for p ≤ 0.05. 
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Results 
 
Chemical ischemia causes a decrease in [ATP]i in Cx40-transfected HeLa cells 
One of the several changes that occur in cardiomyocytes during myocardial 
ischemia is a reduction in intracellularATP concentration ([ATP]i) (Kirkels et al., 1989).  
To determine whether chemical ischemia indeed effected a decrease in [ATP]i, changes 
in [ATP]i were measured at various times during cell cultures maintained in normoxic 
conditions, or following chemical ischemia.  Cx40-transfected HeLa cells were exposed 
to either maintained in normoxic or chemical ischemic buffer for various times, and total 
ATP concentration in the HeLa cells was determined using the CellTiter-Glo luminescent 
cell viability assay kit (Promega, Madison, Wis., USA) as described in Methods.  ATP 
concentration was ~ 2 µM/ 104 cells (n=4) prior to the onset of normoxia and ~ 1.8 µM/ 
104 cells (n=4) 15 min following normoxia.  In contrast [ATP] was ~ 2 µM/ 104 cells 
(n=4) prior to the onset of chemical ischemia and decreased to less than ~ 0.4 µM/ 104 
cells (n=4) within 15 min of chemical ischemia (Fig. 4.1).  Thus, these data indicate that 
chemical ischemia resulted in a rapid decrease in ATP concentration within 15 minutes in 
Cx40-transfected HeLa cells confirming that chemical ischemia induced an inhibition of 
glycolysis and the electron transport chain in these cells, and thus caused a decrease in 
[ATP]i. 
Chemical ischemia causes a decrease in Cx40-mediated cell-to-cell dye transfer 
Ischemia is known to decrease gap junction-mediated electrical (gap junction 
conductance) and biochemical communication (gap junction permeability) in 
cardiomyocytes (Burt, 1987a; White et al., 1990).  Cardiomyocytes express at least 3 
different connexins, namely Cx40, Cx43 and Cx45. To determine whether like Cx43, 
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Cx40-mediated cell-to-cell dye transfer was inhibited by ischemia (Li and Nagy, 2000), 
Cx40-transfected HeLa cells were incubated in either normoxic or ischemic buffer at 
20ºC for various times.  Dye transferred initially to 8.2 ± 0.5 cells (n=7) and to 8.8 ± 0.5 
cells (n=5) 3 hours in normoxic media at 20ºC.  Whereas dye transferred to 8.0 ± 0.4 cells 
(n=5) prior to the onset of chemical ischemia, it transferred to 8.8 ± 0.6 cells (n=9) 3 
hours following chemical ischemia at 20ºC (Fig. 4.5).   Thus, this data suggests that 
chemical ischemia induced at 20ºC did not affect Cx40-mediated cell-to-cell dye transfer 
for up to 3 hours; therefore experiments were performed at 37oC as this more accurately 
reflects the physiologic state of cells in the heart.  When cells were maintained at 37oC 
dye initially transferred to 8.4 ± 0.3 cells (n=9) and to 8.8 ± 0.9 cells (n=6) 3 hours in 
normoxic media at 37oC.  In contrast, whereas dye transferred to 8.0 ± 0.7 cells (n=5) 
prior to the onset of chemical ischemia, it decreased to 5.3 ± 1.5 cells (n=8) 3 hours 
following the onset of chemical ischemia at 37oC (Fig.4.2).  Thus, these data 
demonstrates that chemical ischemia ≥ 3 hours caused ~ 40% inhibition in Cx40-
mediated cell-to-cell dye transfer at 37oC. 
Changes in [Ca2+]i following the onset of chemical ischemia in Cx40-transfected HeLa 
cells 
In the heart, a sustained increase in [Ca2+]i occurs during myocardial ischemia 
where [Ca2+]i increases from ~ 300 nM (resting) to ~ 900 nM (20 min ischemia) in 
perfused rat hearts (Marban et al., 1990). An ischemia-dependent increase in [Ca2+]i is 
known to decrease gap junction-mediated electrical (gap junction conductance) and 
biochemical communication (gap junction permeability) in cardiomyocytes (Burt, 1987a; 
White et al., 1990).  The question addressed here is whether inhibition of Cx40-mediated 
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cell-to-cell dye transfer (Fig.4.2) correlated with ischemia-mediated changes in [Ca2+]i. 
To determine whether [Ca2+]i changed in HeLa cells following the onset of chemical 
ischemia, Cx40-transfected HeLa cells were loaded with Fura-2 and then exposed to 
either normoxic or hypoxic buffer for various times at 37ºC. It was discovered that 
changes in [Ca2+]i could not be measured during chemical ischemia at 37oC due to the 
loss of Fura-2 fluorescence at this elevated temperature (37ºC) as indicated by the 
decrease in absolute fluorescence signals measured at either 340 nm or 380 nm (Fig. 
4.3B).  Therefore it could be speculated that at 37ºC, the loss of Fura-2 fluorescence may 
be due to its release from the cells or that this fluorescent dye is hydrolyzed to a non-
fluorescent product. 
To determine whether inducing chemical ischemia at 20ºC affected Fura-2 
fluorescence, Cx40-transfected HeLa cells were incubated with the Ca2+-sensitive dye 
Fura-2 AM and then exposed to either normoxic or ischemic buffer for various times at 
20ºC.  In contrast to measurements at 37oC, this absolute fura-2 fluorescence signal did 
not significantly decrease at 20oC (Fig. 4.3A).  Thus, ischemia-mediated changes in 
[Ca2+]i were measured using Fura-2 at 20oC as this temperature was used in all previous 
experiments.  To determine whether [Ca2+]i in HeLa cells was modified following 
chemical ischemia at 20ºC, Cx40-transfected HeLa cells were incubated with the Ca2+-
sensitive dye Fura-2 AM and then exposed to either normoxic or hypoxic buffer for 
various times at 20ºC.  [Ca2+]i was initially 0.03 ± 0.002 µM (n=10), and 0.07 ± 0.002 
µM (n=12) at 15 min, 0.10 ± 0.003 µM (n=11) at 30 min, 0.10 ± 0.002 µM (n=10) at 45 
min, 0.13 ± 0.002 µM (n=10) at 1 hour, 0.12 ± 0.001 µM (n=10) 2 hours and 0.11 ± 
0.008 µM (n=7) 3 hours incubation in normoxic buffer at 20ºC.  Thus, there was a 
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modest increase in [Ca2+]i following 3 hours incubation at 20ºC.  In contrast, [Ca2+]i was 
0.03 ± 0.001 µM (n=12) prior to the onset of chemical ischemia, 0.05 ± 0.001 µM (n=15) 
at 15 min, 0.05 ± 0.002 µM (n=11) at 30 min, 0.12 ± 0.006 µM (n=10) at 45 min, 0.26 ± 
0.01 µM (n=10) at 1 hour, 2.0 ± 0.17 µM (n=11) 2 hours and to 1.9 ± 0.08 µM (n=15) 3 
hour following onset of chemical ischemia (Fig. 4.4), indicating that chemical ischemia 
induced a significant increase in [Ca2+]i at 20ºC.     
The chemical ischemia-dependent inhibition of Cx40-mediated cell-to-cell dye transfer 
appears to be Calmodulin-dependent 
Although changes in [Ca2+]i could not be measured using Fura-2 at 37oC, based 
on the data at 20oC there likely was an increase in [Ca2+]i in these HeLa cells at 37oC 
which could have been responsible for the ischemia-mediated decrease in Cx40-mediated 
cell-to-cell dye transfer.  It has been shown in the previous chapter that the Ca2+-
dependent inhibition of Cx40-mediated cell-to-cell dye transfer is Calmodulin-dependent.  
Therefore, to determine whether the ischemia-mediated decrease in Cx40-mediated cell-
to-cell dye transfer was Calmodulin-dependent, Cx40-transfected HeLa cells were pre-
incubated with the Calmodulin inhibitor, calmidazolium prior to incubation in either 
normoxic or chemical ischemic media at 37oC.  Dye transferred initially to 9.6 ± 0.3 cells 
(n=3), and to 8.6 ± 0.3 cells (n=3) after 3 hours following incubation in normoxic media 
(Fig. 4.6A) in agreement with the data in Fig. 4.3.  In contrast, whereas dye transferred to 
9.5 ± 0.6 cells (n=4) prior to the onset of chemical ischemia (Fig. 4.2), it decreased to 4.8 
± 0.3 cells (n=4) 3 hours following chemical ischemia in the absence of calmidazolium 
(Fig. 4.6B) in agreement with the data in Fig. 4.3.  In the presence of the Calmodulin 
inhibitor calmidazolium, dye transferred to 9.3 ± 0.7 cells (n=3) and to 8.5 ± 0.5 cells 
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(n=2) 3 hours following incubation in normoxic buffer plus calmidazolium (Fig. 4.6A), 
indicating no nonspecific action of this inhibitor on gap junctions in normoxic media.  In 
contrast, whereas dye transferred to 8.6 ± 0.7 cells (n=3) prior to the onset of chemical 
ischemia, it transferred to 9.0± 0.4 cells (n=5) 3 hours following chemical ischemia in the 
presence of the Calmodulin inhibitor calmidazolium (Fig. 4.6B).  Thus, pre-treating cells 
with the Calmodulin inhibitor calmidazolium prevented the ischemia-mediated decrease 
in Cx40-mediated cell-to-cell dye transfer indicating that the ischemia-dependent 
decrease in Cx40-mediated cell-to-cell dye transfer at 37oC appears to be Calmodulin-
dependent. 
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Discussion 
 
The present study demonstrates for the first time that chemical ischemia causes a 
partial inhibition of cell-to-cell dye transfer in Cx40-transfected HeLa cells that appears 
to be Calmodulin-dependent.  
During ischemia there is a significant decrease in intracellular ATP concentration 
that is known to be associated with the inhibition of cardiac gap junction-mediated 
electrical conduction (Beardslee et al., 2000).  To confirm that similar changes in 
intracellular ATP levels occurred in HeLa cells, ATP was measured, and was shown to be 
significantly decreased within 15 minutes of the onset of ischemia (Fig. 4.1), indicating 
that the chemical ischemia described here was indeed induced by iodoacetate, cyanide 
and 2-deoxyglucose treatment of HeLa cells.   
In the heart, a sustained increase in [Ca2+]i occurs during myocardial ischemia 
where [Ca2+]i increases from ~ 300 nM (resting) to ~ 900 nM (20 min ischemia) in 
perfused rat hearts (Marban et al., 1990). Burt et al (1987) have demonstrated that 
ischemia caused an increase in [Ca2+]I(Burt, 1987a; White et al., 1990), there also 
observed an ischemia-dependent decrease in gap junction-mediated electrical (gap 
junction conductance) and biochemical communication (gap junction permeability) in 
cardiomyocytes, whether this increase in [Ca2+]i was responsible for the ischemia-
mediated decrease in gap junction is not known.  Since there was an increase in [Ca2+]i 
during ischemia in cardiomyocytes, an increase in [Ca2+]i  was expected in Cx40-
transfected HeLa cells.  However, the chemical ischemia-mediated changes in [Ca2+]i 
could not be measured using Fura-2 (Fig. 4.3B)  at 37oC due to the loss of Fura-2 
fluorescence at this temperature due either to the Fura-2 being released by HeLa cells, or 
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hydrolyzed by the cells thus making it impossible to measure [Ca2+]i using Fura-2 at this 
temperature.   
When chemical ischemia-mediated changes in [Ca2+]i were determined with Fura-
2 at 20ºC, an increase in [Ca2+]i was observed, confirming many other studies (Churchill 
et al., 1996; Yashiro and Duling, 2000)  that the fluorescence intensity of Fura-2 was not 
affected at this temperature (Fig.4.3A).  To determine if this ischemia-mediated change in 
[Ca2+]i correlated with the inhibition of Cx40-mediated cell-to-cell dye transfer, dye 
transfer was measured during normoxia or ischemia for various times at 20ºC.  Inducing 
chemical ischemia at 20ºC did not affect Cx40-mediated cell-to-cell dye transfer even by 
2 or 3 hours by which time [Ca2+]i had increased (Fig. 4.5).  Thus, although chemical 
ischemia effected a significant increase in [Ca2+]i  as early as 2 hours (Fig. 4.4), this 
change in [Ca2+]i did not correlate with decrease in Cx40-mediated cell-to-cell dye 
transfer. 
Rodriguez-Sinovas et al. (2006) have demonstrated an increase in [Ca2+]i in rat 
cardiomyocytes using the same ischemia protocol as used in this study (Rodriguez-
Sinovas et al., 2006), so an increase in [Ca2+]i  was expected in Cx40-transfected HeLa 
cells.  Although changes in [Ca2+]i could not be measured using Fura-2 at 37oC, there was 
an ischemia-dependent increase in [Ca2+]i observed at 20ºC that did not affect Cx40-
mediated cell-to-cell dye transfer.   
It could be speculated that if there is an increase in [Ca2+]i at 37oC which may be 
in part responsible for the chemical ischemia-dependent decrease in Cx40-mediated cell-
to-cell dye transfer at this temperature, it may be Calmodulin-dependent as shown in 
Chapter 3.  To determine if the chemical ischemia dependent decrease in Cx40-mediated 
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cell-to-cell dye transfer was Calmodulin-dependent, cells were pre-incubated with the 
Calmodulin inhibitor calmidazolium and cell-to-cell dye transfer was subsequently 
measured during normoxia or ischemia for various times at 37oC.  The data reported here 
demonstrated that calmidazolium prevented the chemical ischemia-dependent decrease in 
Cx40-mediated cell-to-cell dye transfer at 37oC (Fig. 4.6B), indicating that the ischemia-
mediated decrease in Cx40-mediated cell-to-cell dye transfer at 37oC appears to be 
Calmodulin and therefore likely Ca2+-dependent. 
A possible explanation for this slow onset of gap junction closure at 37oC may be 
that there are confounding changes in intracellular pH ([pH]i) or changes in Cx40 
phosphorylation state.  Although changes in [pH]i were not measured during chemical 
ischemia in this study, it could be speculated that there may be a decrease in [pH]i during 
chemical ischemia.  An increase in [H+]i as occurs during chemical ischemia may 
decrease the Ca2+ sensitivity of proteins due to H+ ions binding to the Ca2+ binding sites 
thus decreasing their affinity for Ca2+ ions.  Thus an increase in [Ca2+]i may not now 
affect Cx40 gap junctions because of its inability to bind to its receptor that our data 
would indicate is likely Calmodulin. 
In Cx40-transfected HeLa cells [Ca2+]i increased within 1 min after ATP addition 
as demonstrated in chapter 2 and within 15 min of chemical ischemia at 20ºC, yet neither 
of these increases in [Ca2+]i were associated with a decrease in Cx40-mediated cell-to-cell 
dye transfer.  That both ATP and chemical ischemia-mediated increase in [Ca2+]I at 20ºC 
did not correlate with a decrease in Cx40-mediated cell-to-cell dye transfer may be due 
the protocol/method used to raise [Ca2+]i.  As described by Dakin et al (2005) and 
discussed in Chapter 3 (Dakin et al., 2005), a sustained elevation in [Ca2+]i using 
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ionomycin increased [Ca2+]i to micromolar levels when the [Ca2+]o was elevated from 1.8 
mM to 21.8 mM.  This increase in [Ca2+]i resulted in > 50% inhibition of Cx40-mediated 
cell-to-cell dye transfer, whereas a transient increase in [Ca2+]i using agonists such as 
ATP also increased [Ca2+]i to micromolar levels but did not affect Cx40-mediated cell-to-
cell dye transfer.  The possible explanation for this is described by the same group (Dakin 
et al., 2005), where  [Ca2+] is likely higher  in the close proximity of gap junctions than in 
the cytoplasm following an influx of Ca2+ from the extracellular space.  When Ca2+ is 
released from intracellular stores, the cytosolic [Ca2+] increases to ≥ 0.5 µM but the 
[Ca2+] in the vicinity of gap junctions may be lower than that reported by Fura-2 for the 
average cytoplasmic [Ca2+] because the distance traveled by Ca2+ from the intracellular 
stores to the plasma membrane is greater than the distance Ca2+ traveled from the 
extracellular space to the vicinity of gap junctions.   
Acute cardiac ischemia is known to be associated with ventricular arrhythmia and 
fibrillation.  One of the major factors responsible for the impaired action potential 
propagation during arrhythmias and fibrillation is uncoupling of gap junctions (Dhein, 
2006).   This gap junction uncoupling is known to lead to predominant transverse 
(myocardial end-to-end) uncoupling. Complete gap junction uncoupling would initiate 
arrhythmia (Kojodjojo et al., 2006), while intermediate uncoupling has been shown to 
enhance the safety factor of propagation, limiting the current loss to non-depolarized 
areas. Therefore, as demonstrated in this study, an ischemia-dependent decrease in Cx40-
mediated cell-to-cell dye transfer would enhance the safety factor of propagation 
therefore preventing the complete block of electrical conduction to the infarct areas of the 
heart. 
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Fig. 4.1: Effect of chemical ischemia on intracellular ATP concentration in Cx40-
transfected HeLa cells.  Cx40-transfected HeLa cells were incubated with either 
normoxic or ischemic buffer (see Methods) for various times at 37oC and [ATP] was 
measured using the CellTiter-Glo luminescent cell viability assay.  The Luminescent 
signal was recorded using a BMG-Lumistar luminometer. * p ≤ 0.05  from [ATP] prior to 
ischemia or maintenance in normoxic buffer. 
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Fig. 4.2: Effect of chemical ischemia on Cx40-mediated cell-to-cell dye transfer at 37oC. 
Cx40-transfected HeLa cells were incubated in either normoxic or chemical ischemic 
buffer for various times at 37oC.  At various times subsequently Alexa Fluor 594 was 
microinjected into one cell and 2 min later the number of cells receiving dye was 
counted. * p ≤ 0.05 from number of cells receiving dye prior to further incubation in 
normoxic or chemical ischemia media. 
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Fig. 4.3: Effect of temperature on Fura-2 fluorescence. Cx40-transfected HeLa cells were 
loaded with Fura-2 AM as described in "Methods".   Cells were then maintained in (A) 
20 oC  or (B) 37oC for various times when the fluorescence at 340 nm and 380 nm was 
captured using the Metafluor software from which the average number of fluorescence 
pixels in each cell was later determined. * p ≤ 0.05 from average number of fluorescence 
pixels in each cell prior to further incubation in normoxic or chemical ischemia media. 
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Figure 4.3 
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Fig. 4.4: Effect of chemical ischemia on [Ca2+]i in Cx40-transfected HeLa cells at 20οC. 
 
Cx40-transfected HeLa cells were incubated with either normoxic or ischemic buffer for 
various times at 20ºC and then intracellular Ca2+ was measured with Fura-2. * p ≤ 0.05 
from [Ca2+]i  prior to further incubation in normoxic or chemical ischemia media. 
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Fig. 4.5: Effect of chemical ischemia on Cx40-mediated cell-to-cell dye transfer at 20ºC. 
x40-transfected HeLa cells were incubated with in either normoxic media or chemical 
ischemic buffer for various times at 20ºC.  At various times subsequently Alexa Fluor 
594 was microinjected into one cell and 2 min later the number of cells receiving dye was 
counted.  
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Figure 4.5 
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Fig. 4.6: Effect of the Calmodulin inhibitor calmidazolium on the chemical ischemia-
dependent decrease in Cx40-mediated cell-to-cell dye transfer at 37oC. Cx40-transfected 
HeLa cells were pre-incubated with calmidazolium (2 µM) before incubation in either 
(A) normoxic media or (B) chemical ischemia.  At various times subsequently , Alexa 
Fluor 594 was microinjected into one cell and 2 min later the number of cells receiving 
dye were counted. * p ≤ 0.05 from number of cells receiving dye at prior to further 
incubation in normoxic or chemical ischemia media. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 190 
 
 
 
 
 
 
 
 
Figure 4.6 
. Normoxia 
 
A
 
Time in hours
0.0 0.5 1.0 1.5 2.0 2.5 3.0 3.5
N
um
be
r o
f c
el
ls
 re
ce
iv
in
g 
dy
e
4
6
8
10
CDZ + Normoxia
Normoxia
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 191 
 
 
 
 
 
 
 
 
Figure 4.6 
. Chemical ischemia 
 
 
 
 
B
 
 
Time in hours
0.0 0.5 1.0 1.5 2.0 2.5 3.0 3.5
N
um
be
r o
f c
el
ls
 re
ce
iv
in
g 
dy
e
4
5
6
7
8
9
10
*
Chemical ischemia
CDZ+ Chemical ischemia11
 
 
 
 
 
 
 
 
 
  
 192 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
CHAPTER 5 
 
 
 
 
 
Regulation of Connexin43 Hemichannels 
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Introduction 
Evidence for the existence of non-junctional gap junction connexon hemichannels 
in the plasma membrane was first provided by electrical studies on horizontal cells of fish 
retina (Malchow, 1993; De Vries, 1992).  Since then, many different connexins have 
been shown to form functional hemichannels ncluding all three of the cardiac connexins, 
Cx40, Cx43 and Cx45 (Beyer et al, 1990; Hagendorff and Plum, 2000; Kondo et al, 
2000; John et al, 1999).   
Hemichannels are half gap junctions, composed of 6 protein subunits called 
connexins.  Like any plasma membrane channel, hemichannels connect the interior of the 
cell to the exterior space.  Each conne embrane domains with the amino- 
and carboxyl-termini in the cytoplasm.  Cardiomyocytes are known to express functional 
hemichannels (Kondo et al., 2000).  Thus, John, Kondo et al. (1999) and Kondo, Wang et 
al (2000) have examine n isolated 
ardiomyocytes demonstrating hemichannel-mediated conductance and calcein dye 
ptake that was increased in the presence of reduced extracellular Ca2+ or metabolic 
hibition in the presence of normal extracellular Ca2+ (John et al., 1999) indicating the 
resence of functional hemichannels in the heart (Kondo et al., 2000).  The presence of 
ndogenous hemichannels in cardiac myocytes may have both physiological and 
athophysiological significance, since their activation during ischemia is known to enable 
 non-selective current to exchange [K+]i for [Na+]o and [Ca2+]o.   
The physiological function of these hemichannels is unclear, although 
emichannel activity has been reported to be gated by [Ca2+]o (Valiunas, 2000; Ebihara, 
993; Pfahnl, 1998), metabolic state (Contreras, 2002; John, 1999), membrane potential 
 i
xin has 4 transm
d the properties of functional hemichannels i
c
u
in
p
e
p
a
h
1
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(Valiunas, 2000; Trexler, 1996; Ebihara, 1993; De Vries, 1992), Protein Kinase C (Li, 
1996), 
 in 
al., 
ne (Cherian et al., 2005), outer hair cell in the cochlea (Zhao 
and Fle
 plasma 
et 
.  
a 
orm 
ns opened 
hemich fer 
, 
and Ca2+ (Quist, 2000).  Many of the properties of these hemichannels are similar 
to those of the corresponding gap junction channels (Francis, 1999; Trexler, 1996). 
Cx43 is ubiquitously expressed through out the body and is the major connexin
the heart.  The existence of functional hemichannels has been demonstrated in a number 
of cell types such as astrocytes (Ye et al., 2003), monocytes, macrophages (Wong et 
2006), osteocytes in the bo
ming, 2005) including cardiomyocytes in the heart (Kondo et al., 2000).  
Hemichannels provide a direct link between the extracellular space and the cytoplasm, 
and have been proposed to open under both physiological and pathophysiological 
conditions allowing movement of molecules, ions, and second messengers (< 1000 Da) 
from the cytoplasm to the extracellular space and vice versa.  Hemichannels have been 
shown to open when [Ca2+]o is reduced to nano molar concentrations, when the
membrane is depolarized (Gomez-Hernandez et al., 2003; Pfahnl et al., 1997; White 
al., 1999), by metabolic inhibition, and by mechanical stimulation (Stout et al., 2002)
Hemichannels have been shown to close in the presence of millimolar [Ca2+]o, by plasm
membrane hyperpolarization (Trexler et al., 1996), by reduced [pH]o (Trexler et al., 
1999) and by gap junction blockers (John et al., 1999).  Cx43 has been shown to f
functional hemichannels when exogenously expressed in HEK293 cells (John et al., 
1999), decreasing [Ca2+]o from 1.8 mM to nanomolar concentratio
annels and made them permeable to large fluorescent dyes such as Luci
Yellow, and were reversibly blocked by halothane and irreversibly blocked by lanthanum
indicating that the dye uptake was through Cx43 hemichannels in Cx43-transfected 
  
 195 
HEK293 cells.  Metabolic inhibition in the presence of [Ca2+]o also opened Cx43 
hemichannels in these Cx43-transfected HEK293 cells (John et al., 1999). 
ATP is released with norepinephrine from sympathetic nerve terminals 
(Burnst
 
d to the 
 
s 
s 
 
43 
ock, 1995), from endothelial cells during vascular injury (Born and Kratzer, 
1984), and from cardiomyocytes during hypoxia (Forrester and Williams, 1977). A close 
association between elevated extracellular ATP concentration and ischemia has also been
reported (Kuzmin et al., 1998). The increased premature ventricular contraction and 
increased frequency of ventricular tachycardias in ischemic rat hearts corresponde
peak levels of interstitial ATP concentration (Kuzmin et al., 1998). Little information is
known about the subcellular ionic changes which accompany purinergic receptor 
activation (caused by ATP) of cardiac myocytes, even under physiological conditions. 
Since cardiomyocytes are known to express Cx43 hemichannels (Kondo et al., 2000) it i
important to understand the effect of agonists such as ATP on Cx43 hemichannels. 
Therefore it was important to understand whether cardiac Cx43 hemichannel activity wa
regulated by agonists such as ATP that are released during cardiovascular ischemia.  To
study the regulation of Cx43 hemichannels alone, studies were conducted using Cx43-
transfected HeLa cells and measuring the uptake of fluorescent dye via functional Cx
hemichannels. 
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Methods 
Materials 
Dulbecco’s Modified Eagles Medium (DMEM), Hank’s balanced salt so
without divalent cations (HBSS--) or with divalent cations (HBSS++), ATP, Staurospo
and Lucifer Yellow were purchased from Sigma Chemical Co. (St. Louis, MO). Fetal 
bovine serum (FBS) was purchased from Hyclone (Logan, UT).  G418 (Geneticin) and 
Hygromycin B were obtained from Invitrogen (Carlsbad, CA). 
HeLa cell culture 
Untransfected or stably Cx43-transfected HeLa cells were grown overnight on 25
mm coverslips in 35 mm culture dishes.  Cells were grown in DMEM supplement
10% v/v fetal bovine serum and Pen-Strep (100 U/ml Penicillin and 0.1 mg/ml 
Streptomycin) with or without 0.4 mg/ml (G418) geneticin, and were kept at 37ºC in a 
5% CO atmosphere maintained with nearly 100% relative humidity. 
Dye Uptake measurements 
Visual method: 
Untransfected wild type and Cx43-transfected HeLa cells were grown on 18 mm
glass coverslips overnight for all hemichannel experiments. Glass coverslips with 
adherent cells w
lution 
rine 
 
ed with 
2 
 
ere transferred to an experimental microincubation chamber and washed 
with bath solution (1.8mM Ca2+ or Ca2+ free HBSS buffer) once.  Cells were then 
incubated in bath solution containing 1.8mM Ca2+ or Ca2+ free HBSS buffer and 1mM 
Lucifer Yellow CH dilithium salt solution for 20 min at 20ºC.  The cells were then 
washed ten times with bath solution containing 1.8 mM Ca2+.  Cells were imaged using 
Nikon Epi-fluorescence microscope and images were captured using the Metafluor 
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software to permit visual determination of the number of Lucifer Yellow positive cells in 
d of cells.  Cells were considered Lucifer Yellow positive when the 
fluores ce 
d: 
m the 
n 
uorescence pixels 
at was cell-free (background)]. 
d Statistical Procedures 
e 
ples 
a given fiel
cence intensity in the cell was greater than that of the the background fluorescen
of neighboring cells that had not taken up dye.  Data is reported as the percentage of cells 
that took up Lucifer Yellow dye relative to the total number of cells in the image.  
Measuring dye uptake by this “visual method” was used as the initial standard assay for 
determining hemichannel activity. 
Quantitative metho
Metafluor software was used to capture images from which the number of Lucifer 
Yellow positive cells was determined in each image. The fluorescence intensity of each 
cell in the field was calculated by subtracting a threshold value (background) fro
mean of the fluorescence intensity of each cell [i.e., the number of fluorescence pixels i
each cell = Mean of the fluorescence pixels in each cell – number of fl
in an identically sized area th
Data Analysis an
Data for each experimental set was pooled, averaged, and expressed as the Mean 
± SE for identical treatments and time points. For each treatment a minimum of fiv
observations were made. Statistical differences were tested for multiple treatments 
against the control using the One-Way ANOVA, and differences between two sam
were conducted using a t-test. Differences were considered significant when p≤0.05. 
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Results 
 
 
To demonstrate that Cx43 was indeed expressed in these cells, Cx43-transfected 
HeLa cells were analyzed by Western Immunoblotting.  Membranes from Cx43-
transfected HeLa cells were isolated, solubilized in SDS, electrophoresed on 10% PAGE
and prepared for Western Immunob
Expression of Cx43 in Cx43-transfected HeLa cells 
 
lotting as described in Methods (Fig. 5.1). A single 
as observed only in Cx43-transfected HeLa cells (Fig. 5.1 lane 1) 
which w
Functional analysis of Cx43 hemichannels in transfected HeLa cells 
 
 of functional Cx43 
treated with reduced extracellular calcium 
([Ca2+]
ere 
5.2B) compared to cells incubated in 1.8 mM [Ca2+]o.  A series of experiments was 
carried out to determine what influenced dye uptake levels.  In this study the effect of 
Lucifer Yellow dye concentration, incubation time and temperature were examined. 
component of 43 kDa w
as absent in untransfected HeLa cells (Fig. 5.1 lane 2), confirming the expression 
of this connexin in Cx43-transfected HeLa cells. 
 
 
Uptake of Lucifer Yellow (LY) dye from the bath solution was used as a measure
of hemichannel functional activity.  To examine the existence
hemichannels, transfected HeLa cells were 
o) (~ 10 nM) by incubation in 1 mM EGTA.  It has been demonstrated previously 
that reduced [Ca2+]o resulted in an increased open probability of Cx43 hemichannels 
(DeVries and Schwartz, 1992).  When non-confluent Cx43-transfected HeLa cells w
incubated in low Ca2+ buffer (HBSS--) [[Ca2+] ~ 10 nM] Lucifer Yellow (1 mM) uptake 
from the bathing solution occurred in a significant percentage of cells (~ 40 %) (Fig. 
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To determine whether dye uptake varied with dye concentration, Cx43-transfected 
HeLa cells were incubated in buffer containing different concentrations of Lucifer 
Yellow (e.g., 0.25, 0.5, 0.75 or 1mM ) for 20 min at 20ºC. The cells were then washed 
with ba  
ffer. 
s 
 0.25 mM LY, 1.46 ± 0.9 % cells took 
up dye in 0.5 mM LY, 3.0 ± 1.9 % cells took up dye in 0.75 mM LY and 1.6 ± 1.1 % 
cells took up dye in 1.0 mM LY (Fig.5.3).  Thus, there was no significant dye uptake 
when c
n 
hen 
th solution containing 1.8 mM Ca2+ fifteen times.  Experiments were performed in
both physiological Ca2+ (1.8 mM) and reduced [Ca2+]o (10 nM) (1 mM EGTA) bu
Reducing the [Ca2+]o from 1.8 mM to ~10 nM Ca2+ resulted in an increased uptake of dye 
such that 6.9 ± 2.8% cells took up dye in the presence of 0.25 mM LY, 25.1 ± 8.4% cell
took up dye in 0.5 mM LY, 39.1 ± 13.7% cells took up dye in 0.75 mM LY, and 44.0 ± 
13.5% cells took up dye in 1.0 mM LY (Fig.5.1).  In contrast, in 1.8 mM [Ca2+]o only 
1.23 ± 1.23 % cells took up dye in the presence of
ells were incubated in varying concentrations of Lucifer Yellow in 1.8 mM 
[Ca2+]o. 
To determine whether Lucifer Yellow dye uptake varied with time of incubatio
with dye, Cx43-transfected HeLa cells were incubated in 1 mM Lucifer Yellow in low 
[Ca2+]o ~10 nM [Ca2+]o buffer for various times at 20˚C. The cells were then washed 
fifteen times with media containing 1.8 mM [Ca2+]o.  The number of cells taking up dye 
increased with time with 8.2 ± 1.38 % cells taking up dye at 5 min, 10.9 ±1.5 % cells 
taking up dye at 10 min, 15.3 ± 4.2 % cells taking up dye at 15 min and 20.8 ± 2.6 % 
cells taking up dye at 20 min (Fig. 5.4).    No significant dye uptake was observed w
cells were incubated with Lucifer Yellow in media containing 1.8 mm [Ca2+]o. 
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To determine whether Lucifer Yellow dye uptake varied with temperature, Cx43-
transfected HeLa cells were incubated at different temperatures in media containing
mM Lucifer Yellow in either ~10 nM or 1.8 mM [Ca2+]o. The cells were then washed 
fifteen times with media containing 1.8 m
 1 
 
, 
.2 
f 
o 
Cx43 h
, 
 
TP 
(Burnstock and Kennedy, 1985).  There is little information about any changes which 
M [Ca2+]o.  The percentage of cells taking up 
dye increased with increasing temperature such that in ~10 nM [Ca2+]o 7.7 ± 1.8 % cells
took up dye at 15oC, 28.9 ± 3.3 % cells at 20oC, 48.3 ± 1.7 % cells at 25oC,  60.7 ± 5.3 % 
cells at 30oC, and 62.6 ± 2.6 % cells took up dye at 35oC (Fig.5.5).  In the presence of 1.8 
mM [Ca2+]o, 3.8 ± 1.5 % cells took up dye at 15oC, 3.6 ± 2.0 % cells took up dye at 20oC
10.7 ± 2.2 % cells took up dye at 25oC,  17.6 ± 4.7 % cells took up dye at 30oC, and 37
± 4.7 % cells took up dye at 35oC indicating Lucifer Yellow dye uptake increased with 
increasing temperature at both ~10 nM and 1.8 mM [Ca2+]o, although the percentage o
cells taking up dye was very much lower when cells were incubated in 1.8 mM [Ca2+]
(Fig. 5.5). 
 
emichannel permeability is inhibited by purinergic receptor activation 
Extracellular ATP levels are known to be elevated during myocardial ischemia 
(Zhang et al, 2001).  Li et al. (1996) and others have shown that like intact gap junctions
connexin hemichannels are also regulated by 2nd messenger-activated protein kinases.  
Given the presence of these several Protein Kinase C (PKC) consensus sequences in 
Cx43 it was important to determine whether agonists that activate PKC are also able to
regulate Cx43 hemichannels.  The heart contains P2X and P2Y purinergic receptors that 
are classified based on the order of agonist potency of structural analogues of A
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accomp
; 
h 
 of cells taking up dye was determined. 19.8 ± 2.0 % cells took up dye in the 
absence of ATP, whereas in the presence of ATP 9.1 ± 0.9 % cells took up dye in 10 nM 
e 
presenc
he 
s 
ed 
 of 
any purinergic receptor activation of cardiomyocytes even under normal 
physiologic conditions. Purinergic receptor activation results in the activation of PKC, 
and  a transient increase in intracellular [Ca2+] in cardiomyocytes (Kusakari et al., 2002
Scamps and Vassort, 1994).  It has been shown previously in this laboratory that 
extracellular addition of ATP resulted in a delayed, transient inhibition of Cx43 gap 
junctions that was Protein Kinase C-dependent.  To determine whether like Cx43 gap 
junctions, Cx43 hemichannels are also regulated following purinergic receptor activation, 
the effect of ATP on Cx43 hemichannel-mediated Lucifer Yellow dye uptake was 
studied.  Cx43-transfected HeLa cells were grown overnight on glass coverslips as 
described in Methods, then incubated with 1 mM Lucifer Yellow in the presence or 
absence of ATP (25 µM) in ~10 nM [Ca2+]o HBSS buffer for 20 min.  Cells were then 
washed with 1.8 mM [Ca2+] HBSS buffer and digitized images were recorded from whic
the number
[Ca2+]o (Fig. 5.6).  Thus, Cx43 hemichannels appear to be partially inhibited in th
e of ATP (25 µM) in ~ 10 nM [Ca2+]o indicating that purinergic receptor 
activation by ATP effected an inhibition of Cx43 hemichannel permeability. 
In the heart, purinergic receptor activation results in the activation of Protein 
Kinase C (Kusakari et al., 2002; Scamps and Vassort, 1994).  To determine whether t
purinergic receptor activation-mediated inhibition in Cx43 hemichannel permeability wa
mediated by the activation of Protein Kinase C, experiments were performed in the 
presence or absence of Protein Kinase C inhibitor, Staurosporin.  Cells were incubat
with the PKC-inhibitor Staurosporin (10 nM) prior to addition of ATP.  In the presence
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1.8 mM [Ca2+]o,  8.1 ± 3.0 % cells took up dye, while in the presence of ~ 10 nM 
28.2 ± 2.9 % cells took up dye.  When cells were incubated with ATP (25 µM) alone in
10 nM [Ca2+]o 11.1 ± 1.5 % cells took up dy
 [Ca2+]o 
 ~ 
 
itor 
low 
43 
7), the 
 
take should 
have be
e 
e, while 27.7 ± 3.1 % cells took up dye when
incubated with Staurosporin only.  When cells were incubated with the PKC-inhib
Staurosporin (10 nM) prior to the addition of ATP 28.6 ± 3.3 % cells took up dye 
indicating that staurosporin appeared to prevent the ATP-mediated inhibition of Cx43 
hemichannel-mediated dye uptake (Fig. 5.7).   Thus, inhibition of Protein Kinase C 
prevented the ATP-mediated inhibition of Cx43 hemichannel-mediated Lucifer Yel
dye uptake, suggesting that purinergic receptor activation mediated inhibition of Cx
hemichannels required the activation of Protein Kinase C. 
Reliability of the Hemichannel dye uptake Assay 
All the above data was collected using the “visual method” as described in 
Methods, since this has been the most commonly used method to analyze hemichannel 
functional activity  along with measuring single channel currents (Alves et al., 1996; 
Kondo et al., 2000).  Subsequent to the completion of the ATP experiments (Fig. 5.
visual method for assaying hemichannel activity did not produce results that were
consistent with our previous data (where Cx43 hemichannel-mediated dye up
en ~ 40% in ~ 10 nM [Ca2+]o and < 2% in 1.8 mM [Ca2+]o), so a quantitative 
method for assaying hemichannel activity was examined.  In this method the fluorescenc
intensity of each cell (i.e., the number of fluorescent pixels in each cell) was calculated 
by subtracting background fluorescence (i.e., the number of fluorescent pixels in an 
identical sized cell-free area) from the mean of the fluorescence intensity of each cell 
(Fluorescence intensity of cell = Mean fluorescence of cell – background fluorescence). 
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The data was then analyzed using different measures of variation or difference from the 
mean values.  The goal was to determine whether it was possible to identify whether a 
defined level of variation could reproducibly demonstrate significant differences in ± 
Ca2+, ± ATP experiments as had been observed using the “visual method” for assaying
hemichannel activity. 
The variations tested statistically were: 
1. Mean value ±  1 Standard deviation 
2. Mean value ± 2 Standard deviations 
3. Mean value  ± 10% of Mean value 
4. Mean value ± 20% of Mean value 
 
on, it 
t 
ce 
els 
5. Mean value ± 30% of Mean value 
Since standard deviation is the most common measure of statistical dispersi
was used to measure the widely spread values in this data set.  Therefore it was importan
to use this alternative threshold levels to measure variation about the mean fluorescen
of each cell. Mean + 10, 20 or 30% of the mean was also used to measure variability 
within this distribution because of the data spread. 
To measure the percentage of cells taking up dye using this quantitative approach 
non-confluent wild type HeLa cells were incubated in either low Ca2+ buffer ([Ca2+]o was 
~ 10 nM) or physiological Ca2+ buffer ([Ca2+]o was 1.8 mM) containing Lucifer Yellow 
(1 mM).  A significant percentage of cells appeared to take up dye from the bathing 
solution in both low and normal Ca2+ buffers when analyzed using the 5 different lev
of variation of the mean (Fig. 5.9A).   
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To measure the percentage of Cx43-transfected HeLa cells taking up dye using 
this quantitative approach, cells were incubated in either low Ca2+ buffer ([Ca2+]o was ~
10 nM) or physiological Ca2+ buffer ([Ca2+]o was 1.8 mM) containing Lucifer Yellow 
mM
 
(1 
e from the bathing solution in both low and normal Ca2+ buffers 
when a  variation of the mean (Fig. 5.9B).  These 
high pe ntag  type and Cx43-transfected HeLa 
cells in  pre ot consistent with our “visual 
method ata o s (Alves et al., 1996; Kondo et al., 
2000). ta an d for both untransfected and Cx43-
transfec ffer demonstrated a high percentage of 
cells ap
).  However, similar to wild type HeLa cells, a significant percentage of cells 
appeared to take up dy
nalyzed using the five different levels of
rce es of cells taking up dye in both wild
 the sence of normal [Ca2+ ]o (1.8 mM) is n
” d r that published by other laboratorie
 Da alyzed using the quantitative metho
ted HeLa cells in low or normal [Ca2+]o bu
peared to take up dye irrespective of the way threshold levels were calculated 
indicating that the dye uptake approach could not be used as a reliable assay for 
measuring Cx43 hemichannel activity. 
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Discus
 
 
d from 
 
 by 
 
 
easing 
 time of incubation of dye (Fig. 5.4) and 
temperature (Fig. 5.5), indicating that hemichannel-mediated dye uptake appeared 
saturable as would be expected to a gap junction mediated process. 
Cx43 is a phospho-protein (Crow et al., 1990) and potential consensus 
phosphorylation sites for Protein Kinase C have been identified.  Since ATP is an 
important potential regulating molecule in the heart, it was important to determine the 
effect of purinergic receptor activation by ATP on Cx43 hemichannel-mediated dye 
uptake.  Extracellular addition of ATP (25 µM) resulted in an apparent ~ 50% decrease in 
dye uptake through Cx43 hemichannels using the “visual method” for assaying dye 
uptake (Fig. 5.6).  Pre-inhibition with Staurosporin to inhibit PKC prevented the ATP-
sion 
Are Cx43 hemichannels regulated by the purinergic receptor agonist ATP? 
Using the “visual method” for analyzing hemichannel-mediated dye uptake, this 
data appeared to demonstrate that ATP, a purinergic receptor agonist that is release
sympathetic nerves during myocardial ischemia (Sesti et al., 2003) and injury, effected a
decrease in the Lucifer Yellow permeability of Cx43 hemichannels. Furthermore, this 
purinergic receptor-mediated inhibition of Cx43 hemichannels appeared to be dependent 
on the activation of Protein Kinase C. 
In this study the presence of functional Cx43 hemichannels were demonstrated
determining the uptake of dye into Cx43-transfected HeLa cells from the medium.  To
optimize experimental conditions dye uptake assays were analyzed with varying dye 
concentrations, time of incubation with the dye, and temperature.  As determined using
the “visual method”, Cx43 hemichannel-mediated dye uptake increased with incr
Lucifer Yellow concentration (Fig. 5.3),
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dependent inhibition of dye uptake by Cx43 hemichannels in Cx43-transfected HeLa 
rgic 
recepto
 
en used previously to analyze hemichannel 
permea
 
 
al 
also provided 
variabl  HeLa 
stent 
at 
 
cells.   This data demonstrates that Cx43 hemichannels are regulated by purine
rs via the activation of Protein Kinase C (Fig.5.7).  This data complements the 
data published by Bao et al (2004) that phosphorylation of the Cx43 hemichannels by 
Protein Kinase C decreases dye coupling in oocytes, and that this appears to be via 
purinergic receptor activation as shown in this study. 
The data collected up to this point was accomplished using the “visual method” as
described in Methods, since this has be
bility. After the ATP ± Staurosporin experiments, the “visual method” for 
assaying hemichannel activity did not produce consistent results as shown previously in
Fig. 3, where < 2% of cells received dye in 1.8 mM [Ca2+]o, whereas now a high 
percentage of cells took up dye in 1.8 mM [Ca2+]o (~ 12.7%) in Cx43-transfected HeLa 
cells (Fig. 5.9), so a quantitative method was developed where the fluorescence intensity
of each cell in the field was calculated by subtracting various threshold values 
(background) from the mean of the fluorescence intensity of each cell.  Like the “visu
method”, quantitative analysis of data with various threshold values 
e results as shown in Fig. 5.9 in both untransfected and Cx43-transfected
cells in both low (~10 nM) and normal (1.8 mM) [Ca2+]o buffer; this was not consi
with the previous data collected in this study and other data published in the literature 
(Alves et al., 1996; Kondo et al., 2000). 
Although dye uptake in the above experiments has been attributed to functional 
hemichannels, it is important to realize that there are other nonjunctional channels th
have permeability properties that are also consistent with the data presented in favor of
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hemichannel involvement, since there was also an apparent significant percentage of d
uptake in connexin-deficient wild type HeLa cells (Fig. 5.9A).  A major limitation i
hemichannel field is the absence of selective hemichannel inhibitors, thereby 
compromising attempts to identify connexin hemichannels  through their blockade.  
There are several reagents that are known to block gap junctions and hemichannels,
including 18 -glycyrrhetinic acid and its derivative ca
ye 
n the 
 
s oocytes (where carboxyfluorescein uptake and enhancement by Protein Kinase
C inhibitors have been reported in the absence of measurable hemichannel currents (Ba
et al., 2004b), lack of opening of Cx43 hemichannels at potentials below 0 mV in HeLa 
 
rbenoxolone, fenamates, certain 
lipophi
milar 
ential
les such as heptanol, octanol and arachidonic acid, and quinine and its derivatives.  
These gap junction blockers are also known to block P2X7-induced dye uptake at si
concentrations (Suadicani et al., 2006) and some are also known to block other pot
hemichannel  flux pathways, suggesting that these gap junction blockers should be used 
along with other channels blockers that mimic hemichannel behavior, further making it 
challenging to unambiguously measure hemichannel function. This ambiguity is due to 
the observations in this study that apparent hemichannel-mediated dye uptake was 
detected in the presence and absence of divalent cations, occurs in cells in the p
absence of connexins as shown in this study, and is blocked by one or more non-specific
gap-junction blockers as shown in several studies in the literature (Contreras et al., 
Contreras et al., 2002; Eskandari et al., 2002; Srinivas et al., 2005a).   
Even though hemichannel currents have been m
resence or 
 
2003; 
 
ession of functional Cx43 hemichannels  in 
Xenopu  
o 
easured successfully in several 
studies, there is still controversy in the literature regarding hemichannel opening under
low [Ca2+]o, for example the lack of expr
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transfectants (Contreras et al., 2003), and by variable activation of Cx43 hemichannels by 
reduced Ca2+ (Contreras et al., 2003). 
One main conclusion that can be deduced from this study is that studyi
hemichannels is technically challenging, due to the lack of specific hemichannel block
and similar channel properties of hemichannels to other channels such as pannexins, 
P2X7, and voltage dependent anion conductance.  Furthermore, it is clear that the use of
dye uptake to measure hemichannels is problematic because of its lack of consistency. 
In contrast to the dye uptake method to measure hemic
ng 
ers 
 
 
hannel function, studies using 
single channel current of connexin hemichannels expressed in oocytes have proved to be a
reliable method to measure hemichannel function in other laboratories and could be used to 
determine the effect of ATP on Cx43 hemichannels in future experiments (Srinivas et al., 
2006; Srinivas et al., 2005b; Tong and Ebihara, 2006; Tong et al., 2004).  
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Fig. 5.1: Expression of Cx43 in HeLa cells transfected with Cx43.  Western Immunoblot 
f Cx43.  Lane 1 contains membrane isolates from Cx43-transfected HeLa cells and lane 
2 contains membrane isolates from untra eLa cells; 50 µg of protein per lane 
as loaded. A 40 kDa band of Cx43 was seen in Cx43-transfected HeLa cells (lanes 1) 
hich was absent in untransfected HeLa cells (lane 2). 
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Figure 5.1 
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Fig. 5.2: ediated dye 
ptake. Cx43 transf r Yellow (1 mM) for 20 
in in ~10 nM Ca2+ buffer. A. Phase contrast view of a typical field of cells B. Lucifer 
ellow fluorescence image showing cells which have taken up dye. 
 Effect of reduced extracellular [Ca2+] on Cx43 hemichannel-m
ected HeLa cells were incubated with Lucifeu
m
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Fig. 5.3: Effect of dye concentration on Cx43 hemichannel-mediated dye uptake.  Cx43-
transfected HeLa cells were incubated  with varying Lucifer Yellow concentrations (0.25, 
0.5, 0.75 and 1.0 mM) in either 1.8 mM (grey bars) or 10 nM (black bars) [Ca2+]o for 20 
min at 20ºC.  Cells were then washed and the number of cells taking up dye determined. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5.3 
 
 
Lucifer Yellow (mM)
Pe
rc
en
ta
ge
 o
f c
el
ls
 re
ce
iv
in
g 
dy
e
0
10
20
30
40
50
60
70
10 nM [Ca2+]o
1.8 mM [Ca2+]o
0.25 0.50 0.75 1.00
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 5.4: Effect of time of incubation with dye on Cx43 hemichannel-mediated dye 
uptake. Cx43-transfected HeLa cells were incubated with Lucifer Yellow (1 mM) in ~10 
nM [Ca2+]o for various times at 20oC; cells were then washed and the number of cells 
taking up dye determined. 
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Fig. 5.5: Effect of temperature on Cx43 hemichannel-mediated dye uptake.  Cx43-
transfected HeLa cells were incubated with Lucifer Yellow (1mM) in either 1.8 mM or 
10 nM [Ca2+]o for 20 min at various temperatures (15, 20, 25, 30, 35˚C).  Cells were then 
washed and the number of cells taking up dye determined. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5.5 
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Fig. 5.6: Effect of ATP on Cx43 hemichannel-mediated dye uptake.  Cx43-transfected 
HeLa cells were incubated with ATP (25 µM) and  Lucifer Yellow (1mM) in the 
presence 1.8 mM [Ca2+]o for 20 min at 20ºC.  Cells were then washed and the number of 
cells taking up dye determined. ** p ≤ 0.05 from number of cells taking up dye in the 
absence of ATP. 
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Fig. 5.7: Effect of a PKC inhibitor on the ATP-dependent inhibition of Cx43 
hemichannels.  Cx43-transfected HeLa cells were pre-incubated with Protein Kinase C 
inhibitor, Staurosporin (10 nM) for 15 min and then incubated with ATP (25 µM) and  
Lucifer Yellow (1mM) in the presence 1.8 mM [Ca2+]o for 20 min at 20ºC.  Cells were 
then washed and the number of cells taking up dye determined. 
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Fig. 5.8: Effect of reduced [Ca2+]o on Cx43 hemichannel-mediated dye uptake. Cx43-
transfected HeLa cells were incubated with Lucifer Yellow (1 mM) for 20 min in ~10 nM 
[Ca2+] buffer. A. Phase contrast view of a typical field of cells B. Lucifer Yellow 
fluorescence image showing cells which have taken up dye.  Data was analyzed using the 
visual method as described in “Methods”. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5.8 
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Fig. 5.9: Effect of reduced extracellular [Ca2+] on hemichannel-mediated dye uptake 
analyzed using the quantitative method. A. untransfected HeLa cells B. Cx43-transfected 
HeLa cells were incubated with Lucifer Yellow (1 mM) for 20 min in either 1.8 mM or 
~10 nM [Ca2+]o  buffer.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5.9 
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B. Cx43-transfected HeLa cells 
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At the onset of this research little was known regarding the regulation of Cx40.  
Thus, the goal was to better understand the regulation of Cx40, an atrial cardiac 
connexin, in both physiological and pathophysiological conditions.  The four main 
conclusions from this research are: (1) β-adrenergic receptor activation increases Cx40-
mediated cell-to-cell dye transfer which requires the activation of PKA; (2) A sustained 
elevation in [Ca2+]i causes a partial inhibition of Cx40 gap junction-mediated cell-to-cell 
dye transfer which appeared to be Calmodulin-dependent; (3) Chemical ischemia causes 
  partial inhibition of Cx40 gap junction-mediated cell-to-cell dye transfer which 
appeared to be Calmodulin-dependent; (4) Dye uptake assays are an unreliable method 
for measuring gap junction hemichannel function. 
The first objective of this thesis was to determine whether Cx40 gap junctions 
ere regulated by β-adrenergic receptor activation and the pathway/s involved in the β-
drenergic receptor signaling.  Previous investigators have shown that the cell permeant 
AMP analog, 8-bromo cAMP effected an increase in cell-to-cell dye transfer in Cx40-
ansfected SkHep cells (Van-Rijen et al., 2000), but the pathway by which this cAMP 
nalog effected this activation of Cx40 gap junctions was not determined.  This was 
accomp shed by activating several steps in the β-adrenergic receptor signaling pathway 
and then Cx40 gap junction permeability was determined by measuring the cell-to-cell 
transfer of Alexa Fluor 594 dye.  The data reported here has demonstrated for the first 
time that a β-adrenergic receptor-mediated increase in Cx40-mediated cell-to-cell dye 
transfer occurred via the adenylate cyclase/cAMP/PKA signaling pathway. It was further 
demonstrated that the β-2 receptor subtype was functionally responsible for the β-
a
w
a
c
tr
a
li
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adrener
d 
ation 
g 
te site for Protein Kinase A was 
identifi
 
he 
rane 
slowly depolarizes following termination of an action potential, until threshold for a new 
gic receptor-dependent increase in Cx40-mediated cell-to-cell dye transfer in 
Cx40-transfected HeLa cells. 
In this study it has been demonstrated that the β-adrenergic receptor-mediate
increase in Cx40-mediated cell-to-cell dye transfer is affected by the adenylate 
cyclase/cAMP/PKA signaling pathway.  Further insight into the regulation of Cx40 by 
PKA-dependent β-adrenergic receptor activation, could be derived by identifying the 
Cx40 amino acid substrate responsible for the β-adrenergic receptor-mediated increase in 
Cx40-mediated cell-to-cell dye transfer.  When the potential consensus phosphoryl
sites for protein kinases in Cx40 were determined by analysis of the Cx40 sequence usin
the Expasy Prosite-Scan database, only one substra
ed at amino acid 343.  To determine if this residue is indeed critical for Cx40 
regulation by β-adrenergic receptor activation, a Cx40 mutant could be developed in 
which this candidate serine 343 residue for the Protein Kinase A pathway is mutated to 
alanine residue.  This construct could then be transfected into communication-deficient 
HeLa cells that are treated with β-adrenergic receptor agonists to determine if this residue 
is indeed critical for this regulation of Cx40. 
In the heart, the action potential is generated in the sino-atrial node (SA node) and
it is regulated by the modulation of various ion channels in the cardiac membrane 
(DiFrancesco, 1993).  The mechanisms responsible for action potential propagation in t
SA node are the delayed rectifier current IK, the L-type calcium currents ICa, and the 
hyperpolarization-activated cation channel If.  The spontaneous activity of the pacemaker 
cells of the SA node results from slow diastolic depolarization.  The cardiac memb
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action potential is reached.  Thus, the diastolic depolarization is responsible for initiat
rhythmic behavior and charact
ing 
erizes action potentials of SA node and other 
spontan a 
  During 
e 
rents 
f 
the firing rate of action potential initiation in 
the SA
rom 
ct.  
eously active cardiomyocytes.  This diastolic depolarization is associated with 
decaying K+ current due to decreased K+ permeability (Noble and Tsien, 1968).
this phase there is a slow increase in [Na+]i and [Ca2+]i.  This depolarization is mainly du
to the slow influx of Ca2+ by the L-type Ca2+ channels which open when threshold is 
achieved (between -40mV and -50mV) (Noma et al., 1980).  These L-type Ca2+ channels 
close soon after they open thus decreasing [Ca2+]i, during this phase there is also a 
decrease in [Na+]i, thus increasing the influx of K+ which repolarizes the cell. 
Beta-adrenergic stimulation is known to have several actions on the ionic cur
in the generation of electrical activity of SA node cells. β-adrenergic stimulation is 
known to increase IK resulting in rate dependent shortening of action potentials and 
increase in the amplitude of the [Ca2+]i transient  thus increasing heart rate.  Activation o
β-adrenergic receptors regulates the activity of ion channel proteins via a cAMP-
dependent Protein Kinase A (PKA) or by direct binding of cAMP to channel subunits. 
Thus beta-adrenergic stimulation increases 
.  Since Cx40 gap junctions are present in the AV node, AV bundle branches, atria, 
Purkinje fibers and low levels in the ventricles.  This action potential propagation f
the SA node to the AV node, atria and ventricles by Cx40 gap junctions by β-adrenergic 
agonists would increase electrical conduction thus having a positive dromotropic effe
The ability of β-adrenergic agonists to increase Cx40 conduction provides a mechanistic 
explanation for this beta-adrenergic stimulation-mediated increase in heart rate.  
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The second objective of this thesis was to examine the effect of [Ca2+]i on Cx40 
gap junctions and the mechanisms underlying any action of [Ca2+]i on Cx40 
permeability.  This was achieved by elevating [Ca2+]i in Cx40-transfected HeLa cells by 
adding ionomycin to permeabilze the plasma membrane  to Ca2+, and then elevating 
[Ca2+]o from 1.8 to 21.8 mM by adding CaCl2 to the bathing buffer which elevated [Ca2+]i 
from nano molar to micro molar.  The data reported here demonstrated for the first tim
that a sustained elevation in [Ca2+]i, caused a partial inhibition of Cx40-mediated cell-to-
cell dye transfer which appeared to be Calmodulin-dependent. 
To obtain more insight into the regulation of Cx40 by [Ca2+]i,  the Cx40
gap junction 
e 
 region 
respons
x40-
tor of 
 to 
 
 
x40 
mutant could be developed in which this Calmodulin binding site is either deleted or 
ible for the elevated [Ca2+]i-mediated decrease in Cx40-mediated cell-to-cell dye 
transfer could be identified. This increase in [Ca2+]i resulted in > 50% inhibition of C
mediated cell-to-cell dye transfer which was prevented by prior addition of an inhibi
the Ca2+ binding protein Calmodulin.  Whether this action of Ca2+ + Calmodulin results 
from the direct interaction of Calmodulin with Cx40 is not known, but it can be 
speculated that like other gap junction proteins [for example Calmodulin directly binds
Cx32 resulting in channel closure (Peracchia et al., 2000)], Calmodulin may bind directly
to Cx40 protein.  When the Cx40 protein sequence was examined using the Calmodulin 
target database for identifying Calmodulin binding sites, there was one site identified in 
the C-terminus just outside the fourth transmembrane domain (Fig. 6.1).  That a 
Calmodulin binding site was identified in the Cx40 C-terminus indicates that Calmodulin
may bind directly to Cx40 thus altering the conformation of the connexin and closing the 
channel.  To determine if this region is critical for Cx40 regulation by [Ca2+]i, a C
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mutated
ding peptide displays 
high af
mically 
d cell-
ce 
d 
 to abolish its high Calmodulin binding affinity.  This construct could then be 
transfected into communication-deficient HeLa cells that can then be exposed to elevated 
[Ca2+]i to determine if this region is critical for this regulation of Cx40 by Ca2+.  An 
alternative method would be by constructing peptides corresponding to the candidate 
Calmodulin-binding region in Cx40.  To determine if this region is critical for this 
regulation of Cx40 by Ca2+, biophysical approaches such as circular dichroism or 
fluorescence spectroscopy could be performed to determine if the peptide binds to 
Calmodulin in a Ca2+-dependent manner.  If this calmodulin bin
finity for Calmodulin in the presence of Ca2+ this would indicate that this 
Calmodulin binding region of Cx40 would be saturated with Calmodulin when [Ca2+]i is 
elevated providing a mechanistic explanation for the ability of Ca2+ to inhibit Cx40 gap 
junctions. 
The third objective of this thesis was to examine the effect of chemical ischemia 
on Cx40 gap junction permeability.  This was achieved by inducing ischemia che
by inhibiting the electron transport chain with sodium cyanide and glycolysis with 2-
deoxyglucose and iodoacetate, when Cx40 gap junction permeability was determined by 
measuring cell-to-cell transfer of Alexa Fluor 594 dye. This study, which is the first to 
examine the effect of chemical ischemia on Cx40 gap junction-mediated cell-to-cell dye 
transfer, revealed that there was a partial inhibition of Cx40 gap junction-mediate
to-cell dye transfer when measured at 37oC.  This ischemia-mediated inhibition in Cx40-
mediated cell-to-cell dye transfer appeared to be Calmodulin-dependent.  Changes in 
[Ca2+]i could not be measured using Fura-2 at 37oC due to the loss of Fura-2 fluorescen
at this temperature due either to the Fura-2 being released by HeLa cells, or hydrolyze
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by the cells thus making it impossible to measure [Ca2+]i using Fura-2 at this temperatu
When chemical ischemia-mediated changes in [Ca2+]i were determined with Fura-2 at 
20ºC, there was an increase in [Ca2+]i, but Cx40-mediated cell-to-cell dye
re.  
 was 
in 
a 
 such 
Newton 
-
nsfer.  There was an elevation in [Ca2+]i which could be measured at 20ºC 
with Fu  
 transfer
not affected.  Thus, an increase in [Ca2+]i did not appear to correlate with a decrease 
Cx40-mediated cell-to-cell dye transfer at 20oC.   
Several intracellular changes occur during myocardial ischemia including 
reduction in [ATP]i and [Mg2+]i (Kirkels et al., 1989), accumulation of various ions
as [H+]i, [Ca2+]i (Kihara et al., 1989), [Na+]i (Malloy et al., 1990), [K+]o (Wilde and 
Aksnes, 1995), accumulation of fatty acids (Vusse et al., 1994), catecholamines (
et al., 1997) and free radicals (Kukreja and Hess, 1992).  This study has demonstrated 
that chemical ischemia-mediated a slow onset partial inhibition of Cx40-mediated cell-to
cell dye tra
ra-2 but could not be determined at 37oC due to the loss of Fura-2 fluorescence at
this elevated temperature.  This inhibition of Cx40-mediated cell-to-cell dye transfer 
following chemical ischemia at 37oC was prevented by the Calmodulin inhibitor 
calmidazolium, indicating that the ischemia-mediated inhibition in Cx40-mediated cell-
to-cell dye transfer appeared to be Calmodulin-dependent and thus Ca2+-dependent.   
Resolving these contradictory data will be an important future study.  It could be 
that a decrease in [pH]i during ischemia affects the Ca2+ dependency so that at 20oC, 
[Ca2+]i increases but it now cannot inhibit Cx40-mediated cell-to-cell dye transfer as the 
affinity of Cx40 for Calmodulin is altered.  At 37oC the chemical ischemia-dependent 
decrease in Cx40-mediated cell-to-cell dye transfer appeared to be Calmodulin-dependent 
indicating the role of Ca2+.  To determine if Ca2+ plays a role in this chemical ischemia-
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dependent decrease in Cx40-mediated cell-to-cell dye transfer, cells could be loaded with 
the cell permeant Ca2+chelator BAPTA-AM to prevent an increase in [Ca2+]i.  Chemical 
ischemia could then be induced to determine if pre-loading cells with the [Ca2+]i chelato
BAPTA prevented the chemical ische
r 
-
e 
 
ion 
BCECF
 
be 
mia-dependent decrease in Cx40-mediated cell-to
cell dye transfer.  
It would be important to further determine the time point at which [ATP]i 
decreases significantly being so much sooner than the time of onset of an increase in 
[Ca2+]i, and the decrease in gap junction permeability.  However, it would also be 
important to measure other changes such as intracellular pH and how increased this 
affects Cx40 regulation during ischemia.  The chemical ischemia-mediated slow decreas
in gap junction closure at 37oC may be due to a decrease in intracellular pH or changes in 
Cx40 phosphorylation state.  A decrease in intracellular pH as occurs during chemical 
ischemia may decrease the Ca2+ sensitivity of intracellular Ca2+ binding proteins due to 
H+ binding to the Ca2+ binding sites on these proteins thus decreasing their affinity for
Ca2+.  In such circumstances, an increase in [Ca2+]i may not affect Cx40 gap junct
function.  Therefore it would be important to accurately monitor changes in [pH]i 
following chemical ischemia. This could be accomplished by using the pH sensitive dye 
 to measure changes in intracellular pH to determine whether the decrease in Cx40 
gap junction permeability was more closely tied to a decrease in intracellular pH than
changes in [Ca2+]i. 
The chemical ischemia-mediated decrease in gap junction closure at 37oC may 
due to changes in Cx40 phosphorylation states. Therefore it would be important to 
determine whether the level of Cx40 phosphorylation changes following chemical 
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ischemia.  To determine alterations in Cx40 phosphorylation, Western Immunoblot 
analysis could be performed and a phosphorylation-dependent mobility shift assay could 
be used to determine whether chemical ischemia results in changes in Cx40 
phosphorylation. Densitometry could be used to determine the relative amounts of the 
nonphosphorylated and phosphorylated forms of Cx40 following chemical ischemia.  
Should aches 
s 
emia.  
o 
 
3  be 
to 
bjective of this thesis was to examine the effect of agonists such as 
ATP on
sing 
 there be no change in Cx40 mobility in Western blots two alternative appro
could be used.  In the first, Cx40 could be immunoprecipitated from crude membrane
isolated from Cx40 transfected HeLa cells prior to and subsequent to chemical isch
Following SDS-PAGE and Western blotting, any changes in the level of Cx40 
phoshophorylation could be determined by probing the Western blots with phospho-
serine, phospho-threonine or phosphotyrosine antibodies as described by Saleh et al 
(Saleh et al., 2001).    Subsequent incubation with secondary antibodies could be used t
determine the changes in relative levels of phosphate incorporated into Cx40.   In the 
second alternative approach, cells could be metabolically labeled with 1-2 mCi/ml [32P]
PO - in phosphate-free basal minimal medium. A plasma membrane preparation could
subsequently isolated from cells after each treatment and Cx40 could be 
immunoprecipitated from these membranes, fractionated on SDS -PAGE, transferred 
nitrocellulose membranes, and the relative levels of incorporation of 32Pi into the 
connexins evaluated by auto radiography. 
The fourth o
 Cx43 hemichannel function.  This was accomplished by measuring the uptake of 
fluorescent dye via functional Cx43 hemichannels in Cx43-transfected HeLa cells u
the “visual method”.  Cells were considered Lucifer Yellow positive when the 
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fluorescence intensity in the cell was greater than the background fluorescence.  Aft
ATP experiments, the “visual method” did not continue to produce consistent results as 
previously shown in this study and other hemichannel studies in the literature
al., 1996; Kondo et al., 2000), where there should have been minimal dye uptake in the
presence of 1.8 mM [Ca2+]o (< 2%), yet a high percentage of cells took up dye (~ 12.7%
so a quantitative method was developed.  In this, the fluorescence intensity of each cell 
(i.e., the fluorescent pixels in each cell) in the field was calculated by subtracting 
background fluorescence from the mean of the absolute dye fluorescence intensity of 
each cell (Fluorescence intensity of cell = Mean fluorescence of cell – backgrou
fluorescence). The fluorescence intensity increase of a given cell was calculated by 
subtracting the fluorescence intensity of the cell from various alternative threshold le
from the experimental levels.  Five different thresholding criteria were used to either 
narrow or broadened the spread of data and to determine which method would provide
the greatest consistency with data collected previously in our laboratory and with data 
published by other laboratories (Alves et al., 1996; Kondo et al., 2000) using the “visual 
method”.  Analyzing data using the quantitative method for both untransf
transfected HeLa cells in either low or normal [Ca2+]o buffer demonstrated a high 
percentage of cells appeared to take up dye irrespective of the way threshold levels wer
calculated.  No significant difference could
er the 
 (Alves et 
 
),  
nd 
vels 
 
ected and Cx43-
e 
 be determined between the untransfected and 
connex a 
pressed in 
in-transfected HeLa cells and the quantitative data was unable to confirm the dat
collected previously using the “visual method”.  Therefore, these hemichannel 
experiments were terminated because the dye uptake assay is not a reliable measure of 
hemichannel function.  Studies using single channel current of hemichannels ex
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oocytes have proved to be a reliable method to measure hemichannel function in other 
laboratories and would be a more reliable approach for examining the effects of ATP on 
Cx43 hemichannels (Srinivas et al., 2006; Srinivas et al., 2005b; Tong and Ebihara, 2006; 
Tong et al., 2004).  
Taken together, the results reported here demonstrate for the first time that Cx40 but 
not Cx43 gap junctions are regulated by β-adrenergic receptor activation in a PKA-
dependent manner, suggesting differential regulation of these two cardiac connexi
Furthermore, Cx40 gap junctions can be regulated by elevated [Ca2+]i in a Calmodulin-
dependent manner.  Finally chemical ischemia results in a decrease in Cx40-mediated c
cell dye transfer that is Calmodulin-dependent, although the exact role that Ca2+ plays in
inhibition remains to be defined.   
ns.  
ell-to-
 this 
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Fig. 6.1: Cx40 amino acid sequence with the putative transmembrane regions (TM1- 
TM4 highlighted in grey) and the possible C odulin binding region (highlighted in 
ink) in the C-terminus as identified using the Calmodulin target database (Zhou et al., 
006) obtained from Ikura Lab, Ontario Cancer Institute.   
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